Volume 1; Issue 5

European Journal of Cancer Supplements

Volume 1; Issue 5

1

1 The clinicopathological and molecular features of MALT lymphoma

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 140 KB

english, 2003

2

2 Supportive care in cancer — the ultimate challenge in modern multiprofessional oncology

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 140 KB

english, 2003

3

3 Creating the future of radiation oncology

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

4

4 Therapy of acute leukaemia in children — the decisive first 25 years

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

5

5 What is new in breast cancer surgery: a tallored approach

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

6

6 Rna polymerase III transcription and cancer — the opposing effects of RB, p53 and c-Myc

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 216 KB

english, 2003

7

7 Translational research in radiation oncology

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

8

8 Proteomics in translational cancer research

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

9

9 Oesophageal and gastric cancer — classification and surgical consequences

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 328 KB

english, 2003

10

10 Cancer related anemia and its modification

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

11

11 Targeting host-tumour interactions in myeloma therapies

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

12

12 Immunotherapy of cancer - T-cell therapies

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

13

13 The biology of paediatric cancer

K. Pritchard-Jones

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 273 KB

english, 2003

14

14 The status of bone marrow transplant clinical trials

T. Demirer, J. Ledermann, S. Leyvraz, D. Niederwieser, D. Blaise, M. Aglietta, N. Ueno, G. Rosti

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 107 KB

english, 2003

15

15 Monotoring cancer occurrence and outcome in Europe in the 21st century

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 107 KB

english, 2003

16

16 A combined analysis of three European audits of primary breast cancer management

M. Schwenkglenks, M. Constenia, R. Leonard, R. Paridaens, A. Bosly, C. Jackisch, R. Pettengell, T.D. Szucs

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 258 KB

english, 2003

17

17 Can danish breast cancer patients by early diagnosis achieve the same survival as observed in Sweden? A study in screened and non-screened Danish and Swedish populations

A.R. Jensen, J.P. Game, H.H. Storm, M. Ewertz, S. Cold, T. Alvegaard, J. Overgaard

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

18

18 Impact of early start of adjuvant chemotherapy in breast cancer in Denmark

S. Cold, M. Ewertz, A. Knoop, M. Dyring, K. Gunnarsdottir

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

19

19 Fractionation sensitivity of breast cancer. Results of a randomised trial

J.R. Owen, A. Ashton, J. Regan, B. Broad, C. Jackson, J. Homewood, J. Bliss, S.M. Bentzen, J.R. Yarnold

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

20

20 The effect of treatment interruptions in the postoperative irradiation of breast cancer

N.S. Bese, P.A. Sut, A. Ober

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

21

21 Histologic type of local recurrence and prognostic significance in breast conservation vs. mastectomy in invasive breast cancer: A 20-year update of a randomized trial

M. Nielsen, M. Blichert-Toft, S. Møller, M. Overgaard, F. Rank, H.T. Mouridsen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

22

22 Total tumour tissue levels of tissue inhibitor of metalloproteinases-1 as a prognostic marker in breast cancer: an EORTC validation study of 2984 patients

A. Schrohl, M.N. Holten-Andersen, M.P. Look, H.A. Peters, J.G.M. Klijn, N. Brünner, J.A. Foekens

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

23

23 Factors influencing the number of sentinel lymph nodes removed in breast cancer

A. Goyal, R.E. Mansel

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 323 KB

english, 2003

24

24 Cost and economic evaluation of radiotherapy. Activity-based costing and modelling techniques

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 157 KB

english, 2003

25

26 Single nucleotide polymorphisms in candidate genes correlate with clinical normal tissue radiosensitivity

C.N. Andreassen, J. Alsner, M. Overgaard, J. Overgaard

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 182 KB

english, 2003

26

27 Prospective assessment of cd4 and cd8 T-lymphocyte apoptosis in the prediction of radiation-induced late toxicity in 399 individual consenting patients

M. Ozsahin, L. Li, N.E.A. Crompton, Y. Shi, A. Zouhair, P. Coucke, R.O. Mirimanoff, D. Azria

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 182 KB

english, 2003

27

28 Radiotherapy and concomittant mitomycin c(MMC) for locally advanced head and neck cancer. Final report of the IAEA multicentre randomized trial

C. Grau, J.P. Agarwal, K. Jabeen, A.R. Khan, S. Abeyakoon, T. Hadjieva, I. Wahid, S. Turkan, H. Tatsuzaki, J. Overgaard

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 338 KB

english, 2003

28

29 Erythropoletin improves the oxygen carrying capacity of mouse blood without changing hypoxia in a murine tumour model

M.R. Horsman, A. Finch, J. Overgaard

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

29

30 Recurrences after parotid-sparing radiotherapy

B. Bussels, A. Maes, R. Hermans, S. Nuyts, C. Weltens, W. Van den Bogaert

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

30

31 Final results of a randomized fractionation trial on radiotherapy for neuropathic bone pain (Trans-tasman radiation oncology group, TROG 96.05)

D.E. Roos, S. Turner, B. Burmeister, J. Smith, P. Hoskin, N. Spry, P. O'Brien, D. Ball

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

31

32 Radiotherapy for high-grade glioma: Is altered fractionation beneficial?

C. Nieder, N. Andratschke, E. Mergen, A. Grosu, M. Molls

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

32

33 Phase I study of OSI-774 alone or with temozolomide in patients with malignant glioma

M. Prados, S. Chang, E. Burton, I. Parney, A. Kapadia, J. Rabbitt, M. Page, A. Federoff, S. Kelley, G. Fyfe

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

33

34 The TGF-beta2 antisense ollgonucleotide ap 12009 as a therapeutic agent in recurrent high-grade glloma: safety and efficacy results of phase I/II clinical trials

P. Hau, U. Bogdahn, J. Schlaier, M. Mehdorn, G. Wurm, J. Pichier, M. Kunst, M. Goldbrunner, K.H. Schlingensiepen, G. Stauder

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

34

35 Development of glioma-like models in mice and its application in chemotherapy intervention studies

M. Kemper, W. Boogerd, W.P.J. Leenders, B. Kusters, J.H. Beijnen, O. Van Tellingen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 333 KB

english, 2003

35

36 Paclitaxel/Carboplatin(TC) vs Paclitaxel/Carboplatin sequentially followed by Topotecan (TC-Top) in first-line treatment of ovarian cancer Flgo stages IIB – IV interim results of a gynaecologic cancer intergroup phase III trial of the Ago ovarian cancer study group and Gineco

E. Pujade-Lauraine, J. Pfisterer, A. Lortholary, R. Kimmig, B. Weber, A. du Bois, H. Bourgeois, U. Wagner, W. Meier, S. Costa

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

36

37 Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer (AOC): long-term efficacy results

G. Aravantinos, G. Fountzlias, P. Kosmidis, Ma. Dimopoulos, Gp. Stathopoulos, N. Pavildis, D. Bafaloukos, S. Rigatos, S. Karpathios, Dv. Skarlos

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

37

38 Influence of amifostine on neuroprotection in 1st-line treatment of advanced ovarian cancer with carboplatin/taxane-based chemotherapy - a double-blind, placebo-controlled, randomized phase II-study from the AGO Ovarian Cancer Study Group

P. Wimberger, R. Kimmig, F. Hilpert, A. Stähle, A. Burges, O. Tomé, D. Rossner, K. Späthe, V. Heilmann, A. du Bois

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 327 KB

english, 2003

38

39 Topotecan versus treosulfan in recurrent ovarian cancer after initial chemotherapy with platinum and paclitaxel. a prospective randomised phase III study of the AGO ovarian cancer study group

S. Loibl, W. Meier, A. du Bois, W. Kuhn, J. Pfisterer, R. Kimmig, S. Olbricht, B. Richter

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

39

40 Prognostic significance of P53, EGFR and Her-2 expression in borderline and epithelial ovarian cancer

J. Stab Nielsen, E. Jakobsen, B. Hoelund, K. Bertelsen, A. Jakobsen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

40

41 HER2-expression in advanced ovarian cancer: A prognostic and predictive marker? An study of the AGO ovarian study group

H.J. Lück, F. Kommoss, E. Riener, N. Arnold, H.P. Adams, F. Hilpert, A. Du Bois, J. Pfisterer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 323 KB

english, 2003

41

42 Phase I study for treatment of ovarian cancer patients with symptomatic ascites using the trifunctional bispecific antibody removab® (anti-CD3 X anti-EpCAM)

A. Burges, P. Wimberger, V.A. Gorbounova, H. Sommer, B. Schmalfeldt, J. Pfisterer, M. Ströhlein, M.R. Lichinitser, A.N. Makhson, R. Kimmig

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

42

43 Serendipitous findings of occult fallopian tube carcinoma in BRCA 12 germ line mutation carriers at prophylactic surgery

R.I. Olivier, M. van Beurden, M.A.C. Lubsen, M. Rookus, L.J. van't Veer, M.J. van de Vijver

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

43

44 Phase III trial comparing epirubicin, cisplatin and 5-FU (ECF) versus 5FU, etoposide and leucovorin (FELV) in previously untreated patients with advanced biliary cancer

S. Rao, D. Cunningham, R. Hawkins, M.E. Hill, D. Smith, F. Daniel, P.J. Ross, J. Oates, A.R. Norman

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

44

45 Perioperative chemotherapy in operable gastric and lower oesophageal cancer: a randomised, controlled trial of the UK NCRI upper GI clinical studies group (the MAGIC trial, ISRCTN 93793971)

D. Cunningham, W. Allum, S. Weeden

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

45

46 Randomized phase II trial of LV5FU2, LV5FU2-cisplatinum or LV5FU2-irinotecan in patients (pts) with metastatic gastric or cardial adenocarcinoma (MGA): final results of study FFCD 9803

J.L. Raoul, O. Bouché, M. Giovannini, P.L. Etienne, L. Bedenne, G. Lledo, D. Arsene, J.F. Paitel, J.F. Seitz, C. Milan

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

46

47 Gemcitabine versus GEMOX (gemcitabine + oxallplatin) in non resectable pancreatic adenocarcinoma: a GERCOR/GISCAD intergroup phase III

C.H. Louvet, R. Labianca, P. Hammel, G. Lledo, F. de Braud, T. Andre, M. Cantore, M. Ducreux, A. Zaniboni, A. de Gramont

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

47

48 Phase I study of HSPPC-96 (oncophage®) vaccine in patients with completely resected pancreatic adenocarcinoma

R.G. Maki, J.J. Lewis, S. Janetzki, D. Klimstra, D. DeSantis, C. Hirst, A.N. Houghton, P.K. Srivastava, M.F. Brennan

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

48

49 Gemcitabine mediates cell death in human pancreatic cancer by recruitment of CD95 and the mitochondrial apoptosis pathway

B. Schniewind, M. Christgen, S. Haye, H. Ungefroren, H. Kalthoff

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

49

50 Immunotherapeutic application of novel pancreatic cancer-specific tumor marker PaCaAg1

R. Hannan, R. Fischer, Y. Khutoretskaya, A. Jones, S. Bradu, R. Huyhn, H. Von Gyszecki, B. Scharf, M. Pincus, J. Michl

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

50

51 The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer: analysis from a prospective randomised controlled trial

I. Chau, M.J. Allen, D. Cunningham, A.R. Norman, H.E.R. Ford, N. Tebbutt, D. Tait, M. Hill, P.J. Ross, J. Oates

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

51

51A Docetaxel (D), cisplatin (C) 5-fluorouracil (F) compared to cisplatin (C) and 5-fluorouracil (F) for chemotherapy-naive patients with metastatic or locally recurrent, unresectable gastric carcinoma (MGC): Interim results of a randomized phase III trial (V325)

E. Van Cutsem, V. Moiseyenko, S. Tjulandin, M. Fodor, C. Boni, E. Zuber, S. Assadourian

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

52

52 Rapid and durable objective responses in patients with advanced non-small-cell lung cancer in phase II trials (IDEAL 1 and IDEAL 2) treated with gefitinib

U. Gatzemeier, J.Y. Douillard, M. Kris, M. Fukuoka, R. Herbst, J. Schiller, M. Wolf, A. McPartiane, A. Kay, A. Fandi

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

53

53 A phase I study of epidermal growth factor receptor (EGFR) antibody EMD 72000 in combination with paclitaxel (P) in patients (pts) with EGFR-positive advanced non-small cell lung cancer (NSCLC)

C. Bokemeyer, C. Kollmannsberger, M. Schittenhelm, F. Honecker, H.J. Ahrens, J. Tillner, L. Kanz

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 334 KB

english, 2003

54

54 The epidermal growth factor receptor tyrosine kinase inhibitor, eriotinib (Tarceva TM, OSI-774), is an active agent in bronchioloalveolar carcinoma (BAC) and its variants: interim results of a phase II trial

J. Patel, V. Miller, M. Kris, N. Shah, L. Tyson, B. Pizzo, M. Zakowski, M. Cespon, R. Heelan, D. Johnson

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

55

55 Randomized phase II clinical trial of cetuximab in combination with cisplatin (C) and vinorelbine (V) or CV alone in patients with advanced epidermal growth factor receptor (EGFR)-expressing non-small-cell lung cancer (NSCLC)

R. Rosell, R. Ramlau, A. Szczesna, C. Daniel, M. Bertrand, R. Garcia-Arroyo, K. O'Byrne, I. Montaner, M. Mueser, U. Gatzemeier

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

56

56 An epidemiological survey for interstitial lung disease induced by getitinib in patients with advanced non-small cell lung cancer. West Japan thoracic oncology group (WJTOG)

K. Tamura, N. Yamamoto, K. Takeda, M. Ando, T. Seto, M. Endo, K. Kimura, K. Ichikado, T. Johkoh, T. Kato

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 325 KB

english, 2003

57

57 Pemetrexed vs docetaxel: a phase III study in patients with advanced non-small cell lung cancer (NSCLC) who were previously treated with chemotherapy

C. Manegold, R. Gervais, K. Aigner, C. Desch, H. Lim, K. Szondy, C. Bagnes, S. Paul, J. Perez-Gracia, R. Stahel

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

58

58 GLOB 2: a randomised phase III study comparing doublets including navelbineâ (NVB) with either gemcitabine (GEM) or carboplatin (C) in inoperable non-small-cell lung cancer (NSCLC) patients

E.H. Tan, R. Abratt, M. Krzakowski, U. Gatzemeier, K. Mattson, M. Wernil, P. Reiterer, R. Hui, O. Berbetto, P.J. Souquet

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

59

59 Health related quality of life (HRQOL) in randomised controlled trials for non small-cell lung cancer (NSCLC) patients — what is the added clinical value

A. Bottomley, F. Efficace, R. Thomas, V. Vanvoorden, S.H. Ahmedzai

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

60

60 Concurrent targeted and chemotherapy treatments is the best way to go

B. Leyland-Jones

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

61

61 Concurrent targeted and chemotherapy treatments is the best way to go. CONTRA

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

62

62 Who should receive adjuvant treatment?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

63

63 Tailored adjuvant therapies

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

64

64 The prognostic and predictive role of HER-2 and topoisomerase II alpha in breast cancer (BC)

A. Di Leo, D. Larsimont, M.J. Piccart, J. Isola

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 313 KB

english, 2003

65

65 New endocrine agents

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

66

66 Lymphangiogenic growth factors and tumor metastasis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

67

67 Angiogenesis and tumour pathophysiology

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

68

68 Vascular targeting trials

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

69

70 Biology of pancreatic cancer and implications for clinical management

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

70

71 Adjuvant treatment for pancreatic cancer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

71

72 Current status of investigational chemoradiotherapy regimens in pancreatic cancer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

72

73 New paradigms in pancreas cancer management

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 325 KB

english, 2003

73

74 How do we choose new molecular targets for clinical exploitation?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

74

75 p53 signaling and novel mechanisms for targeted radiosensitizers

S. Bodis, M. Pruschy

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

75

76 EGF-receptor inhibition and radiotherapy

M. Baumann, M. Krause, D. Zips, F. Hessel, C. Petersen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

76

77 The PI3K/AKT pathway: a target for new chemo-radiation approaches?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 333 KB

english, 2003

77

78 Modulators of apoptotic signalling

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

78

79 Molecular determinants of glioma biology

V.P. Collins, L.M. Bäcklund, B.R. Nilsson, L. Liu, K. Ichimua

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

79

81 Does radiotherapy matter?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

80

82 Current status of malignant glioma chemotherapy - hype or hope?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 339 KB

english, 2003

81

83 Investigational therapies in glioma — from drugs to biological modifiers and back

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 176 KB

english, 2003

82

84 Epidemiology (including HPV)

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 176 KB

english, 2003

83

85 Surgery for primary and recurrent disease

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 176 KB

english, 2003

84

86 Advances in the treatment of cervical carcinoma: hemoglobin, hypoxia and concurrent chemo-radiotherapy

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

85

87 Chemotherapy and new approaches in cervical cancer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

86

88 Quality control in surgical oncology: breast cancer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

87

89 Rectal cancer surgical quality — the key to effective multimodality treatment

C.J.H. van de Velde, K.C.M.J. Peeters

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 340 KB

english, 2003

88

90 Cancer of the oesophagus and gastro-oesophageal junction

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 175 KB

english, 2003

89

91 Is quality control of radical prostatectomy feasible?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 341 KB

english, 2003

90

92 MLL gene rearranged leukemia: from biology to therapy

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

91

93 Risk adapted treatment for childhood ALL: the BFM experience

M. Schrappe, A. Schrauder, T. Flohr, C.R. Bartram, M. Zimmermann

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

92

94 Prognostic relevance of minimal residual disease in risk stratification of childhood ALL

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

93

95 What is the best treatment for ALL in adolescents and young adults?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 245 KB

english, 2003

94

96 Childhood ALL: from the randomized clinical trials to an evidence-based approach

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 79 KB

english, 2003

95

97 Phase I study of cetuximab (C225)in combination with cisplatin or carboplatin and 5-fluorouracil (5-FU) in patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R&M SCCHN)

J. Bourhis, F. Rivera, R. Mesia, A. Awada, L. Geoffrois, C. Borel, L. Duck, E. Bessa, M. Mueser, N. Amellal

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 154 KB

english, 2003

96

98 Neoadjuvant chemotherapy plus radiotherapy versus radiotherapy alone and the quality of radiation therapy in the treatment of locally advanced nasopharyngeal carcinomas

E. Ciuleanu, N. Todor, T.E. Ciuleanu, N. Ghilezan

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 154 KB

english, 2003

97

99 Experience of the AJCC/UICC 5th edition nasopharyngeal cancer TNM in a single radiotherapy practice outside Southeast Asia

B. O'Sullivan, L. Gitterman, D. Payne, K. Schulze, J. Waldron, J. Kim, A. Bayley, J. Ringash, B. Cummings, P. Groome

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 328 KB

english, 2003

98

100 Radiotherapy for oropharyngeal cancer. Results from 1998 to 2001 with emphasis on the correlation between treatment technique and side effects

K. Jensen, C. Grau

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 178 KB

english, 2003

99

101 Accelerated postoperative radiation therapy with weekly concomitant boost in patients with advanced head and neck cancer

M. Ozsahin, D. Azria, P. Pasche, P. Coucke, R. Stupp, J. Chevalier, R.O. Mirimanoff, A. Zouhair

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 178 KB

english, 2003

100

102 Late normal tissue sequelae and performance status with brachytherapy or surgery in tonsillar fossa and soft palate tumors. Can we be more selective?

P. Levendag, W. Nijdam, I. Noever, C. Braat, M. Pol, P. Schmitz, M. Boer de, P. Jansen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 322 KB

english, 2003

101

103 Comparative study between intravenous and subcutaneous amifostine administered for the prevention of radiation induced toxicities in patients with head and neck cancer

M. Synodinou-Menegaki, D. Antonadou, N. Coliarakis, G. Sarris, M. Paraskevaidis, K. Kyprianou, D. Misailidou, H. Athanassiou, K. Chrysanthou, P. Karageorgis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

102

104 Oral cavity verrucous carcinoma

C. Kang, T. Chang, T. Chen, I. Chen, C. Liao

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

103

105 Glottic cancer and the impact of the duration of symptoms

O. Hansen, K.E. Jorgesen, S. Larsen, L. Bastholt

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

104

106 Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients

J. Akervall, X. Guo, M. Qian, J. Schoumans, J. Yuhas, T. Carey, B. Leeser, C. Bradford, J. Tennvall, B. Teh

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 179 KB

english, 2003

105

107 Phase II continuous 7 days per week irradiation concomitantly with chemotherapy in advanced head and neck tumors treatment

T. Rutkowski, W. Sasiadek, A. Mucha, K. Skladowski, M. Sygula, M. Golen, W. Przeorek, B. Pilecki

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 179 KB

english, 2003

106

108 Stereotactic radiotherapy (SRT) plus external radiotherapy as radical treatment in nasopharyngeal carcinoma (NPC) with first local recurrence (LR), Queen Elizabeth hospital experience

F.Y. Cheung, P.F. so, Y.T. Fu, S. Yau, J. Lam, C. Chan

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 179 KB

english, 2003

107

109 Cisplatin-DNA adduct measurements in head and neck cancer patients treated by chemoradiotherapy

F.J.P. Hoebers, D. Pluim, H. Bartelink, A.J.M. Balm, A.C. Begg, C.R.N. Rasch, J.H.M. Schellens, M. Verheij

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 316 KB

english, 2003

108

110 Cisplatin + vinorelbine in recurrent salivary gland malignancies: final report on 42 cases

M. Airoldi, S. Marchionatti, F. Pedani, C. Bumma

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 141 KB

english, 2003

109

111 Early stage oral cavity squamous cell carcinoma

T.M. Chen, J.T. Chang, I.H. Chen, C.J. Kang, C.T. Liao

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 141 KB

english, 2003

110

112 Head and neck reconstruction in oncology

M. Ribeiro, C. Sanches, D. Cunha, F. Sousa, D. Brito, E. Monteiro, J.L. Pontes

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 306 KB

english, 2003

111

113 Preliminary results of a prospective randomized study of chemoradiation comparing cisplatin vs carboplatin in locally advanced nasopharyngeal cancer

I. Chitapanarux, V. Lorvidhaya, P. Kamnerdsupaphon, Y. Sumitsawan, K. Katanyoo, E. Tharavichitkul, N. Pukanhapan

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

112

114 Prognostic factors in follicular and huerthie cell carcinoma of the thyroid gland — A multivariate survival analysis

N. Besic, J. Zgajnar, D. Bergant, M. Hocevar, F. Pompe, M. Auersperg, S. Grazio-Frkovic

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

113

115 Phase I/II dose escalation study of intensity modulated radiotherapy (IMRT) in cancer of the thyroid, larynx and hypopharynx: report of acute toxicity

M.T. Guerrero Urbano, C. Clark, E. Miles, M. Bidmead, C. Harner, K. Harrington, C. Nutting

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

114

116 Phase II analysis of taxol and capecitabine in the treatment of recurrent or disseminated, squamous cell carcinoma of the head and neck region

J.D. Bentzen, H.S. Hansen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

115

117 Oxaliplatin plus capecitabine in advanced neuroendocrine tumours (NETs): Is the new WHO classification applicable to daily practice?

L. Catena, E. Bajetta, G. Procopio, L. Ferrari, S. Della Torre, E. Verzoni, E. Bichisao, R. Buzzoni, S. Iacobelli, A. Falcone

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

116

118 Conformal radiotherapy for carcinoma of the nasopharynx: pattern of acute and late toxicities

J. Domont, P. Giraud, C. Jaulerry, F. Brunin, M. Jouve, D. Point, T. Jouffroy, V. Mosseri, S. Zefkili, J. Rodriguez

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

117

119 Re-irradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors

D.C. Oksuz, G. Meral, O. Uzel, S. Turkan, P. Cagatay

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 330 KB

english, 2003

118

120 Long time treatment outcome of accelerated hyperfractionated radiotherapy for stage II laryngeal cancer

K. Karasawa, K. Seki, M. Kohno, H. Shinoda, S. Nasu, H. Muramatsu, K. Maebayashi, N. Mitsuhashi

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

119

121 Is the usefulness of routine triple endoscopy for head and neck cancer patients debatable?

X. Pivot, O. Dassonville, E. Guardiola, G. Poissonnet, P.Y. Marcy, M. Schneider, J.v. Vallicioni, J. Otto, E. Francois, F. Demard

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

120

122 Adjuvant chemo-radiotherapy in high risk head and neck elderly cancer patients (pts)

M. Airoldi, S. Marchionatti, G. Cortesina, C. Giordano, F. Pedani, A.M. Gabriele, C. Bumma

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

121

123 Medullary thyroid carcinoma (MTC): genetic screening in Slovenia 1997–2002

D. Bergant, D. Glavac, N. Besic, M. Hocevar

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 329 KB

english, 2003

122

124 High MMP-13 expression levels are associated with increased risk of recurrent tumor in squamous cell cancer of head and neck

M. Luukkaa, P. Vihinen, P. Kronqvist, V.-M. Kähäri, S. Pyrhönen, R. Grenman

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

123

125 Management of the clinically negative neck nodes in early stage mobile tongue carcinoma

S. Córdoba, J. Romero, A. de la Torre, F. Valcárcel, R. Magallón, C.A. Regueiro, M.I. García-Berrocal, I. Zapata, C. de la Fuente, E. Chajón

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

124

126 Comparison between 2D-conventional, 3D-CRT and IMRT techniques for irradiation of parotid gland carcinoma. Clinical experience in IMRT

F. Munoz, B. Balotto, M. Gatti, P. Gabriele

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

125

127 Chemoradiotherapy for stage IV, unmetastatic, head and neck cancer. Preliminary results of a prospective, single-institutional, phase II trial

F. Arias de la Vega, R. Vera, M.A. Dominguez, E. Oria, P. Romero, E. Villafranca, E. Martinez, J.J. Illarramendi, A. Manterola, J.I. Arrarás

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

126

128 Functional analysis of the larynx reconstructed with a vestibular fold flap after cordectomy

R.C. Mamede, H.M.A. Ricz, L.N. Aguiar-Ricz

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

127

129 Induction chemotherapy (CT) followed by hyperfractionated radiation therapy (HFRT) in unresectable squamous cell carcinoma of the head and neck. Experience with an institutional protocol

L. Heras, R. Mesia, M. Majern, R. Galiana, A. Montes, J. Nogues, A. Mari, X. Perez, F. Cardenal, J.R. Germa

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

128

130 Resectable thymoma: treatment outcome and prognostic factors in the late adolescent and adult age group

Y. Eralp, A. Aydiner, A. Kizir, E. Kaytan, E.N. Oral, E. Topuz

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 331 KB

english, 2003

129

131 Cisplatin + irinotecan in recurrent/metastatic salivary gland malignancies

F. Pedani, M. Airoldi, S. Marchionatti, C. Bumma

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

130

132 Effect of radiation therapy fraction size on local control of T1 and T2 glottic carcinoma

E. Nedea, K. Sultanem, T. Vuong, R. Corns, G. Shenouda

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

131

133 Transoral CO2 laser surgery for organ preservation in hypopharynx carcinomas

I. Vilaseca-González, J.J. Grau, J.J. Blanch-Alejandro, M. Moragas-Lluis, M. Bernal-Sprekelsen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

132

134 Squamous cell carcinoma of the soft palate managed with primary radiation therapy: patterns of nodal failure

J. Waldron, L. Gitterman, A. Bayley, B. Cummings, J. Kim, J. Ringash, P. Warde, B. O'Sullivan

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 327 KB

english, 2003

133

135 The effect of STI 571 on deoxycytidine kinase activity in head and neck squamous cell carcinoma in vitro: clinical implications

I. Bruce, T.H. Ward, J.J. Homer, N.J. Slevin

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

134

136 Phase II trial of docetaxel (D) and cisplatin (C) combination in locally advanced undifferentiated carcinoma of nasopharyngeal type (UCNT)

M. Yamouni, Y. Beldjillali, I. Lahfa, K.A. Benhadji, B. Larbaoui, M. Brahimi, M. Ait-Said, L. Djellali, K. Bouzid

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

135

137 Advanced tumors of the skull base. Diagnostic, clinical and therapeutic features

A.M. Mudunov, E.G. Matyakin, O.M. Meluzova

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

136

138 Tumors of maxilla defeating the orbit

U.T. Holtaev, R.I. Azizyan

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 333 KB

english, 2003

137

139 The impact of prognostic factors and treatment on the outcome of anaplastic carcinoma of thyroid

A. Mahmud, J. Tonita, G. Kaban, C. MacDonald, R. Alvi, A. Kirby

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

138

140 Prognostic factors of overall survival for patients with recurrent head and neck cancer: a retrospective study

L. Chaigneau, T. Nguyen, U. Stein, E. Guardiola, A. Danzon, P. Bontemps, X. Pivot

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

139

141 A phase II feasibility study of concurrent radiotherapy and gemcitabine for patients with cancer of the head and neck

J. Van Den Brande, M. Rasschaert, D. Van den Weyngaert, C. Van Laer, J. Dyck, P. Wilmes, B. Pauwels, J.B. Vermorken

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

140

142 Phase II study of imatinib mesylate in salivary gland adenoid cystic carcinoma

E. Winquist, E. Lamont, S. Hotte, M. MacKenzie, S. Brown, A. Murgo, L. Siu

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 333 KB

english, 2003

141

143 Stereotactic irradiation for olfactory neuroblastoma of the sinonasal tract

H. Sato, H. Honjo, J. Ebi, F. Shishido

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

142

144 Low clinical value of squamous cell carcinoma antigen in irradiated patients with advanced head and neck cancer

J. Büntzel, A. Hornig, M. Glatzel, O. Micke, F. Bruns, U. Schäfer, N. Willich

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

143

145 Combination docetaxel, cisplatin, and 5-fluorouracil as induction chemotherapy for locally advanced head and neck cancer

Z. Jian, Y. Qing-Wei, L. Wei-Wei, X. Guang-Po, Z. Zong-Yuan

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

144

146 Capecitabine combined with cisplatin in patients with advanced nasopharyngeal carcinoma (ANPC)

Y. He, Y. Li, Y. Deng, B. Hu, Y. Lin, Z. Lin, Y. Chen, K. Xu, Q. Zhou, Q. Lin

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 313 KB

english, 2003

145

147 Prognostic factors of combined modality treatment in patients with laryngeal cancer basing on modified Peters' scale of risk of recurrence

A. Mucha-Malecka, K. Skladowski, A. Wygoda, W. Sasiadek

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 147 KB

english, 2003

146

148 Prognostic and predictive factors in patients with advanced squamous cell head and neck cancer (HNSCC) treated with induction chemotherapy (CT) and radiotherapy (RT)

A. Mucha-Malecka, S. Korzeniowski, J. Rys

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 147 KB

english, 2003

147

149 Neoadjuvant docetaxel/cisplatin/fluorouracill (TPF) before concurrent chemo-radiotherapy (CT-RT) versus concomitant CT-RT alone in locally advanced squamous cell carcinoma (SCC) of head and neck. A phase II feasibility study

M.G. Ghi, A. Paccagnella, P. D'amanzo, C.A. Mione, S. Fasan, R. Carnuccio, C. Mastromauro, G. Turcato

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 305 KB

english, 2003

148

150 Small cell carcinoma of the head and neck: experience of a single comprehensive cancer centre

R. Dinniwell, J. Ringash, M. Lock, B. O'Sullivan, A. Bayley, B. Cummings, J. Kim, J. Waldron

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

149

151 Long-term outcome of complications after thyroid cancer surgery

A. Czarniecka, E. Paliczka, Z. Puch, B. Jurecka-Lubieniecka, M. Jarzab, M. Mietelka, J. Wloch, B. Maka

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

150

152 Efficacy of I-131 ablation therapy using different doses based on postoperatine thyroid scan uptake in patients with differentiated thyroid cancer

J. Zidan, E. Hefer, A. Kuten, O. Israel

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

151

153 Prognostic significance of telomerase activity in oral squamous cell carcinoma

A.J. Cheng, I. Chen, H. Wang, C. Liao, L. Hsieh, J. Chang

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

152

154 Cysteine proteinase inhibitor cystatin C (CC) in operable squamous cell carcinoma of the head and neck (SCCHN): expression pattern and relation to prognosis

P. Strojan, B. Svetec, L. Smid, J. Kos, J. Kos

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

153

155 Hemoglobin as a factor influencing the outcome in inoperable oropharyngeal carcinoma treated by concomitant radiochemotherapy

I. Oblak, P. Strojan, B. Zakotnik, M. Budihna, L. Smid

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

154

156 Prognostic value of 99Tc-methoxyisobutilisonitrile (MIBI), Kl-67 and p53 in head and neck carcinoma treated with chemo-radiotherapy (CT-RT). Preliminary results

M. Krengli, G. Sacchetti, D. Beldi, L. Turri, G. Valente, E. Prudente, G. Loi, E. Inglese

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 332 KB

english, 2003

155

157 Overall survival advantage for pegylated liposomal doxorubicin compared to topotecan in recurrent epithelial ovarian cancer

A. Gordon, A. Teitelbaum

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

156

158 Phase I dose finding study of capecitabine, cisplatin and radiotherapy in the treatment of locally advanced squamous cervical cancer

R.P. Symonds, S. Chan, T. Habeshaw, N. Reed, L. McMahon, J. Curto

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

157

159 Phase II study of OSI-774 given in combination with carboplatin in patients (pts) with recurrent epithelial ovarian cancer (EOC): NCIC ctg Ind.149

H. Hirte, A. Oza, P. Hoskins, S. Ellard, R. Grimshaw, J. Dubuc-Lissoir, I. Kerr, B. Fisher, L. Seymour

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

158

160 Patterns of relapse influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus

H. Sommer, W. Janni, B. Rack, B. Strobl, D. Rjosk, C. Schindlbeck, W. Thieleke, F. Hepp, S. Braun, K. Friese

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 327 KB

english, 2003

159

161 Radical pelvic radiation for uterine cervix cancer in the elderly

P. Vitek, P. Holeckova, M. Pala, J. Zamecnik, V. Stahalova

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

160

162 Significant impact of integrin beta-3 expression in cervical cancer treated with radiotherapy +/− chemotherapy

G. Gruber, R.H. Greiner, J. Hess, P.W. Stiefel, H.J. Altermatt, V. Djonov

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

161

163 Capecitabine chemoradiation for stage II B- III B cervical cancer: preliminary phase I results, Mexican Oncology Study Group

L. Torrecillas, D. Ballesteros, G. Cervantes, P. Cortes, F. Aldaco, R. Martell, A. Fernandez, B. Ortega, L. Rosas, A. Erazo

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

162

164 Primary therapy of ovarian cancer with paclitaxel/carboplatin/gemcitabine (TCG): a phase II study (ovar-8 protocol)

A.K. Belau, U. Wagner, J. Pfisterer, B. Richter, A. Stähle, C. Jackisch, H.J. Lück, W. Schröder, S. Olbricht, A. du Bois

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 334 KB

english, 2003

163

165 Gemcitabine (G) plus carboplatin (C) in patients whose epithelial ovarian carcinomas (EOC) relapsed ≥ 6 months after platinum-containing first-line therapy: Preliminary results of a phase II study

F. Kose, J. Sufliarsky, S. Beslija, P. Saip, K. Krejcy, T. Minarik, E. Fitzthum, G. Tulunay, A. Melemed

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

164

166 Ct scan-generated small bowel dvh's, and small bowel toxicity profiles, in post-operative gynaecological cancer patients, a prospective study assessing the impact of a bellyboard device

J. Martin, K. Fitzpatrick, R. McCloy, G. Horan, C. Faul

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

165

167 Is 5-year survival rate a real measure of outcome in cervix cancer patients treated by radiotherapy? Long-term results in patients treated with external beam radiation therapy and high dose rate brachytherapy

L. Souhami, R. Corns, M. Duclos, G. Stanimir

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 337 KB

english, 2003

166

168 A phase II study of docetaxel, epirubicin, and cispiatin with G-CSF (ienograstim) support in patients with advanced ovarian cancer

R. Lalisang, F. Erdkamp, J. Wils, J. Vreeswijk, J. Wals, J. Stoot, Y. Groot, J. Smeets, H. van Geuns

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

167

169 Uterine papillary serous and clear cell carcinoma: analysis of the impact of pelvic radiation therapy in early stage disease

B. Kim, R. Vongtama, M. Lee, M. Amneus, C. Walsh, G. Juillard, J. Berek

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

168

170 The necessity of treatment planning and optimisation in each high dose rate brachytherapy fraction using tandem and ovoids

M.G. Dalmaz, A. Toy, N. Tuncel, H. Gulkesen, F. Koseoglu, A.Ü. Kizildag, M. Garipagaoglu

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

169

171 Vaginal cuff irradiation using ovoids: The benefit of treatment planning and dose calculation in each fraction

F. Koseoglu, A.U. Kizildag, N. Tuncel, H. Gulkesen, M.G. Dalmaz, A. Toy, M. Garipagaoglu

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

170

172 Phase I/II study of PLD and carboplatin in patients with advanced gynaecological carcinomas. An interim analysis of the GYN II trial of the AGO ovarian cancer study group

V. Heilmann, A. Burges, M. Gropp, J. Pfisterer, B. Schmalfeldt, B. Richter, Ch. Jackisch, A. Stähle, R. Kimmig, A. du Bois

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

171

173 Clinical significance of E-cadherin, alpha catenin and gamma catenin immunoexpression in epithelial ovarian cancer

C. Faleiro Rodrigues, I. Macedo Pinto, D. Pereira, C. Lopes

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

172

174 A phase II study of capecitabine in patients who have failed first-line treatment for locally advanced or metastatic cervix cancer (MCC)

V. Lorvidhaya, P. Phromratanapongs, I. Chitapanarux, P. Kamnerdsupaphon, P. Lertsanguansinchai, C.Y. Hsieh, Y. Kongthanarat, E. Visetsiri

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 156 KB

english, 2003

173

175 The biological relevance of the E-cadherin/catenin complex in epithelial ovarian tumours

C. Faleiro Rodrigues, I. Macedo Pinto, S. Maia, R. Vieira, C. Lopes

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 156 KB

english, 2003

174

176 Molecular biomarkers in ovarian cancer

Y. Shishkin, E. Stepanova

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 156 KB

english, 2003

175

177 Clinicopathological study of treatment in patients with uterine sarcoma

Y. Terai, S. Takeuchi, T. Kita, J. Kigawa, T. Tabata, T. Ogasawara, M. Sakata, K. Itoh, S. Sagae, T. Sugiyama

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 325 KB

english, 2003

176

178 The impact of spontaneous apoptosis on DNA ploidy, proliferative activity, status of human papillomavirus (HPV) and treatment outcome in cervical carcinoma

S.G. Tang, J.H. Hong, P.K. Tsay, C.S. Tsai, C.H. Lai, T.C. Chang

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

177

179 A phase II second line study of liposomal doxorubicin and carboplatin in patients with recurrent ovarian cancer with a disease free interval equal or greater than 6 months

D.A. Vorobiof, B.L. Rapoport, R. Mahomed, A. Uys, C. Slabber, R. Eek, G. Cohen, A.S. Alberts, J. Raats

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

178

180 Combined radiotherapy with irinotecan (CPT-11), interferon a2b (IFNa2b) and amifostine in patients with locally advanced cervical carcinoma (LACC)

G. Sarris, D. Bafaloukos, N. Koliarakis, Th. Akrivos, H. Athanassiou, M. Synodinou, C. Chrysanthou, C. Beroukas, D. Pektasides, P. Karageorgis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

179

181 A pilot phase II study of cisplatin and capecitabine in patients with recurrent cervical carcinoma

M. Benjapibal, D. Tresukosol, A. Vasuratana, P. Kasemsarn, P. Mekariya, I. Suphanit

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

180

182 The clinical implications of radiotherapy on renal function in patients with hydronephrosis in stage IIIB cancer of the cervix

G. Horan, O. McArdle, J. Martin, C. Faul

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

181

183 Intensity modulated arc therapy and carboplatin/paclitaxel chemotherapy for treatment of high-risk endometrial malignancies

D. D'Souza, E. Wong, J. Chen, T. Coad, G. Rodrigues, M. Lock, G. Bauman

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

182

184 Improved dose distribution for complex radiotherapy of cervical cancer using an innovative brachytherapy technique

J. Hadjiev, G. Antal, F. Prievara, Zs. Antalffy, Cs. Glavak, K. Hideghety, P. Bogner, Cs. Zsolt, R. Imre

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 331 KB

english, 2003

183

185 Early results of a phase II study of oral topotecan and intravenous cisplatin in epithelial ovarian cancer recurring more than 6 months following initial platinum therapy

K. Jasas, M. Trudeau, G. Stuart, B.E. Gillesby, N. Fields, A. Oza

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

184

186 Clinical significance of beta catenin immunoexpression in epithelial ovarian cancer

C. Faleiro Rodrigues, I. Macedo Pinto, D. Pereira, M. Soares, C. Lopes

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

185

187 The role of 3rd therapy in recurrent ovarian carcinoma or primary peritoneal carcinoma

A. Sella, D. Schnider, S. Kovel, E. Shapira, R. Halperin, N. Wallach, A. Fishman

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

186

188 Determining predominating histologic component in malignant mixed mullerian tumors: does it really work?

M. Ozguroglu, A. Bilici, I. Sennur, H. Turna, N. Mandel, S. Serdengecti

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 326 KB

english, 2003

187

189 Evaluation of human papilloma virus infection in cervical cancer and P53 gene mutations

R. Salehi, M. Salehi, P. Shoaie

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

188

190 E-cadherin and beta catenin immunoexpression in primary ovarian carcinomas: an association with clinicopathological features

C. Faleiro Rodrigues, I. Macedo Pinto, D. Pereira, C. Coutinho, C. Lopes

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

189

191 Phase II trial of gemcitabine and capecitabine (GemCap) in patients with advanced biliary cancer

J.J. Knox, D. Hedley, A. Oza, L. Siu, R. Feld, E. Chen, M. Nematollahi, G. Pond, M. Moore

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 313 KB

english, 2003

190

192 Gastrectomy with small intestine reservoir formation

A. Popov, V. Repin, M. Repin, O. Gudkov, V. Cherkasov, U. Zimovina

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 157 KB

english, 2003

191

193 Development of early gastric cancer 4 years after complete remission of Helicobacter pylori-associated gastric low-grade B-cell MALT lymphoma

P. Heras, S. Karagiannis, G. Gagaris

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 157 KB

english, 2003

192

194 In-DOTATOC: An useful diagnostic method for pancreatic tumor

Y. Lin, C. Chen, S. Wang, W. Lin

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 157 KB

english, 2003

193

195 Photodynamic therapy (PDT) of esophageal cancer: 11-years clinical experience

V. Sokolov, E. Filonenko, E. Karpova, A. Marmarova

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 157 KB

english, 2003

194

196 The efficacy, toxicity and pharmacokinetic findings of S-1 in patients (pts) with advanced biliary tract cancer (BTC): a phase II trial

H. Ueno, T. Okusaka, M. Ikeda, Y. Takezako, C. Morizane

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

195

197 Molecular mechanism of down-regulation by CPT-11 of thymidylate synthase highly expressing in gastrointestinal cancer xenografts during combined treatment with oral fluoropyrimidines

M. Fukushima, J. Uchida, T. Takechi, K. Sakamoto, K. Kitazato, T. Taguchi

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

196

198 Combination of docetaxel with 5-fluorouracil and cisplatin in patients with advanced gastric cancer (AGC)

M. Narimanov, I. Bazin, A. Tryakin, D. Titov, S. Tjulandin, A. Garin

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

197

199 Sentinel node biopsy (SNB) for colon cancer: personal experience

C. Codignola, A. Zaniboni, F. Zorzi, V. Prandini, C. Tonti, S. Mutti, V. Postiglione, S. Fiaccavento, G.B. Morandi

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 317 KB

english, 2003

198

200 Efficacy of intraoperative cytological examination

N. Volchenko, Z.D. Gladunova, E.N. Slavnova

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

199

201 Analysis of G/A SNP change at position 2494 in the E-cadherin gene in Italian patients with sporadic, diffuse gastric cancer

A. Ruzzo, F. Graziano, A. Costagliola, E. Testa, F. Andreoni, F. Arduini, A. Antolini, I. Bearzi, A. De Gaetano, M. Magnari

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

200

202 Should gastrectomy be performed for metastatic stomach carcinoma?

V. Skoropad, B. Berdov

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

201

203 Outcome of patients receiving radiation with or without chemotherapy for squamous cell carcinoma of the esophagus

Y. Kagami, A. Imai, Y. Ito, M. Sumi, H. Ikeda

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 324 KB

english, 2003

202

204 Stent placement in malignant superior vena cava syndrome

A. Stamatelopoulos, N. Baltayiannis, D. Magoulas, D. Anagnostopoulos, N. Bolanos, N. Tsirikos, D. Doltsiniadis, V. Siemekis, E. Kayianni, A. Chatzimichalis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

203

205 Weekly gemcitabine with concurrent radiation for unresectable pancreatic cancer

A. Cringeanu, D. Stanculeanu, R. Anghel, L.N. Minea, D. Mitulescu

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

204

206 Fortnightly intravenous irinotecan plus oral capecitabine as treatment for gastroesophageal cancer — a phase 1 and 2 study

D.P. Jackson, D. Smith, C. Topham, D.A. Anthoney, K. Patel, A. Forsyth, F. Halstead, M.T. Seymour

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

205

207 Radiochemotherapy (RCT) of locally advanced oesophageal cancer — preoperative RCT vs. definitive RCT alone

T. Hoelscher, C. Petersen, M. Dawel, C.H. Koehne, D. Ockert, Th. Herrmann, M. Baumann

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 132 KB

english, 2003

206

208 Chemoradiotherapy after surgery for adenocarcinoma of the stomach. Final results of a prospective, phase II, single-institutional program

F. Arias de la Vega, R. Vera, M.A. Dominguez, B. Larrinaga, J.J. Iñigo, P. Romero, P. Villafranca, E. Martínez, J. García-Foncillas, A. Manterola

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 132 KB

english, 2003

207

209 Treatment of pancreatic tumour cells with IC261 and spindle poisons alone or in combination leads to different effects on cell growth

C. Brockschmidt, A. Hillenbrand, M. Stoeter, D. Henne-Bruns, U. Knippschild

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 294 KB

english, 2003

208

210 An analysis of CDH1 −160 C/A promoter polymorphism and the risk of diffuse gastric cancer in Italy

A. Ruzzo, C. Spino, F. Graziano, E. Testa, A. Costagliola, F. Arduini, D. Santini, F. Andreoni, M. Magnani

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

209

211 Intraluminal high dose rate brachytherapy in the treatment of carcinomas of the subhepatic region

J. Dvorak, J. Petera, Z. Papik, T. Kohlova, B. Melichar, Z. Zoul, R. Voboril, J. Mergancova, P. Jandik

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

210

212 Does the temperance prevent metachronous multiple squamous cell carcinoma of the esophagus after endoscopic resection?

Y. Shimizu, H. Tsukagoshi, M. Fujita, M. Hosokawa, M. Kato, M. Asaka

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

211

213 MEN4901/T-0128: a new camptothecin derivative-carboxymethyldextran conjugate with potent anti-tumor activities in a panel of human tumor xenografts in nude mice

F. Fujita, M. Koike, M. Fujita, Y. Sakamoto, S. Okuno, T. Kawaguchi, S. Kudo, M. Kakushima

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

212

214 Safety and efficacy of CPT11/FA/5-FU (ILF) versus ELF in previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction

M. Möhler, J. Siebler, T. Hoehler, J. Janssen, A. Wein, M. Menges, D. Flieger, T. Geer, P.R. Galle, M. Heike

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

213

215 A randomized, multinational phase III study in first line metastatic and locally recurrent gastric cancer (MGC): CPT-11 plus 5-fluorouracil (5-FU)/leucovorin (LV) versus cisplatinum (CDDP) plus 5-FU

M. Dank, J. Zaluski, C. Barone, V. Valvere, S. Yalcin, C. Peschel, E. Goker, M. Wenczl, S. Assadourian, R. Bugat

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

214

216 Postoperative mortality after surgery for gastro-intestinal cancer in octogenarians and nonagenarians

R.A.M. Damhuis, W.S. Meijer, C.J.C. Meurs

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 331 KB

english, 2003

215

217 Increased bone marrow-derived endothelial cells in Barrett's metaplasia

P. Naughton, J. Kelly, C. Condron, S. Tormey, P. Broe, T.N. Walsh, D.J. Bouchier-Hayes

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

216

218 Oxaliplatin plus capecitabine in advanced biliary adenocarcinomas: a multicenter phase II trial

O. Nehls, H. Oettle, J.T. Hartmann, R. Hofheinz, A. Weisser, M. Makowski, D. Arnold, M. Gregor, B. Klump

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

217

219 Outcomes in patients with metastatic colorectal cancer (MCRC) treated with infusional cpt-11/5fu/leucovorin (CFL)under a stringent positive-response dependent protocol: less treatment does not compromise outcome

R. Chan, Y. Fu, G. Au, W. Lau, C. Kwok, C. Yau, K. Chu, J. Ho, J. Sham, D. Choy

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

218

220 Dose escalation with hyperfractionation and concurrent FP chemotherapy in inoperable esophageal cancer

J. Kim, J. Park, E. Choi, S. Ahn, S. Lee, S. Shin, S. Kim, S. Park, H. Song, H. Jung

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

219

221 Modified capecitabine regimen for advanced/metastatic gastric cancer: Final results from a multicenter phase II trial

K. Kondo, K. Chin, J. Sakamoto, H. Kojima, M. Terashima, Y. Yamamura, T. Tsujinaka, I. Hyodo

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

220

222 Gastrazole, a novel CCKB/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials

I. Chau, D. Cunningham, C. Russell, A.R. Norman, P. Harper, P. Harrison, P.J. Ross, R. Hull, M. Walker, J. Black

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

221

223 Clinical results of proton radiation therapy alone for esophageal cancer

S. Sugahara, K. Tokuuye, T. Okumura, A. Nakahara, Y. Saida, K. Kagei, K. Ohara, S. Hata, N. Tanaka, Y. Akine

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 330 KB

english, 2003

222

224 Docetaxel and cisplatin combination chemotherapy in patients with advanced or metastatic gastric cancer: results of a multicentre phase II study

J. Fahlke, K. Ridwelski, E. Kettner, U. Keilholz, C. Schmidt, K. Eichelmann, H. Lippert

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

223

225 Prognostic value of KIT mutation in localized gastrointestinal stromal tumors (GIST)

T.W. Kim, H. Lee, M.H. Ryu, M. Choe, J.S. Kim, H.M. Chang, J.H. Yook, B.S. Kim, J.S. Lee, Y.K. Kang

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

224

226 Size and geometry of radiofrequency lesions: crucial knowledge to prevent local recurrence

S. Mulier, Y. Ni, Y. Miao, A. Rosière, A. Khoury, G. Marchal, L. Michel

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

225

227 Daily stereotactic ultrasound targeting for radiotherapy of upper abdominal malignancies: improvement of target setup

M. Fuss, S.x. Cavanaugh, C. Fuss, B.J. Salter, C.R. Thomas Jr., T.S. Herman

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

226

228 Adjuvant chemo-radiotherapy with 5FU/FA/DDP/paclitaxel in locally advanced gastric cancer (UICC II–IV M0)

W. Budach, T. Hehr, C. Kollmannsberger, C. Bokemeyer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

227

229 Suppression of TGF-beta2 in pancreatic cancer by the antisense oligonucleotide ap 12009: preclinical efficacy data as basis for clinical studies

G. Stauder, P. Jachimczak, R. Schlingensiepen, M. Goldbrunner, K. Graf, M. Kielmanowicz, M. Hafner, M. Szyrach, A. Bischof

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

228

230 Fifteen-month registration of patients with digestive endocrine tumors (DET) in France (FFCD-ANGH-GERCOR study)

C. Lombard-Bohas, D. O'Toole, C. Louvet, G. Cadiot, T. Lecomte, J.F. Seitz, J.L. Legoux, M. Ducreux, J. Taieb, E. Mitry

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

229

231 Prospective randomised trial comparing multimodal therapy with surgery alone for oesophageal adenocarcinoma: a long-term follow-up

P. Naughton, S. Tormey, A. Kelly, P.W.N. Keeling, N. Noonan, T.P. Hennessy, T.N. Walsh

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

230

232 Evaluation of messenger RNA of beta-1,6-N-acetylglucosaminyltransferase V as a molecular marker for micrometastasis in gastrointestinal cancer

M. Valladares-Ayerbes, M. Reboredo, P. Iglesias, I. Brandon, M. Haz, M. Lorenzo, L. Calvo, S. Antolin, G. Alonso, L.M. Anton-Aparicio

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

231

233 Thymidylate synthase is a predictor for response and survival of patients with isolated unresectable liver tumors receiving hepatic artery infusion chemotherapy

A. Hillenbrand, A. Formentini, L. Staib, K. Danenberg, P. Danenberg, M. Kornmann

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

232

234 Immunohistochemical characterization of human hepatocellular carcinomas

P. Nagy, D. Görög, J. Regöly-Mérei

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 314 KB

english, 2003

233

235 The use of a novel chromatographic molecular method for the detection of the membrane cancer antigen Ep-CAM (17-1A) in peripheral blood and bone marrow of patients with metastatic colorectal cancer

I. Skiadas, S. Georgakopoulou, C. Karanikiotes, M. Karina, C. Mitropoulos, I. Roukas, P. Didaggelos, G. Fountzilas, E. Georgakopoulos, E. Prinarakis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

234

Evaluation of tumor board recommendations as the center of gastrointestinal oncology (ZGO) at Tübingen University

C. Burkart, N. Höppel, W. Budach, B. Klump, R. Teichmann, J. Hartmann, P. Pereira, L. Kanz, C. Bokemeyer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

235

237 A phase I study of irinotecan (CPT-11) and capecitabina (XL) as second line treatment in advanced colorectal cancer

P. Garcia-Alfonso, A. Munoz, M. Méndez, S. Garcia-Adrian, P. Lopez-Criado, R. Alvarez, I. Siso, G. Pérez-Manga

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

236

238 Gemcitabine (GEM) as salvage treatment in patients (pts) with advanced colorectal cancer (CRC) progressing after treatment with 5-fluorouracil (FU), irinotecan (lrl) and oxaliplatin (oxa)

C. Aschele, S. Lonardi, S. Garrè, C. Caroti, M. D'Amico, L.M. Pasetto, M. Stefani, P. Pronzato, L. Gallo, S. Monfardini

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

237

239 A phase II trial of oxaliplatin (L-OHP) and UFT/leucovorin (LV) for advanced colorectal cancer (ACC) in elderly patients

G. Rosati, S. Cordio, G. Blanco, R. Bordonaro, G. Reggiardo, L. Manzione

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

238

240 The potential role of TGF-beta-1, TGF-beta -2 and TGF-beta-3 proteins expression in colorectal carcinomas, and their possible correlation with classic histopathologic factors and patients survival

A.C. Tsamandas, V. Zolota, P. Ravazoula, T. Kourelis, C. Kalogeropoulou, I. Tsota, T. Petsas, K. Tepetes, D. Bonikos, D. Kardamakis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

239

241 Phase II study of bl-weekly oxaliplatin, UFT and leucovorin (OXA-UFT-LV) in pretreated metastatic colorectal cancer(MCRC)

E. González-Flores, R. Luque, J. Valdivia, V. Conde, A. Irigoyen, J.R. Delgado, P. Ballesteros, A. Bezares, E. López, J. Belón

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 330 KB

english, 2003

240

242 Phase I study of irinotecan (I), raltitrexed (R), and 5-fluorouracil (5FU) in the treatment of metastatic colorectal cancer (MCRC) refractory to thymidylate synthase inhibitors (TSI)

R. Goel, J. Maroun, C. Cripps, D. Jonker, G. Chiritescu, S. Dahrouge, L. Douglas

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

241

243 Preoperative chemotherapy plus concomitant radiotherapy in rectal cancer patients (pts): updated results of a phase II study

M. Scartozzi, E. Galizia, S. Antognoli, R. Bracci, F. Grillo-Ruggieri, G. Mantello, C. Marmorale, R. Berardi, S. Cascinu, R. Cellerino

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

242

244 The conservative treatment of anal canal carcinoma

N. Raffetto, M. Santarelli, A.M. Ascolese, C. Caruso, A. Papaleo, R. Rossi, V. Tombolini, R. Maurizi Enrici

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

243

245 Three drugs schedulein metastatic colorectal cancer (MCC). A phase II study of sequential Irinotecan (CPT11), oxaliplatin (I-OHP) plus folinic acid (FA) and short fluorouracil (5FU) infusion

V.D. Ferrari, L. Vassalli, G. Rangoni, S. Grisanti, E. Simoncini, V. Amoroso, P. Marpicati, F. Valcamonico, A. Maissouradze, G. Marini

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

244

246 Preliminary data on weekly irinotecan with continuous oral administration of capecitabine in metastatic colorectal cancer

H. Burris, L. Kalman, L. Bertoli, R. Foulke, L. Ratner, L. Schwartzberg, A. Weitberg, J. Lokich

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

245

247 Colorectal cancer screening practice in Greece: rates and missed-events

D. Mauri, V. Lakiotis, G. Christoforidis, K. Kambosioras, I. Karathanassi, K. Moulakakis, P. Kalantidou, A. Gourgoutsi, C. Tolis, A.G. Sofos

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

246

248 Postoperative adjuvant chemotherapy with or without radiotherapy for rectal cancer

K.-R. Park, K.-K. Lee, I.-Y. Kim, K.-Y. Sim, D.-S. Kim, J.-Y. Lee

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

247

249 Continuous infusion of oxaliplatin plus chronomodulated capecitabine in advanced colorectal cancer (CRC): a feasibility study

D. Santini, M. Di Seri, B. Vicenzi, P.P. Petrella, A. La Cesa, R. Rossi, C. Grilli, M.L. Colloca, G. Tonini

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

248

250 Preoperative chemotherapy in combination with intraoperative radiotherapy for T3–4Nx rectal cancer

S. Sadahiro, K. Ishikawa, T. Suzuki, H. Makuuchi, C. Murayama

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

249

251 Down-regulated expression of thymidyalte synthase protein and messenger rna by oxaliplatin in colon cancer cells

K.H. Yeh, S.H. Yeh, J.P. Wan, J.S. Lin, A.L. Cheng

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 319 KB

english, 2003

250

252 Preoperative chemoradiation with oral Tegafur for locally advanced rectal cancer: Intermediate results

F.A. Calvo, J.A. Diaz-Gonzalez, F.J. Serrano, M. Gomez-Espl, M.D. De la Mata, E. Lozano, E. Del Valle, F. Muñoz-Jimenez, R. Herranz

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 152 KB

english, 2003

251

253 The potential roleof erbb-2 and cyclooxygenase-2 expression in human colon carcinoma and risk conditions

A.C. Tsamandas, V. Zolota, P. Ravazoula, T. Kourelis, C. Kalogeropoulou, I. Tsota, P. Petsas, K. Tepetes, D. Bonikos, D. Kardamakis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 152 KB

english, 2003

252

254 Radiotherapy for rectal cancer causes acute and prolonged impairment of cobalamin status

M. Gurren, J. Schneede, K.M. Tveit, P.M. Ueland, S. Dueland

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 152 KB

english, 2003

253

255 Oxaliplatin or irinotecan based chemotherapy for metastic colorectal cancer in the elderly

T. Aparicio, J. Désramé, T. Lecomte, E. Mitry, J. Belloc, I. Etienney, S. Montembault, L. Vayre, C. Loche, J. Eizenfis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

254

256 The carcinoembryonic antigen (CEA)family: gene expression in colorectal tumor samples by real-time quantitative polymerase chain reaction (RT-QPCR)

I. Moreno, M. Monzo, R. Ibeas, R. Artells, F. Martinez, J. Moreno, G. Torres, A. Alcaide, J.M. Vila, J. Pie

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

255

257 The impact of microsatellite instability and its correlation with p53 expression in sporadic colorectal cancer (sCRSC)

S. Meditskou, V. Kotoula, P. Stravoravdi, A. Barich, G. Geromichalos, Th. Toliou, K. Dimitriadis, K. Papadimitriou

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

256

258 Prognostic factors of survival after oxaliplatin therapy in colorectal cancer patients pretreated by irinotecan

B. Melichar, T. Kohlova, P. Vesely

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 331 KB

english, 2003

257

259 Patterns of failure after liver resectionin patients receiving FOLFOX4 for metastatic colorectal cancer (MCRC) limited to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study

S. Alberts, J. Donohue, M. Mahoney, W. Horvath, W. Sternfield, S. Dakhil, R. Levitt, K. Rowland, D. Sargent, R. Goldberg

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

258

260 A phase II study of preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with locally advanced rectal adenocarcinoma: the RadiOxCape study

B. Honhon, L. Duck, B. Coster, J.-C. Coche, J.-L. Canon, P. Scalliet, C. Sempoux, Y. Humblet, A. Kartheuser, J.-P. Machiels

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

259

261 Phase I dose-escalationstudy with Raltitrexed (‘Tomudex’) combined with UFT in metastatic colorectal cancer

J.R. Mel, J.M. Vieitez, P. Garcia-Alfonso, M. Gonzalez-Baron, E. Alvarez, A. Jimenez-Lacave, J. Nuevo, R. Cajal, H. Bovio

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 319 KB

english, 2003

260

262 First line simplified FOLFOXIRI in metastatic colorectal cancer (MCRC) patients (pts): results of a phse II study

G. Masi, G. Allegrini, S. Cupini, L. Marcucci, E. Cerri, I. Brunetti, S. Ricci, E. Baldinacci, M. Andreuccetti, A. Falcone

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 154 KB

english, 2003

261

263 A study of capecitabine in elderly patients as first line treatment in advanced or metastatic colorectal cancer

J. Feliu, P. Escudero, F. Losa, M. Bolaños, J. Vicent, A. Yubero, J. Sanz-Lacalle, R. López, L. López-Gómez, M. González-Barón

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 154 KB

english, 2003

262

264 Optimal dosing schedule for combination therapy with capecitabine and irinotecan in a human colorectal cancer (CRC) xenograft model

M. Y anagisawa, K.F. Ouchi, Y. Tanaka

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 314 KB

english, 2003

263

265 Capecitabine combined with radiothrapy in Chinese patients with advanced or relapsed rectal carcinoma

W. Shen, Y. Liu, X. Ma, J. Ceh, Z. Zeng, Y. Li, G. Li, J. Wang, L. Li, Z. Xiao

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

264

266 E-cadherin expression in commonly downregulated by promoter methylation in colorectal cancer cell lines

Y.Q. Liu, Y. Hong, K.W. Eu, F. Seow-Choen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

265

267 Serum concentrations of MMP-2 and TIMP-1 are of independent prognostic value for cancer specific survival in patients with metastatic colorectal carcinomas under chemotherapy

W.M. Bruecki, A. Wein, C. Petry, C. Koebnick, B. Hanke, V. Bruecki, M. Hautmann, E.G. Hahn, D. Schuppan

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

266

268 A phase II trial of aroplatin (L-NDDP), a liposomal DACH platinum, in patients with metastatic colorectal cancer (CRC) - a preliminary report

T. Dragovich, D. Mendelson, A. Hoos, J. Lewis, S. Kurtin, K. Richardson, D. Von Hoff

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 333 KB

english, 2003

267

269 Predicting response of invasive rectal cancer to brachytherapy by mathematical modeling of p21, bcl-2 and p53 immunohistochemistry

I. Zlobec, T. Vuong, C. Compton, S. Zlobec

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

268

270 A phase II study of oral uracil/ftorafu (UFT) plus leucovorin in combination with mitomycin-C in patients with metastatic colorectal cancer

N. Glydenkerne, B. Glimelius, J.-E. Frödin, M. Kjaer, P. Pfeiffer, F. Hansen, N. Keldsen, E. Sandberg, A. Jakobsen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

269

271 Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advance colorectal cancer

R. James, C. Blanco, C. Farina

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

270

272 A multicenter prospective phase II study of oxaliplatin (OXA), 5-fluorouracil 95FU) and leucovorin (LV) followed, by irininotecan (IRI), 5FU and LV after progression, in patients (pts) with untreated metastatic colorectal carcinoma (MCRC)

C. Almanza, L. De Paz, M. Valladares, M. Jorge, S. Candamio, M. Salgado, C. Castañon, E. Alvarez, C. Romero, F. Vazquez

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

271

273 Site of intracellular expression of beta-catenin influences the outcome in sporadic colorectal cancer

R. Sivakumar, J. Elder, A. Grennhough, J. Lacy-Colson, P.W. Jones, C. Hall, M. Deakin, P.R. Hoban, J.B. Elder

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

272

274 Neoadjuvant treatment of metastatic liver disease with raltitrexed and oxaliplatin in colorectal cancer patients

F.R. Garcia-Arroyo, J.M. Garcia-Bueno, M. Constenia, C. Vadell, P. Palacios, I. Manchengs, A. Fernandez-Renedo, J.M. Campos, A. Galan, J. Belon

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

273

275 Phase 2 study of CT-2103 in patients with colorectal cancer having recurrent disease after treatment with a 4-fluorouracil-containing regimen

C. Redfern, J. Schulz, H. Burriss, M.G. Bolton

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 336 KB

english, 2003

274

276 Promising activity with capecitabine and mitomycin C (MMC) as third line therapy for patients with metastatic colorectal cancer (MCRC) resistant to fluorouracil (5-FU) and irinotecan: results of a phase II study

J.L.B. Dickson, S. Rao, M.E. Hill, T.J. Price, A.R. Norman, J. Oates, D. Cunningham

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

275

277 Combination of irinotecan and capecitabine as first line treatment in advanced colorectal cancer (ACC): results of a phase II multicenter trial

C.J.A. Punt, J.W.R. Nortier, W.W. ten Bokkel Huinink, S. Falk, D.J. Richel, T. Maughan, G. Groenewegen, J.M. Smith, J.M. Bakker, D.W. Rea

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

276

278 Functional status during and after adjuvant therapy for colorectal cancer

J.M. Watters, M.C. Cripps, K. O'Rourke, S.M. Kirkpatrick, J. Maroun, R. Goel, D. Jonker

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

277

279 p53, p21, p27 and bcl-2 as predictors for clinical outcome in rectal cancer

L.C. Lin, W.S. Hwang, P.S. Lee, C.T. Hwang, J. Que, K.L. Lin, F.C. Lin

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

278

280 Survival expression: an independent prognostic factor in rectal cancer patients with and without radiotherapy

A. Knutsen, G. Adell, X.-F. Sun

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

279

281 Quality of life in patients with rectal carcinomas treated by preoperative radiotherapy: a longitudinal prospective study

A.S. Allal, P. Gervaz, Ph. Gertsch, J. Bernier, A.D. Roth, S. Bieri

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

280

282 Preoperative radiochemotherapy with capecitabine in locally advanced rectal cancers — a phase-II-study

J. Dunst, T. Reese, T. Hoelscher, J. Debus, V. Rudat, J. Wulf, A. Hinke

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 330 KB

english, 2003

281

283 Evaluation of thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA levels in colorectal cancer reveals significant correlations to tumor histopathology and disease-free survival in 5-FU treated patients

S. Lassmann, M. Hennig, R. Rosenberg, J. Nährig, J. Schreglmann, F. Krause, M. Poignee, H. Nekarda, H. Höfler, M. Werner

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

282

284 DCC protein expression in colorectal cancer (CRC) metastases and lack of response to biochemically-modulated 5-fluorouracil (FU) among patients (pts) with low level of thymidylate synthase (TS) protein expression

S. Lonardi, S. Casazza, D. Debernardis, S. Garrè, L. Gallo, S. Monfardini, C. Aschele

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

283

285 Capecitabine and mitomycin C (MMC) is an active well-tolerated regimen as first line treatment for metastatic colorectal cancer (MCRC)

S. Rao, D. Cunningham, M.E. Hill, T.J. Price, P. Shellito, N. Tebbutt, A.R. Norman, J. Oates

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

284

286 Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary and sporadic colon cancer tissues

P. Plevova, A. Krepelova, M. Papezova, E. Sedlakova, R. Curik, L. Foretova, J. Novotny, J. Palas, J. Nieslanik, Z. Kolar

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

285

287 Differential expression of CXC chemokine receptor 4 (CXCR4) in colorectal carcinomas

V. Valera, M. Kawahara, Y. Koyama, B. Walter, N. Yokoyama, H. Okamoto, T. Iiai, T. Suda, K. Hatakeyama

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

286

288 Sentinel node technique for colorectal carcinoma: colon vs rectum

A.E. Braat, J.W.A. Oosterhuis, F.C.P. Moll, J.E. de Vries

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

287

289 Phase II study of cetuximab combined with FOLFIRI (bi-weekly irinotecan plus infusional 5-FU and folinic acid (FA) in patients (pts) with metastatic, Epidermal growth factor receptor (EGFR)-expressing colorectal cancer (CRC)

J.L. Raoul, J.L. van Laethem, E. Mitry, C. Brezault, F. Husseini, L. Cals, M. Peeters, J.C. Vedovato, M. Mueser, P. Rougier

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

288

290 Nordic 5-fluorouracil/folinic acid bolus schedule combined with oxaliplatin (FLOX) as first-line treatment to metastatic colorectal cancer

H. Sørbye, B. Glimelius, Å. Berglund, T. Fokstuen, K.M. Tveit, M. Braedengen, D. Øgreid, O. Dahl

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

289

291 Prospective multi-centre audit of acute complications following short course preoperative radiotherapy

A. Hartley, S. Giridharan, B. Vakkalanka, M.S. Anwa, C. McConkey, J.I. Geh, M. Churn, F. Adab, R. Grieve

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

290

292 Tegafox, a new combination of UFT/LV and oxaliplatin as first line treatment for patients (pts) with non resectable metastatic colorectal cancer (CRC): results of a completed multicenter phase II

J. Bennouna, H. Perrier, B. Paillot, J.H. Priou, J.H. Jacob, M. Hebbar, S. Bordenave, J.F. Seitz, D. Tonelli, J.Y. Douillard

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 331 KB

english, 2003

291

293 Raltitrexed (tomudex) combined with UFT: a final results phase II study in patients with advanced colorectal cancer (ACRC)

S. Vazquez, A. Jimenez-Lacabe, G. Perez-Manga, J. Feliu, G. Quintero, J.M. Vieitez, J. Nuevo, H. Bovio, M.L. Garcia-deParedes

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

292

294 Tissue inhibitor of metalloproteinase 3 (TIMP-3) is a new putative target gene in colorectal carcinomas with microsatellite instability (MSI)

W.M. Bruecki, J. Grombach, W. Dietmaier, J. Rueschoff, T. Kirchner, E.G. Hahn, W. Hohenberger, A. Wein, A. Jung

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

293

295 Capecitabine plus irinotecan (CAPIRI) vs capecitabine plus oxaliplatin (CAPOX) as first-line therapy of advanced colorectal cancer (ACRC): updated results of a randomized phase II trial

A. Grothey, K. Jordan, O. Kellner, C. Constantin, G. Dietrich, H. Kroening, L. Mantovani, C. Schlichting, H. Forstbauer, H.J. Schmoll

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 326 KB

english, 2003

294

296 Microarray expression analysis indicates a central role for matrix-metalloproteinases MMP-1, MMP-3, MMP-9 and TIMP-3 in the metastatic process of colorectal carcinomas

W.M. Bruecki, I. Zeittraeger, R.S. Croner, A. Jung, T. Papadopolous, T. Kirchner, E.G. Hahn, W. Hohenberger, A. Wein

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

295

297 Preliminary phase I results of the oral, once-daily anglogenesis inhibitor PTK787/ZK 222584 (PTK/ZK) in combination with chemotherapy for the treatment of metastatic colorectal cancer

T. Trabach, A.L. Thomas, C. Bartel, U. Vanhoefer, W.P. Steward, B. Wiedenmann, M. Kowalski, U. Riedel, D. Reitsma, D. Laurent

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

296

298 Comparison between radiotherapy and neodjuvant chemotherapy and radiotherapy in a population based series of epidermoid and carcinomas

P.J. Nilsson, C. Svensson, S. Goldman, O. Ljungqvist, B. Glimelius

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

297

299 Screening for single nucleotide polymorphism (snp) in association with sporadic colorectal cancer

N. Tørring, K. Bihl, T. Ørntoft

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 322 KB

english, 2003

298

300 Effects of capecitabine (Xeloda) on quality of life (QoL) in patients with metastatic colorectal cancer (MCRC)

C.A. Beato, M.H. Federico, S. Cabral, R.C. Duarte, B. Van Eyll, M.P. Carvalho, S. Lago, E. Medeiros, M. Perdicaris, D. Machado

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

299

301 Peritoneal carcinomatosis of colorectal origin: results of palliative surgery and systemic chemotherapy

V. Verwaal, H. Boot, F.A.N. Zoetmulder

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

300

302 Equal prognosis of elderly and non-elderly patients with metastatic colorectal cancer and 5-FU treatment: a retrospective analysis

G. Folprecht, W. Scheithauer, D. Cunningham, F. Di Costanzo, B. Glimellus, E. Aranda, P. Rougier, M. Palmer, J. Wils, C. Köhne

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 335 KB

english, 2003

301

303 Capecitabine plus oxaliplatin (XELOX): findings from a human colon cancer xenograft model and a phase II clinical trial in patients with metastatic colorectal cancer (MCRC)

N. Sawada, Y. Tanaka, C. Twelves, J. Tabernero, E. Diaz-Rubio, E. Van Cutsem

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 178 KB

english, 2003

302

304 Capecitabine plus irinotecan (XELIRI) in first line metastatic colorectal cancer (MCRC): update on a phase II trial

Y.Z. Patt, J. Leibmann, D. Diamandidis, S.G. Eckhardt, M. Javie, G.R. Justice, W. Keiser, F.-C. Lee, W. Miller, E. Lin

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 178 KB

english, 2003

303

305 Twelve weeks of neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation (CRT) and total mesorectal excision (TME) in MRI defined poor risk locally advanced rectal cancer resulted in promising tumour regression and rapid symptomatic relief

I. Chau, D. Cunningham, D. Tait, G. Brown, N. Tebbutt, M. Hill, A. Wotherspoon, A.R. Norman, A. Massey, J. Oates

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 346 KB

english, 2003

304

306 Optimox study: Folfox7 compared to folfox4 in metastatic colorectal cancer (CRC). Results of a randomized study

T. André, A. Cervantes, A. Figer, F. Maindrault-Goebel, E. Carola, P.L. Etienne, F. Rivera, J. Salvador, J.R. Mel Lorenzo, A. de Gramont

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

305

307 Upregulation of HC gp-39 gene in astrocytic gliomas

V.M. Kavsan, K. Shostak, O. Garifulin, G. Zehetner, Yu. Zozulya

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

306

308 Inverse planned stereotactic intensity modulated radiation therapy (IMRT) in the treatment of complex shaped benign meningiomas of the skull base: Acute-, late toxicity and preliminary results

M.W. Münter, H. Hof, C. Thilmann, A. Nikoghosyan, B. Didinger, P. Haering, A. Hoess, S. Nill, J. Debus

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 343 KB

english, 2003

307

309 First line temozolomide (tmz) in recurrent or progressive oligodendroglioma. a phase II study (Gruppo Italiano cooperativo neuro-oncologia)

U. Basso, M. Ermani, M. Reni, F. Vastola, A. Tosoni, L.M. Pasetto, B. Coria, M. Cacciacarne, F. Sala, A.A. Brandes

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

308

310 Sterotactic radiosurgery for cerebral melanoma metastases

U. Selek, E.L. Chang, S. Hassenbusch, P. Allen, M.H. Maor

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

309

311 Temozolomide (TMZ) combined with radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase III study

H. Athanassiou, M. Synodinou, E. Maragoudakis, M. Paraskevaidis, C. Verigos, D. Missailidou, D. Antonadou, G. Sarris, K. Beroukas, P. Karageorgis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 338 KB

english, 2003

310

312 Combined treatment with radiotherapy and temozolomide in recursive partitioning analysis (RPA) class V–VI glioblastoma patients. Preliminary results of a multicenter prospective study

S. Pergolizzi, P. Delia, A. Santacaterina, P. Frosina, G. Frazzetto, A. Girlando, A. D'Agostino, M. Tamburo, G. Ferrera, G. Garufi

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

311

313 Incidence and severity of anaemia in patients with primary lymphoma of the central nervous system treated with high-dose methotrexate

K. Jahnke, A. Korfel, L. Fischer, E. Thiel

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

312

314 Partial brain irradiation (PBI) or whole brain irradiation (WBI), the justified solution

S. Crvenkova, C. Tolevska

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

313

315 Malignant gliomas in elderly: short course radiotherapy is feasible and effective

L. Fariselli, I. Milanesi, A. Gavazzi, L. Brait, M. Botturi

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

314

316 VM-26 and carboplatin in patients with oligodendroglioma recurrent after PCV and temozolomide chemotherapy

A.A. Brandes, U. Basso, F. Vastola, S. Lonardi, A. Tosoni, A. Scola, M.K. Paris, L.M. Pasetto, H. Koussis, M. Ermani

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

315

317 The role of radiosurgery/stereotactic external beam radiotherapy with a linear accelerator in treatment of brainstem gliomas

B. Li, Yu.L. Wang, L. Zhai, T. Zhou, Y. Yin, Z. Chen, Sh. Guo, Y. Wang

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

316

318 Iodine-125 anti-EGFR radioimmunotherapy of malignant gliomas: search for optimal criteria of eligibility

Z. Wygoda, G. Bierzynska-Macyszyn, D. Kula, M. Jarzab, D. Larysz, R. Tarnawski, M. Wojtacha, T. Stepien, J. Slowinski, B. Jarzab

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 186 KB

english, 2003

317

319 Breast cancer radiotherapy — new techniques

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 144 KB

english, 2003

318

320 Whole genome views on cancer

A.L. Børresen-Dale

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 144 KB

english, 2003

319

321 Prospective trials in rectal cancer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 144 KB

english, 2003

320

Pain control

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 175 KB

english, 2003

321

323 Treatment of advanced bladder cancer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 175 KB

english, 2003

322

324 Germ cell tumours

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 175 KB

english, 2003

323

325 Drug interactions with neoplastic agents

J.H. Beijnen, J.H.M. Schellens

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 175 KB

english, 2003

324

326 Adjuvant chemotherapy improves overall and disease-free survival in non-small cell lung cancer (NSCLC): results of the randomized international adjuvant lung cancer trial(IALT)

B. Bergman, A. Dunant, M. Tarayre, G. Hillerdal, E. Papadakis, T. Grodzki, K. Zaragoulidis, A. Rivière, U. Aasebo, D. Grunenwald

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 152 KB

english, 2003

325

327 Randomised trial of paclitaxel in combination with platinum chemotherapy versus platinum-based chemotherapy in the treatment of relapsed ovarian cancer (ICON4/OVAR 2.2)

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 152 KB

english, 2003

326

328 Breast and prostate cancer: 10-year survival gains in the hormonal adjuvant treatment trials

R. Peto, O. Dalesio

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 152 KB

english, 2003

327

329 RNA interference (RNAi): the immune system of the genome

R.H.A. Plasterk

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 152 KB

english, 2003

328

330 Adjuvant chemotherapy should not be given in NSCLC

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 136 KB

english, 2003

329

331 Adjuvant chemotherapy as part of the curative treatment of operable non-small cell lung cancer

T. Le Chevalier

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 136 KB

english, 2003

330

332 Patho-biology of human germ cell tumors

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 146 KB

english, 2003

331

333 Malignant gonadal germ cell tumors (MGCTs) in children

J.R. Mann, K. Robinson, F. Raafat, J. Imeson, P. Gornall, M. Sokal, E. Gray, P. McKeever, J. Hale, A. Oakhill

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 146 KB

english, 2003

332

334 Pediatric extracranial non-gonadal malignant germ cell tumors (EMGCT): Implication of site, age and dissemination

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 146 KB

english, 2003

333

335 Gonadal adult tumours

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 297 KB

english, 2003

334

336 Malignant CNS germ cell tumors (CNS GCTs): A review of the state of art

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

335

337 Radiotherapy guidelines in the treatment of malignant paediatric CNS germ cell tumors (GCTs)

U. Ricardi, C. Alapetite, D. Frappaz, M.L. Garre, J. Nicholson, F. Saran, R.D. Kortmann, G. Calaminus

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

336

338 Regional deep hyperthermia and pei-chemotherapy in children and adoles-cents with unresectable malignant germ cell tumors: an approach for cure

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

337

339 Pathology of local recurrence and occult axillary lymph node metastases

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

338

340 Surgical input to local control and axillary staging

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

339

341 The role of radiotherapy

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

340

342 The influence and impact of chemotherapy on local control (incl. the problem of sequencing)

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 316 KB

english, 2003

341

343 Epidermal growth factor receptor (EGFR) therapies in colorectal carcinoma — the European data

D. Cunningham, I. Chau

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

342

344 EGFR inhibitors in the treatment of lung cancer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

343

345 EGFR therapies with radiation (the head and neck data)

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

344

346 EGFR therapies in other tumour types

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 337 KB

english, 2003

345

347 Melanoma biology and surgical margins

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

346

348 Adjuvant therapy in melanoma

A.M.M. Eggermont

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

347

349 Chemo versus biochemotherapy in metastatic melanoma

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 347 KB

english, 2003

348

350 Design and testing of chemically-defined melanoma vaccines

J.-C. Cerottini

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 181 KB

english, 2003

349

351 Conformal radiotherapy in prostate cancer: development of the new “standard of care”

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 181 KB

english, 2003

350

352 Combination of hormonotherapy (HT) and external irradiation (RT) in prostate cancers. Neo-adjuvant and/or adjuvant hormonotherapy?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 373 KB

english, 2003

351

353 Brachytherapy of the localized prostate cancer: indications, results and side effects

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 196 KB

english, 2003

352

354 The development and expectations of IMRT in the treatment of prostate cancer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 196 KB

english, 2003

353

355 Cancer gene discovery

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 373 KB

english, 2003

354

356 Predicting breast cancer behaviour by genetic analysis

M. Van de Vijver

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 181 KB

english, 2003

355

357 Expression and CGH analysis in soft tissue sarcomas, bladder cancer, and prostate cancer

C. Cooper, Y.-F. Lee, A. Fletcher, S. Edwards, J. Clark, C. Foster, I. Judon, A. Dodson, C. Fisher, A. Feber

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 181 KB

english, 2003

356

358 Proteomic pattern analysis serum for early detection of ovarian cancer

E.C. Kohn, E.F. Petricoin, G. Whiteley, G. Mills, L.A. Liotta

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 181 KB

english, 2003

357

359 Early colorectal cancer - treatment choice

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 340 KB

english, 2003

358

360 The therapeutic relevance of the molecular biology of colorectal cancer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

359

361 Surgery — radiotherapy: when and how to combine?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

360

363 Social inequality and risk of cancer — do we have a problem?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

361

364 Mind and cancer — do psychological factors cause cancer?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 118 KB

english, 2003

362

365 Coping with cancer — what do we know (and why does it matter)?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 118 KB

english, 2003

363

366 Rehabilitation of cancer patients — any scientific evidence?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 118 KB

english, 2003

364

367 A darwinian eye view of cancer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 108 KB

english, 2003

365

368 Anthracyclin-based neoadjuvant chemotherapy for large breast carcinoma: predictors and significance of breast preserving surgery

R. Rouzier, M. Spielmann, M.C. Mathieu, H. Marsiglia, E. Youmsi, J.R. Garbay, S. Delaloge

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 108 KB

english, 2003

366

369 The quality of breast conserving treatment in Denmark, 1989–1998 — nationwide population-based study of the Danish breast cancer co-operative group

M.M. Kempel, M. Ewertz, M. Andersson, P. Christiansen, M. Düring, N. Kroman, M. Overgaard, B.B. Rasmussen, N. Rytov

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 175 KB

english, 2003

367

370 Primary treatment with weekly docetaxel (Taxotere) and trastuzumab (Herceptin) for HER-2 overexpressing locally advanced breast cancer

J. Bines, A. Murad, S. Lago, B. Ferrari, J. Andrade, E. Abdo

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 175 KB

english, 2003

368

371 In vivo-chemosensitivity adapted primary chemotherapy in patients with primary breast cancer. First results of the Gepartrio-Pilot trial

G. von Minckwitz, G. Raab, J.U. Blohmer, B. Gerber, A. Löhr, S.D. Costa, H. Eldtmann, J. Hilfrich, C. Jacksisch, M. Kaufmann

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 175 KB

english, 2003

369

372 Average tumor size and overall survival of patients with primary diagnosis of breast cancer influenced by a more frequent use of mammography

W. Janni, B. Rack, H. Sommer, C. Schindbeck, G. Rammel, T. Dipmfl, D. Rjosk, W. Thieleke, B. Gerber, K. Friese

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 348 KB

english, 2003

370

373 Lack of pharmacokinetic interaction between erlotinib, docetaxel and capecitabine in breast cancer patients

A. Rakhit, S. Fettner, S. Davis, R. Abbas, F. De Rosa, U. Brennschneidt, C. Twelves, J. Baselga

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 177 KB

english, 2003

371

374 Maximizing internal mammary sentinel lymph node identification

O. Oisha, M. Carmon, D.B. Odenheimer, D. Gimmelreich, C. Reinus, D. Hain

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 177 KB

english, 2003

372

375 Breast cancer in the elderly — epidemiological characteristics and treatment approach

A. Jovicevic Bekic, Z. Neskovic Konstantinovic, I. Markovic, D. Jovicevic

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 177 KB

english, 2003

373

376 Primary chemotherapy with gemcitabine (G), myocet (M) and docetaxel (T): results of a phase I/II trial

P. Schmid, K. Krocker, A. Dieing, K. Michniewcz, V. Heilmann, J.U. Blohmer, C. Schulz, D. Lueftner, D. Elling, K. Possinger

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 350 KB

english, 2003

374

377 A double marker RT-PCR approach for the detection of disseminating breast cancer cells in peripheral blood

R. Salman, E. Hennessy, V. Uhlmann, C. Curren, D. Courtney

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 177 KB

english, 2003

375

378 Serum levels of matrix metalloprotinase 2 and 9 in patients with breast cancer

R. Salman, C. Curren, V. Uhlmann, D. Courtney

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 177 KB

english, 2003

376

379 Male breast cancer — review of 93 patients

N. Costa, D. Pereira, G. Rocha, C. Costa, C. Coutinho, C. Azevedo

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 177 KB

english, 2003

377

380 Preoperative 99m Tc-MIBI scintigraphy of internal mammary lymph node metastases in breast cancer patients

N.T. Talakhadze, M.I. Nechushkin, S.V. Shiryayev, A.A. Odzharova, Y.V. Vishnevskaya

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 179 KB

english, 2003

378

381 Axillary ultrasound (US) and US-guided fine needle aspiration biopsy in the assessment of lymph-node metastases in breast cancer patients

M. Podkrajsek, K. Hert, M. Hoceva, J. Zgainar, N. Besic, M. Bracko

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 179 KB

english, 2003

379

382 Accuracy of axillary staging using sentinel node biopsy or diagnostic axillary lymph node dissection

M. Leidenius, L. Krogerus, E. Tukianen, K. von Smitten

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 179 KB

english, 2003

380

383 Surveillance of women at risk for breast cancer: who detects breast cancer?

H. Fabry, J. Van Der Sijp, I. Groot, B. Hermsen, J. Berkhof, R. Verheijen, P. Van Leeuwen, s. Meijer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 179 KB

english, 2003

381

384 99m Tc-sestamibi scintigraphy in axillary lymph node metastases detection in patients with primary breast cancer undergoing curative surgery

F. Lumachi, G. Ferretti, M. Povolato, M.C. Marzola, P. Zucchetta, D. Cecchin, F. Bui, A.A. Brandes

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

382

385 Role of HER2 in wound-induced breast carcinoma proliferation

S. Ménard, E. Tagliabue, R. Agresti, M.L. Carcangui, C. Ghirelli, D. Morelli, M. Campiglio, M. Greco, A. Balsari

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

383

386 High-dose chemotherapy with stem cell support in high-risk primary breast cancer. An analysis of the effect on overall survival the Danish experience from a comparison study

T. Palshof, S. Werner Hansen, C. rose, S. Møller, P. Hokland, I. Svane, F. Hansen, L. Jarlbæk, H. Mouridsen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

384

387 Added value of blue dye in sentinel node biopsy for breast cancer

M. Snoj, R. Golouh, B. Vidergar-Kralj

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 329 KB

english, 2003

385

388 The evaluation of early regional recurrence using clinical examination and ultrasonography of the axilla after omitting axillary clearance in patients with tumour negative sentinel nodes

J. Leikola, K. Sarvas, K. von Smitten, M. Leidenius

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

386

389 Shift in pattern of care for breast cancer by sentinel node biopsy

A.E. Braat, J.W.A. Oosterhuis, J.E. de Vries

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

387

390 Breast cancer in the elderly: a 20 years audit

R. Salman, M. Mcdonnell, M. Hayes, C. Curren, F. Given

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

388

391 Basal and retinoic acid-stimulated sodium-iodide symporter expression in breast cancer

M. Jarzab, B. Maka, M. Wiench, V. Piddubnyak, N. Vydra, W. Pekala, J. Pamula, D. Lange, K. Lisowska, Z. Krawczyk

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 324 KB

english, 2003

389

392 Stage and survival in breast cancer in Estonia: the EUROCARE high-resolution study

A. Kupp, M. Kase, T. Aareleid, M. Kuddu

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

390

393 Effect of anastrozole therapy on bone: preliminary results of digital radiometrical analysis of clavicle and rib

J. Wojtacki, K.W. Zielinski, R. Wiraszka, G. Rolka-Stempniewicz, K. Lesniewski-Kmak

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

391

394 Survival and quality of life in breast cancer patients

A. Montazeri, M. Vahdaninia

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

392

395 Is health insurance coverage a major determinant of breast cancer screening practice?

P. Alevizaki, A. Maragkaki, A. Priskos, D. Mauri, C. Peponi, P. Panagoulias, P. Koutsoumbas, K. Moulakakis, E. Christias, A.G. Sofos

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 316 KB

english, 2003

393

396 Randomized controlled study comparing surgery alone, surgery plus tamoxifen, and surgery plus tegafur-uracil in patients with node-negative breast cancer: 5-year results from the Kanto cooperative study group of adjuvant chemo-endocrine therapy for breast cancer (ACETBC) of Japan

M. Kusama, T. Ikeda, K. Enomoto, F. Kasumi, T. Tominaga, S. Haga, M. Fukuda, S. Yamaguchi, H. Nakazato, O. Abe

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

394

397 Preoperative trastuzumab and vinorelbine (HN) is a well-tolerated, active regimen for Her2 3+/FISH+stage II/III breast cancer

L.N. Harris, H. Burstein, R. Gelman, P. Freidman, I. Kuter, V. Borges, C. Kaelin, J. Bellon, D. Smith, E. Winer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

395

398 Self-reported cognitive function appears unimpaired by adjuvant chemotherapy for breast cancer in post-menopausal women

J.M. Watters, J.C. Yau, K. O'Rourke, S. Kirkpatrick, S.Z. Gertler, E. Tomiak

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 311 KB

english, 2003

396

399 Cost-effectiveness of intensive adjuvant chemotherapy for high-risk breast cancer: Is dose-escalated chemotherapy with growth factor support (GFS) more costly and less effective than high dose chemotherapy (HDCT) with peripheral stem cell transplantation (PSCT)?

P. Kellokumpu-Lehtinen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

397

400 Dose-dense sequential adriamycin-paclitaxel-cyclophosphamide (A-T-C) chemotherapy in high-risk early breast cancer — a phase II study

Z. Kahán, G. Uhercsák, R. Hajnal-Papp, K. Boda, L. Thurzó

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

398

401 Adjuvant chemotherapy in breast cancer patients older than 70: CMF or FEC, feasability, acute and late toxicities. Experience of a single institution

A.C. Braud, D. Genre, A. Madroszyk, F. Retornaz, J. Camerlo, G. Gravis, F. Viret, C. Tarpin, P. Viens

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

399

402 Adjuvant endocrine therapy in pre- and postmenopausal women with primary breast cancer. A 25-year report of the Copenhagen breast cancer trials

T. Palshof, H.T. Mouridsen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 148 KB

english, 2003

400

403 Molecular analysis of eighteen most recurrent mutations in the BRCA1 gen in 59 Chilean breast cancer families

J.M. Reyes, S. Ampuero, J.M. Ojeda, S. Santibañez, L. Seccia, J. Rodríguez, G. Lay-Son, R. Blanco, L. Jara

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 148 KB

english, 2003

401

404 G-protein coupled receptors and anti-apoptotic signalling by estrogen independent of estrogen receptor

K.T. Lim, A.D.K. Hill, E.W. McDermott, N.J. O'Higgins, L.S. Young

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 148 KB

english, 2003

402

405 Modeling the effect of age in T1–T2 breast cancer

V. Vinh-Hung, J. Van de Steene, G. Csemi, G. Vlastos, M. Voordeckers, G. Storme

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 307 KB

english, 2003

403

406 Genomic DNA amplification of decoy receptor 3 (DcR3) correlates with lymphatic invasion and lymphnode metastasis in breast cancer

Y. Koyama, C. Kanbayashi, M. Kawahara, K. Kaneko, K. Sakurai, M. Uemura, T. Sato, T. Kanda, K. Hatakeyama

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

404

407 Abnormalities of erbB oncogenes in locally advanced breast cancer

M. Welnicka-Jaskiewicz, A. Zaczek, K. Konopa, M. Swierblewski, K. Bielawski, J. Jaskiewicz, W. Rogowski, J. Jassem

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

405

408 New sequence variants, recurrent BRCA1/BRCA2 mutations and new aberrations in BRCA1 promoter region in breast and ovarian cancer cases from upper silesia in Poland

J. Pamula, H. Zientek, M. Sieminska, W. Pekala, E. Chmielik, J. Rogozinska-Szczepka, B. Utracka-Hutka, M. Rusin, E. Grzybowska

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 340 KB

english, 2003

406

409 Clinical prognosis of BRCA1-associated breast cancer: a cohort study from the upper silesia region in Poland

R. Suwinski, K. Behrendt, E. Grzybowska, H. Zientek, B. Utracka-Hutka, J. Rogozinska-Szczepka, M. Kazimierczak-Maciejewska

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 181 KB

english, 2003

407

410 Correlation between BLC-2 protein expression and the clinical, pathological and biological characteristics of 483 breast cancer patients

R. Pedersini, M. Frisinghelli, M. Giovannini, M. Pavarana, R. Micciolo, F. Bonetti, Q. Piubello, F. Battistelli, G.L. Cetto, A. Molino

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 181 KB

english, 2003

408

411 Highly sensitive detection of the MGB1 transcript(mammaglobin) in the peripheral blood of breast cancer patients

N. Cerveira, L. Torres, P. Rocha, S. Bizarro, D. Pereira, N. Costa, J. Abreu, R. Henrique, M.R. Teixeira, S. Castedo

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 181 KB

english, 2003

409

412 Expression of the Ets transcription factor family in HER2/neu positive breast cancer

E. Myers, A.D.K. Hill, Y. Buggy, E.W. Mc Dermott, N.J. O'Higgins, L.S. Young

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

410

413 Determination of HER2 gene amplification: validating chromogenic in-situ hybridization (CISH) against IHC and FISH

M. van de Vijver, J. Rueschoff, F. Penault-Llorca, M. Bilous, W. Hanna

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

411

414 Up-regulation of p27klp1 reduces matrix metalloproteinase 9 (MMP-9) in the breast cancer cell line resulting in inducing inhibition of invasiveness

M. Mizuma, Y. Katayose, M. Unno, K. Yamamoto, T. Sasaki, S. Shiraso, T. Rikiyama, T. Onogawa, M. Suzuki, S. Matsuno

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

412

415 Effect of herceptin on gene expression in her2 positive breast cancer cell line

C. McMonagle, R. Salman, V. Uhlmann, C. Curren

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

413

416 UK patients are willing to donate biological material for sub-studies in clinical trials

L. Johnson, J. Bliss, P. Ellis, P. Barrett-Lee, S. Johnston, J. Yarnold

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

414

417 HER2 analysis in breast cancer by two-colour FISH-significance of chromosome 17 polysomy

T. Gaiser, M. Hofmann, H. Kneitz, L.P. Weng, C. Schmidtgen, G. Maass, C. Gross, T. Henkel, J. Rueschoff

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

415

418 Anti-metastatic efficacy of clodronate is associated with a decrease in bone turnover

E.V. McCloskey, S. Bal, R. Tähtelä, T. Powles, A.G. Paterson, J.A. Kanis, S. Ashley, A. Tidy, S. Atula, J. Nevalainen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

416

419 Relationship between tumor markers CEA and CA 15-3, TNM staging, estrogen receptor rate and MIB 1 index in patients with pT1–2 breast cancer

F. Lumachi, S.M.M. Basso, M. Ermani, S. Lonardi, A. Tosoni, A.A. Brandes

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 335 KB

english, 2003

417

420 Predictive factors for the status of non-sentinel nodes in breast cancer patients with tumor positive sentinel nodes

V. van Iterson, M.H.K. Leidenius, L.A. Krogerus, K.J.A. von Smitten

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 176 KB

english, 2003

418

421 Expression of estrogen receptor-β2 and β4 mRNA decreases in breast carcinogenesis

B.-W. park, K. Kim, M. Heo, W. Yang, J. Kim

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 176 KB

english, 2003

419

422 Soluble adhesion molecules and oxidative stress in patients with breast cancer

P. Tesarova, M. Kalousova, T. Zima, E. Helmichova, K. Trskova, L. Petruzelka

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 335 KB

english, 2003

420

423 Isolated tumor cells in the bone marrow (ITC-BM) of breast cancer patients before and after anthracyclin based therapy — Influenced by the HER2neu- and topoisomerase IIa-expression/amplification of the primary tumor?

C. Schindlbeck, A. Kornmeier, W. Janni, N. Shabani, C. Kentenich, S. Braun, H. Sommer, K. Friese

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

421

424 Long term results after conservative treatment for invasive breast carcinoma: A 20 year follow-up

I.Monteiro Grillo, M. Jorge, P.Marques Vidal, M. Ortiz, P. Ravasco

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

422

425 Interobserver variability of target volume delineation of breast tissue as well as of boost volume in 19 breast cancer patients after lumpectomy and axillary staging

H. Struikmans, C. Warlam, R. Tersteeg, T. Stam, G. Stapper, C. van Iersel, A. van Veldhuizen, N. Raaijmakers

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

423

426 Intramammary tumor location (ITL) does not influence prognosis, but the prevalence of axillary lymph node metastases

W. Janni, B. Rack, H. Sommer, B. Strobl, D. Rjosk, B. Gerber, M. Schmidt, W. Thieleke, T. Dimpfl, K. Friese

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 332 KB

english, 2003

424

427 Potentiation of radiation-induced subcutaneous fibrosis by concomitant use of tamoxifen in adjuvant breast cancer treatment

D. Azria, W.Jeanneret Sozzi, A. Zouhair, P.A. Coucke, A. Kramar, R.O. Mirimanoff, M. Ozsahin

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

425

428 The predictive value of specimen radiography to predict margins involvement in 188 breast infraclinic carcinomas

C. Mazouni, R. Rouzier, C. Balleyguier, M.C. Mathieu, S. Delaloge, H. Marsiglia, J.-R. Garbay, J.-R. Garbay

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

426

429 Breast cancer: immediate breast reconstruction after radical surgery

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 321 KB

english, 2003

427

430 Second conservative treatment for early breast cancer: 12-years results from a pilot study

B. Guix, I. Henriquez, J.I. Tello, J.A. Lejarcegui, G. Zanon, P. Palombo, D. Rubio, J.M. Del Campo

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 152 KB

english, 2003

428

431 Radiation pneumonitis in early breast cancer patients: effects of systemic treatments

Z. Kahán, Z. Varga, M. Csenki, E. Szil, A. Balogh, Z. Gyulai, Y. Mándi, L. Thurzó

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 152 KB

english, 2003

429

432 Breast scar and tumour cavity visualisation using MR imaging in the conventional radiotherapy treatment position

T. Wells, R. Davies, E. Heath, H. Taylor, A. Thomson, C. Wakeley, E. Whipp

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 312 KB

english, 2003

430

433 Breast morbidity after breast conserving treatment and sentinel node biopsy

R. Rönkä, M. Leidenius, K. Smitten von

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

431

434 Change of cosmetic results in time, evaluation of parameters influencing cosmetic results after breast conserving therapy (BCT) in patients with breast cancer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

432

435 Prognostic factors of breast-conserving treatment for early —stage breast cancer

M.T. Murillo, V. Valentin, M.A. Cabeza, M. Iribar, A. Vilarrasa, M. Valentin, E. Lanzos

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 331 KB

english, 2003

433

436 Renal safety of intravenous ibandronate with short infusion times

M. Pecherstorfer, I. Diel, D. Tripathy, B. Bergstrom

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

434

437 A multicenter phase II trial to evaluate gefitinib (‘Iressa’, ZD1839) (500 mg/day) in patients with metastatic breast cancer after previous chemotherapy treatment

G. von Minckwitz, W. Jonat, M. Beckmann, A. de Bois, U. Kleeberg, H. Kuhnie, E. Kettner, J. Hilfrich, J. Torode, A. Schneeweiss

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

435

438 Increased pretreatment serum lactate dehydrogenase (LDH) is the most important determinant of central nervous system (CNS) metastases in patients with metastatic breast cancer

M. Ryberg, D. Nielsen, K. Osterlind, P.K. Andersen, T. Skovsgaard, P. Dombernovsky

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 326 KB

english, 2003

436

439 Correlation between efficacy of single-agent Trastuzumab (T) and molecular markers in HER-2 positive advanced breast cancer patients

R. Giuliani, V. Durbecq, D. Larsimont, L. Dirix, J.-L. Canon, V. Richard, J.-Y. Leroy, C. Ferrara, M.J. Piccart, A. Di Leo

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

437

440 Superiority of tandem high-dose (HDC) over conventionally-dosed chemotherapy(CDC) in patients (Pts) with metastatic breast cancer (MBC): Updated results of the international randomised breast cancer dose-intensity study (IBDIS)

J. Crown, S. Leyvraz, M. Verrill, V. Guillem, A. Efremedis, J. Garcia, R.Welsh Conde-Bru, A. Montes, R. Leonard, J. Baselga

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

438

441 A phase I study of oral vinorelbine and paclitaxel in metastatic breast cancer (MBC)

T. Pienkowski, N. Tubiana, R. Delva, U. Vanhoefer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 326 KB

english, 2003

439

442 Fulvestrant (‘Faslodex’) demonstrates clinical benefit in heavily pre-treated patients with metastatic breast cancer

G.G. Steger, R. Barisch, C. Wenzel, D. Hussian, U. Plusching, R.M. Mader, C.C. Zielinski

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

440

443 Safety and tolerability of oral ibandronate therapy in patients with metastatic bone disease

I. Diel, M. Pecherstorfer, J.J. Body, D. Tripathy, B. Bergstrom

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

441

444 Predictive outcome assessment and monitoring by serum testing for HER-2/neu, EGFR, uPA and CA 27.29 in metastatic breast cancer

D. Lüftner, P. Henschke, R. Geppert, W. Carney, K.D. Wernecke, K. Possinger

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

442

445 Characteristics of patients with long-term survival after occurrence of liver metastases from breast cancer

M. Eichbaum, M. Kaltwasser, A. Schneeweiss, G. Bastert

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

443

446 Quality of life (QoL) in patients with metastatic breast cancer (MBC) treated with capecitabine (Xeloda)

G. Segalla, C.T. Oliveira, S. Lago, R. Ribeiro, R. Guimarães, S. Cabral, G. Letchakoski, M.H. Federico, J. Bines, M. Perdicaris

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

444

447 Capecitabine and taxanes: combination versus sequential therapy in anthracycline-pretreated metastatic breast cancer (MBC): findings from the Mexican Oncology Study Group (MOSG) phase III trial

S. Reyes, L. Torrecillas, A. Acosta, E. Monzon, F. Lopez, C. Alvarado, F. Gonzalez, M. Perez, G. Morgan, C. Leoner

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

445

448 Alleviation of bone pain with oral and intravenous ibandronate in women with metastatic breast cancer

D. Tripathy, J.J. Body, I. Diel, B. Bergstrom

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 338 KB

english, 2003

446

449 Capecitabine monotherapy is active, well tolerated and provides convenient outpatient therapy for patients with taxane-pretreated advanced breast cancer: findings from an expanded access program

M. Venturini, R. Bell, R. Paridaens, D. Rossner, M. Vaslamatzis, J.W.R. Nortier, H. Rodrigues

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

447

450 Improving clinical outcomes and treatment convenience with oral ibandronate for metastatic bone disease

R. Bell, R. Coleman, B. Bergstrom

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

448

451 Elderly patients with advanced breast cancer: safety and efficacy of capecitabine

G. Procopio, E. Bajetta, L. Gattinoni, S. Della Torre, L. Catena, R. Ricotta, T. Portale, D. Santangelo, A. Fusi, A. Lambiase

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

449

452 Osteoprotegerin (OPG) and osteopontin (OPN): their usefulness in monitoring the Anastrzole (AN) treated advanced breast cancer (ABC) patients bearing bone metastases

N. Zilembo, A. Martinetti, I. La Torre, L. Ferrari, E. Seregni, M. Del Vecchio, R. Longarini, T. Portale, P. Nova, E. Bajetta

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

450

453 Phase I study of vinorelbine (VRL) alternating i.v. and oral in combination with docetaxel (DTX) as 1st line chemotherapy (CT) of metastatic breast cancer (MBC)

M. Campone, P. Fumoleau, A. Tekiela, P. Koralewski, J. Bonneterre, G. Blanchot, B. Longerey, P. Favier

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

451

454 A phase II study of vinorebline (VRL) alterning oral and intravenous (IV) plus epirubicin (EPI) as first line chemotherapy of metastatic breast cancer (MBC)

M. Verrill, D. Serin, A. Jones, T. Delozier, R. Coleman

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 323 KB

english, 2003

452

455 A phase II study of first-line combination chemotherapy with docetaxel and gemcitabine in anthracycline-pretreated, Her-2 negative metastatic breast cancer (MBC)

F. Lenz, F. Beldermann, M. Geberth, G. Bastert, A. Schneeweiss

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

453

456 Caelyx (pegylated liposomal doxorubicin hcl) and conventional doxorubicin have significantly different adverse event profiles

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

454

457 Multicenter phase II study of sequential hormonotherapy with Anastrozol/Exemestane (ARIM-AROM) in metastatic breast disease. Preliminary data of Goim 2107 study

R. Formato, R.V. Iaffaioli, A. Tortoriello, S. Del Prete, A. Pisano, F. Fanelli, G. Ianniello, S. Tafuto, G. Colucci

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

455

458 Weekly paclitaxel plus trastuzumab in metastatic breast cancer (MBC): a multicentre German trial

M. John, H.-J. Hindenburg, A. Hinke, R. Kriebel-Schmitt, J. Papke, M. Stauch

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 329 KB

english, 2003

456

459 Weekly paclitaxel: an effective and well tolerated treatment for advanced breast cancer

P. Kellokumpu-Lehtinen, R. Asola, L. Elomaa, M. Heikkinen, R. Kokko, A. Maiche, J. Kaleva-Kerola, M. Huusko, K. Möykkynen, T. Ala-Luhtala

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

457

460 Reduction of the incidence of central nervous metastases in patients treated with high dose epirubicin and high dose cyclophosphamide compared to high dose epirubicin alone for metastatic breast cancer

M. Ryberg, S. Langer, T. Skovsgaard, P. Grundtvig, P. Dombernowsky

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

458

461 Oral capecitabine monotherapy in taxane & anthracycline pre-treated metastatic breast cancer (mbc): Suffolk oncology centre experience

V.R. Bulusu, J. Le Vay, R. Hockney, R. Jena, M. Iddawela

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

459

462 Intravenous and oral ibandronate reduce the risk of skeletal related events in patients with metastatic bone disease

J.-J. Body, D. Tripathy, M. Pecherstorfer, B. Bergstrom

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 156 KB

english, 2003

460

463 A multicenter phase II study of capecitabine plus paclitaxel in metastatic breast cancer: Survival update

W. Gradishar, L. Meza, T. Hill, D. Samid, Y.-M. Chen, B. Amin

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 156 KB

english, 2003

461

464 Efficacy and toxicity of docetaxel or cisplatin chemotherapy in combination with trastuzumab in the treatment of patients with chemotherapy pre-treated HER-2/neu overexpressed metastatic breast cancer

B. Bauer-Kosinska, I. Lemanska, I. Glogowska, R. Sienkiewicz, T. Pienkowski

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 156 KB

english, 2003

462

465 Hepatic intra-arterial chemotherapy in i.v. chemoresistant breast cancer pts with liver metastases

M. Airoldi, C. Zanon, F. Pedani, R. Clara, S. Marchionatti, M. Bortolini

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 156 KB

english, 2003

463

466 A treatment planning comparison of conventional, 3D conformal, intensity modulated photon — and proton irradiation therapy in the treatment of paranasal sinus carcinoma

U. Mock, J. Bogner, D. Georg, T. Auberger, R. Pötter

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

464

467 The radiosensitising effect of difluorodeoxyuridine, a metabolite of gemcitabine, in vitro

B. Pauwels, A.E.C. Korst, G.G.O. Pattyn, H.A.J. Lambrechts, C.M.J. de Pooter, F. Lardon, J.B. Vermorken

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

465

468 Transfection of human cell lines with the human multi-drug-resistence (MDR-1) gene supresses radiation-induced apoptosis and increases radioresistence

J. Schaefer, K. Fleckenstein, S. Fruehaut, K.J. Weber, F. Wenz

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

466

469 Dose — dysfunction relationships within the parotid gland after radiotherapy

A. Maes, B. Bussels, P. Lambin, P. Flamen, K. Erven, R. Hermans, S. Nuyts, C. Weltens, W. Van den Bogaert

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 336 KB

english, 2003

467

470 Severe radiation-induced bowel complications are not uncommon in patients with uterine cervix cancer

E.-Y. Huang, C.-J. Wang, H.-C. Chen, L.-M. Sun, F.-M. Fang, S.-A. Yeh, H.-C. Hsu, C.-Y. Hsiung

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

468

471 Radiation-induced changes in the cytoskeleton of human endothelial cells in relation to endothelial monolayer permeability

D. Gabrys, K. Trott, G. Tozer, C. Kanthou

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

469

472 Efficacy and morbidity of linear accelerator radiosurgery for cerebral arteriovenous malformations: a comparison with the natural history

M.A. Bollet, L. Picard, I. Buchheit, R. Anxionnat, A. Cordebar, N. Jay, E. Desandes, C. Marchal, P. Aletti, P. Bey

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 329 KB

english, 2003

470

473 The initial clinical experience utilizing an implantable dosimeter for measuring true in vivo radiation dose during external beam radiotherapy

C. Scarantino, C. Rini, T. Carrea, M. Aquino, R. Ornitz, M. Ansher

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

471

474 Plasma osteopontin (OPN) predicts hypoxia and response to the hypoxic sensitiser Nimorazole in radiotherapy of head and neck cancer. Results from the randomized DAHANCA 5 trial

J. Overgaard, M. Nordsmark, J. Alsner, J.G. Eriksen, M.R. Horsman

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

472

475 The prognostic value of serum osteopontin, HIF-1 alpha and pO2 measurements in advanced head and neck tumors treated by radiotherapy

M. Nordsmark, J. Alsner, J.G. Eriksen, M.R. Horsman

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

473

476 Quality assurance report of EORTC 26981/22981 trial on radiotherapy vs radiotherapy and temozolomide for newly diagnosed glioblastoma multiforme: individual case review

F. Ataman, P. Poortmans, R. Stupp, R.O. Mirimanoff

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

474

477 GENEPI — the European normal and tumor tissue bank and database: a new ESTRO activity

T. Hoelscher, Ch. Verfaillie, M. Baumann

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

475

478 Biological assessment of mixed beam irradiation of carbon-ion and X-ray

Y. Demizu, K. Kagawa, Y. Ejima, H. Nishimura, R. Sasaki, T. Soejima, K. Sugimura, Y. Hishikawa, Y. Furusawa

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 326 KB

english, 2003

476

479 Inhibition of angiogenesis and ionizing radiation: treatment-dependent influence on the tumor microenvironment

O. Riesterer, V. Djonov, M. Honer, S. Ametamey, S. Bodis, M. Pruschy

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

477

480 Comparison of in vitro growth-inhibitory activity of paclitaxel and docetaxel on squamous cell carcinoma under normoxic and hypoxic conditions during irradiation

I. Skvortsova, T. Seppi, A. Haidenberger, A. DeVries, S. Skvortsov, H. Geiler, M. Sauer, P. Lukas

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

478

481 An investigation of reoxygenation in high risk prostate cancer following high dose-rate (HDR) brachytherapy

G. Morton, B. Yap, D.A. Loblaw, R. Choo, P. Cheung

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 327 KB

english, 2003

479

482 Enhancement of radiation response by roscovitine in human breast carcinoma in vitro and in vivo xenograft model

L. Maggiorella, E. Deutsch, V. Frascogna, J. Bourthis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

480

483 Erythropoietin receptor expression and the in-vitro effect of erythropoietin on the radiation-response of different cancer cell lines

G. Shenouda, A. Belenkov, L. Souhami, M. Duclos, L. Portelance, T. Chow

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

481

484 Biological markers associated with sensitivity of tumour cells to the epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 and ionizing radiation

S. Burdak-Rothkamm, C.E. Ruebe, T.P. Nguyen, D. Ludwig, K. Feldmann, T. Wiegel, C. Ruebe

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

482

485 Evaluation of the effects of radiotherapy to the chiasm and optic nerve by visual psychophysical-electrophysiological tests

M. Essasolak, U. Karagöz, D. Yalman, S. Kose, Y. Anacak, A. Haydaroglu

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 338 KB

english, 2003

483

486 Evaluation of the new hypoxic cell radiosensitizer doranidazole in a murine tumour and mouse normal tissue

R. Murata, M. Tsujitani, M.R. Horsman

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

484

487 Geographical miss of the primary target and nodes in adjuvant breast radiotherapy as assessed by open MRI scanning

E. Whipp, R. Hartley-Davies, T. Wells, A. McKenzie, H. Appleby, P. Cornes, C. Devrell, M. Halliwell

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

485

488 Selective conformal post-operative radiotherapy in patients with head and neck squamous cell carcinoma (HNSCC). Could the “bath of X-rays” be avoided?

R. Manzo, G. Desuter, M. Hamoir, M.Octave Prignot, H. Reychler, S. Siciliano, V. Grégoire

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 325 KB

english, 2003

486

489 Human papillomavirus (HPV) status in advanced cervical cancer: predictive and prognostic significance for curative radiation treatment

K. Lindel, Ph. Burri, H.U. Studer, H.J. Altermatt, R.H. Greiner, G. Gruber

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 157 KB

english, 2003

487

490 Exploiting the advantages of real-time intraoperative ctv definition: first report of an institutional phase I-II trial of perioperative fractionated HDR brachytherapy (PHDRB)

A. Perez-Ochoa, M. Cambeiro, R. Martínez-Monge, M. Jurado, J. Alcalde, M. San Julián, S. Amillo, C. Concejo, J.L. Hernández-Lizoain, F. Pardo

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 157 KB

english, 2003

488

491 Location of cervical lymph node metastases in oropharyngeal and hypopharyngeal carcinoma: implications for cranial irradiation field borders

P. Braam, C. Raaijmakers, C. Terhaard

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 317 KB

english, 2003

489

492 Quantitative description of late normal tissue complications after radiation therapy

H. Jung, V. Svoboda, W. Alberti, T. Herrmann

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

490

493 Three-dimensional conformal radiotherapy (3D-CRT) planning for prostate cancer: 3 vs 4 vs 6 fields plans

E. Gez, R. Bar-Deroma, V. Bakouche, Z. Bernstein, R. Carmi, A. Kuten

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

491

494 Combination of ibandronate and radiotherapy in metastatic bone disease — final results of a randomized phase II trial

O. Micke, D. Berning, U. Schäfer, F. Bruns, N. Willich

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

492

495 Targeted delivery of radioactive magnetic carriers in a rabbit liver tumor model

J. Geschwind, H. Kobeiter, M. Abusedera, C. Peterson, G. Tapolsky, T. Leakakos

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 336 KB

english, 2003

493

496 Treatment margins and treatment fractionation in conformal radiotherapy of muscle-invading urinary bladder cancer

L.P. Muren, A.T. Redpath, D.B. McLaren

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 175 KB

english, 2003

494

497 Evaluation of cyberknife frameless real-time image-guided stereotactic radiosurgery for spinal lesions

P.C. Gerszten, C. Ozhasoglu, S.A. Burton, W.J. Vogel, B.A. Atkins, W.C. Welch, S. Kalnicki

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 175 KB

english, 2003

495

498 High-dose rate versus low-dose rate intracavitary radiotherapy in the treatment of cervical carcinoma: a meta-analysis

K.K. Lee, K.-R. Park, C.-B Kim, C.-M. Nam, I.-J. Lee, J.-Y. Lee

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 334 KB

english, 2003

496

499 CT-based three-dimensional intracavitary brachytherapy planning in cervix cancer: Is it always better than conventional planning?

K.H. Shin, T.H. Kim, J.K. Cho, S.Y. Park, D. Park, J.W. Kim, E.K. Chie, H.Y. Pyo, D.Y. Kim, K.H. Cho

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

497

500 Dosimetric study of boron neutron capture therapy (BNCT) for multiple liver tumors: dose-volume histogram analyses using the simulation environment for radiotherapy application (SERA) treatment planning system

M. Suzuki, Y. Sakurai, S. Masunaga, Y. Kinashi, K. Nagata, K. Ono

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

498

501 Effects of topographic distribution of small bowel and field sizes on acute diarrhea in gynecologic patients undergoing pelvis irradiation

E.-Y. Huang, C.-J. Wang, L.-M. Sun, H.-C. Hsu

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 321 KB

english, 2003

499

502 Repopulation of the moderately well differentiated GL human squamous cell carcinoma growing in nude mice

F. Hessel, M. Hörcsöki, T. Klinger, M. Krause, D. Zips, C. Petersen, H.D. Thames, M. Baumann

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

500

503 Quantification of a differentially expressed gene, RTP801, in irradiated HeLa cells using real time PCR

Y.S. Lee, M.J. Cho, J.H. Lee, W.H. Lee, J.S. Kim, J.S. Kim

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

501

504 Quality aspects and time gain of an automated procedure for generating an optimized plan in the routine treatment of breast cancer with external tangential beam irradiation

M. Bakker, K. Van Vaerenbergh, W. De Gersem, M. Coghe, T. Boterberg, C. Derie, W. Willaert, W. Duthoy, L. Vakaet, W. De Neve

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 318 KB

english, 2003

502

505 High-dose-rate intracavitary brachytherapy alone in post-hysterectomy for endometrial carcinoma

O. Condon, M. Jorge, M. Ortiz, I. Monteiro

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

503

506 Definitive radiotherapy for cervical cancers: Retrospective analysis of 449 patients treated with external beam-radiotherapy (EBRT) and high-dose-rate-afterloading (HDR)with more than 5 years follow-up

G. Haensgen, H.G. Strauss, J. Dunst, D. Utzig

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

504

507 Impact of anemia on tumor oxygenation and clinical outcome in cervical cancers treated with definitive radiotherapy

G. Haensgen, T. Kuhnt, H.G. Strauss, J. Dunst

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

505

508 Hemoglobin levels during radiation therapy and their prognostic influence on local control and survival of patients with endometrial carcinoma

K. Münstedt, M. Völzing, R. von Georgi

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 323 KB

english, 2003

506

509 Definition of vaginal doses in intrauterine high dose rate brachytherapy

A. Kuten, A. Nevelsky, Y. Gokcen, R. Bar-Deroma

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

507

510 Levels of antioxidant proteins in serum of patients with cancer during radiotherapy

M. Koc, S. Taysi

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

508

511 Respiratory gated radiation treatment system using a 3-D ultrasound device

M. Kokubo, A. Sawada, K. Yoda, Y. Nagata, M. Hiraoka

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 323 KB

english, 2003

509

512 Local superficial radiotherapy in the management of primary cutaneous lymphoma

B. Navalpotro, C. Conill, I. López, I. Toscas, J. Fernández-Ibiza, S. Jorcano, T. Estrach

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

510

513 Total body irradiation; the translation technique: the moving beam approach

C. Zabatis, T. Koligliatis, S. Xenofos, K. Pistevou-Gobakis, E. Kypraiou, A. Fotopoulou, G. Soulimioti, E. Grigoriadis, G. Tsimopoulos, K. Beroukas

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

511

514 Influence of initial electron beam characteristics on Monte Carlo calculated absorbed dose distribution for linac photon beam

A. Tzedakis, J. Damilakis, M. Mazonakis, J. Stratakis, H. Varveris, N. Gourtsoyianis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

512

515 Radiotherapy of primary cutaneous B-cell lymphoma — a clinical follow-up study of 35 patients

H.T. Eich, D. Eich, O. Micke, R. Skripnitchenko, H. Stuetzer, T. Krieg, R.-P. Mueller

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

513

516 Combined effects of SU5416 and fractionated radiotherapy in tumor xenograft model

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 157 KB

english, 2003

514

517 Dose-dependent upregulation of YKL-40 by irradiation in human glioblastoma cells

N. Junker, J.S. Johansen, E.L. Lund, P.E.G. Kristjansen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 157 KB

english, 2003

515

518 Carbon ion beam treatment at the Hyogo Ion Beam Medical Center (HIBMC)

M. Murakami, Y. Hishikawa, K. Kagawa, A. Kawaguchi, H. Mayahara, K. Yoshino, N. Tsubota, N. Nakao, M. Kurosaka, M. Abe

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 157 KB

english, 2003

516

519 Technical factors associated with irradiation pneumonitis after adjuvant breast irradiation

E.K. Chie, K.H. Shin, T.H. Kim, S.Y. Park, D. Park, H.R. Pyo, D.Y. Kim, K.H. Cho, E.S. Lee, J.S. Ro

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 318 KB

english, 2003

517

520 Estimation of dose constraints using biologically-normalized dose-volume histogram (BN-DVH) for hypofractionated radiotherapy in the treatment of prostate cancer

J. Wu, K. Breitman, W. Song

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

518

521 The use of electronic portal image device (EPID) in the isocenter verification in stereotactic radiosurgery

R. Rutkowski, T. Hauser, K. Slosarek

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

519

522 Safe integration of high dose rate endoluminal brachytherapy in the conservative treatment of patients with esophagus cancer and external beam radiation with or without chemotherapy

T. Vuong, M. David, P. Szego, R. Corns, S. Devic, M.D.C. Evans, S. Mayrand, J. Parent

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 326 KB

english, 2003

520

523 Aminothiol WR-1065, the active metabolite of Amifostine (Ethyol), protects in vitro lens epithelial cells against X-ray exposure

Y. Belkacemi, P. Rat, G. Piel, D. Pasquier, B. Castelain, J.-M. Warnet, E. Lartigau

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

521

524 Radiotherapy vs. radiotherapy + chemotherapy of advanced cervical cancer (IIb - IVa): Regression of tumour and early sequelae

S. Cikaric, S. Stupar-Petrovic, V. Plesinac-Karapandzic, I. Marjanov, Lj. Rudan, S. Colakovic, M. Saric, B. Mihajlovic

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

522

525 Evaluation of polymer gels and laser-beam optical CT scanner as a 3-D dosimeter for IMRT

W. Cheng-Shie, Y. Xu, M. Maryanski, M. Maryanski

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

523

526 Circulating lipid peroxide, glutathione and nitric oxide levels in cancer patients irradiated on different anatomic fields

D. Unsal, M. Akmansu, C. Ozer, B. Gonul, H. Bora

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 329 KB

english, 2003

524

527 Movement of calcified mediastinal lymph nodes with breathing

P. Jenkins, C. Salmon, C. Mannion

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

525

528 The choice of optimal radiotherapy technique for locally advanced maxillary carcinoma using 3D treatment planning system

D. Mileusnic, B. Pantic

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

526

529 Differential radioenhancing properties of oxaliplatin and cisplatin in human cervical and lung cancer cell lines

E. Weiss, M. Rave-Fränk, C. Boll, O. Pradier, J. Lehmann, H. Schmidberger, C.F. Hess

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

527

530 Evaluation of quality assurance procedure in brain tumors radiotherapy in children

K. Ficek, S. Blamek, L. Miszczyk, K. Slosarek

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 330 KB

english, 2003

528

531 Radiosensitivity enhancement by a histone deacetylase inhibitor (HDACI), trichostatin A in human glioblastoma cell lines

I.H. Kim, J.H. Kim, J.H. Shin

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

529

532 Analysis of dose-volume parameters for reporting dose distribution in the target volume

A. Terahara, M. Tsubuku, M. Shimada, S. Hayashi

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

530

534 Analysis of dose volume histograms in proton therapy for prostate cancer

K. Nihei, T. Nishio, S. Ishikura, M. Kawashima, T. Ogino

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 303 KB

english, 2003

531

535 Verification of Fluence Map (FM) in dynamic radiotherapy techniques

R. Rutkowski, A. Grzadziel, K. Slosarek

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 141 KB

english, 2003

532

536 A four dimensional simulation model of the response of solid tumours to radiotherapy in vivo: advances and validation

V. Antipas, G. Stamatakos, N. Uzunoglu, M. Synodinou

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 305 KB

english, 2003

533

537 The cribriforme plate on lateral radiographs—a blinded study on the accuracy of radiotherapy planning

S. Gripp, J. Kambergs, M. Wittkamp, A. Saleh

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

534

538 Preclinical studies on the combined effect of radiation and S-1: a new oral formulation of 5-fluorouracil on human colon cancer

C. Murayama, A. Kamijyo, T. Suzuki, K. Ishikawa, Y. Ohizumi, S. Sadahiro

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

535

539 Reproducibility and importance of the bladder status for pelvic irradiation

Z. Cselik, C. Zsolt

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

536

540 The informational needs of the multidisciplinary audience attending monthly irradiation oncology palliative care rounds at the Toronto Sunnybrook Regional Cancer Centre — needs assessment

E. Szumacher, E. Franssen, C. Danjoux, C. Hayter

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 327 KB

english, 2003

537

541 The advantage of proton therapy for soft tissue tumours in childhood

B. Timmermann, T. Lomax, G. Goitein

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

538

542 A multicenter, randomized phase III study on neurotoxicity, safety and efficacy of weekly Pacilitaxel infused over 1-h vs. 3-h in patients with advanced solid tumors

S. Mielke, K. Mross, T.A. Gerds, A. Schmidt, W. Lange, D. Behringer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

539

543 Tolerability of a novel bone-seeking radionuclide — the alpha emitter radium-223 — in patients with skeletal metastases from breast and prostate cancer

S. Nilsson, L. Balteskard, S.D. Fossa, J.-E. Westlin, K. Borch, R.H. Larsen, O.S. Bruland

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 333 KB

english, 2003

540

544 A phase I trial of the novel nucleoside analog osi-7836 given on days 1 and 8 every 3 weeks: ncic ctg ind. 147

L.L. Siu, G.D. Goss, J. Powers, B. Waterfield, M. MacLean, L.M. Adams, D. Drolet, J. Rusk, L. Seymour

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

541

545 A randomized trial of a cd-rom educational intervention for advanced cancer patients (acp) enrolling in early phase trials

F. Hlubocky, N. Kass, L. Fogarty, J. Sugarman, C. Daugherty

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

542

546 A phase I dose-escalation trial of ZD6126 administered as 5 daily dose every 3 weeks to patients with cancer refractory to other treatments

G.T. Budd, J. Evelhoch, P. Langmuir, J. Veiero, K. Shepherdson, P. LoRusso

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

543

547 KOS-862 (Epothilone D): Phase 1 dose escalating and pharmacokinetic (PK) study in patients (Pts) with advanced malignancies

D.R. Spriggs, J. Dupont, S. Pezzulli, J. Larkin, G. Cropp, Y. Zhou, M. Sherrill, R. Johnson Jr., A.L. Hannah

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 341 KB

english, 2003

544

548 CERA (Continuous erythropolesis receptor activator) is an innovative erythropoietic agent with an extended serum half-life: studies of mode of action, pharmacokinetics and erythropoietic activity

A. Haselbeck, B. Reigner, P. Jordan, A. Pannier, J. Glaspy

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

545

549 Liver toxicity: a predictable and manageable toxicity for kahalalide F (KF)

J.H.M. Schellens, L. Paz-Ares, J.M. Trigo, B. Pardo, A. Ruiz-Casado, E. Ciruelos, M. Garcia, J. Beijnen, M.A. Izquierdo

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

546

550 Antitumour efficacy of MEN4901/T-0128, a new camptothecin derivative-carboxymethyldextran conjugate, in a panel of human gastrointestinal tumours xenografted in nude mice

M. Bigioni, F. Animati, M. Kakushima, T. Kawaguchi, C.A. Maggi, S. Manzini, C. Goso

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 333 KB

english, 2003

547

551 Peripheral blood CD3(+) T cells, independent on their cell-cycle status, are inherently resistant to high concentrations of arsenic trioxide

M.J. Huang, S.F. Lin, C.P. Lin, C.R. Liu, J.M. Chow, H.J. Liu

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

548

552 Evaluation of the pharmacokinetic (PK) interactions between cetuximab and irinotecan in patients with epidermal growth factor receptor (EGFR)-expressing advanced solid tumors. Results of a phase I study

C. Delbaldo, J.Y. Pierga, V. Dieras, S. Faivre, M. Bonnay, J.C. Vedovato, M. Mueser, A. Nolting, A. Kovar, E. Raymond

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

549

553 Alternate administration sequences of gemcitabine/vinorelbine in advanced solid tumor: a pharmacokinetic study

M. Airoldi, L. Cattel, S. Novello, R. Passera, M. Medail, S. Marchionatti, O. Bertetto, C. Bumma

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 327 KB

english, 2003

550

554 Phase 1 study of CT-2103/cisplatin in patients with solid tumors

K. Skubitz, A. Kudelka, M.G. Bolton

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

551

555 Phase 1 studies of CT-2103 in patients with non small cell lung cancer and with advanced malignancies

H. Burris, D. Shipley, A. Greco, S. Jones, M.G. Bolton

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

552

556 Clinical pharmacokinetics of erlotinib in healthy subjects

R. Abbas, S. Fettner, M. Riek, S. Davis, M. Hamilton, P. Frohna, A. Rakhit

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

553

557 BBR 3576: phase I dose escalation study in patients with advanced solid tumors (a study with the participation of CESAR-EWIV)

M.E. Scheulen, K. Mross, Ch. Peschel, C. Unger, H. Richly, M.G. Camboni, P. Barbieri, E. Verdi, B. Vincenzi, A. Bernareggi

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 326 KB

english, 2003

554

558 The effect of food on the pharmacokinetics of GW572016

D. Smith, K. Koch, D. Lee, S. Mangum, A. Stead, M. Versola, T. DeBerardinis, H. Burris, S. Jones, N. Spector

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

555

559 Pharmacokinetics of GW572016 in an ascending dose tolerability study of phase I cancer patients

K. Koch, D. Lee, S. Jones, A. Stead, M. Versola, H. Burris, G. Wilding, C. Taylor, N. Spector, D. Smith

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

556

560 Search for drug-drug interaction between oral vinorelbine (VRL) and capecitabine (CAP) in metastatic breast cancer (MBC) during a dose finding study

F. Nolé, C. Catania, G. Sanna, E. Munzone, G. Milano, B. Laffranchi, A. Goldhirsch, G. Blanchot, C. Puozzo

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 325 KB

english, 2003

557

561 Clinical results from an ADME (absorption, distribution, metabolism, and excretion) trial of PTK787/ZK 222584 (PTK/ZK): a novel, oral angiogenesis inhibitor in patients with advanced cancer

J. Knoblich, P.M. Paldánius, H.-P. Gschwind, C. Günther, A. Henry, J. Xia, D. Reitsma, D. Laurent, L. Jost

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

558

562 Dihydropyrimidine dehydrogenase (DPD) activity in peripheral mononuclear cells (PMNC-DPD) during long-term treatment with oral uracll/tegafur (UFT) as postoperative adjuvant chemotherapy for colorectal cancer (CRC)

K. Ishikawa, S. Sadahiro, T. Suzuki, H. Makuuchi, C. Murayama

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

559

563 Pharmacokinetics of epirubicin and paclitaxel during weekly administration in patients with metastasised breast cancer

R.M. Mader, B. Rizovski, C. Wenzel, R. Bartsch, C.C. Zielinski, G.G. Steger

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 326 KB

english, 2003

560

564 Pharmacokinetics and metabolism of fulvestrant after oral, intravenous and intramuscular administration in healthy volunteers

M. Harrison, A. Laight, D. Clarke, P. Giles, Y. Yates

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

561

565 Phase I combination study of oral vinorelbine (VRL) and oral cyclophosphamide (CTX) in patients with metastatic breast cancer (MBC)

A.J. ten Tije, C. Seynaeve, J.H. Schornagel, J.C. Pouget, B. Laffranchi, G. Blanchot, J. Lieverst, J. ter Steg, J. Verweij, J.H.M. Schellens

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

562

566 Phase 1 study of CT-2103/carboplatin in patients with solid tumors

J. Nemunaitis, M. Bolton

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

563

567 A phase I and pharmacokinetic study of BMS-247550 in combination with carboplatin in advanced solid malignancies

R. Plummer, D. Fyfe, P. Woll, B. Reynolds, M. Voi, O. Peeters, P. Hewitt, K. Fishwick, R. Peck, M. Verrill

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 332 KB

english, 2003

564

568 Phase I studies with CERA (Continuous Erythropoiesis Receptor Activator), an innovative erythropoietic agent

B. Reigner, P. Jordan, A. Pannier, J. Glaspy

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

565

569 A phase I and pharmacokinetic study of oral administration of SU5416 in patients with advanced solid tumors

M. Salzberg, M. Pless, C. Rochlitz, P. Scigalla, R. Herrmann

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

566

570 A phase I study to determine the safety and pharmacokinetics of intravenous administration of SB715992 on a once weekly for three consecutive weeks schedule in patients with refractory solid tumors

H. Burris III, P. LoRusso, S. Jones, J. McCormick, N. Willcutt, J. Hodge, P. Bush, L. Pandite, J. Sabry, P. Ho

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 327 KB

english, 2003

567

571 Novel mechanisms of biidioxopiperazine resistance

M. Dejligbjerg, I. Wessel, P.B. Jensen, M. Sehested

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

568

572 Kahalalide F (KF), a new marine compound, in vitro radiosensitizes human tumoral cell lines

S. Córdoba, I. Zapata, J. Romero, J.A. Jimeno, J.A. López-Martín, A. de la Torre, J.A. Vargas, R. Sánchez-Prieto, C.A. Regueiro, R. Magallón

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

569

573 Safety profile for yondelis (ET-743) 1.3 mg/m2 over 3 hours (h)

A. Ruiz-Casado, C. Sessa, M. Provencio, P. Casali, L. Paz-Ares, M. López-Brea, A. Nieto, J.A. López-Martín, M.A. Izquierdo, J. Jimeno

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 320 KB

english, 2003

570

574 Pharmacokinetics and metabolism of CPT-11 (Campto®) combined with capecitabine (Xeloda®) in patients with advanced colorectal cancer: altered disposition of the metabolites SN-38 and SN-38 glucuronide?

M. Czejka, J. Schueller, E. Ostermann, K. Hauer, U. Zeleni

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

571

575 Dose finding study of oral vinorelbine (VRL) in combination with capecitabine (CAP) in patients with metastatic breast cancer (MBC)

F. Nole, C. Catania, G. Sanna, E. Munzone, L. Corsetto, B. Longerey, A. Saindon, C. Zilocchi, B. Laffranchi, A. Goldhirsch

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

572

576 Phase I dose-finding study of the combination of alimta (pemetrexed) and paclitaxel in patients with solid tumors

D. Zingel, C. Bolling, T. Graefe, D. Radtke, J. Latz, J. Blatter, A.-R. Hanauske

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 336 KB

english, 2003

573

577 A phase I dose-escalation study of pemetrexed and docetaxel in patients with locally advanced or metastatic cancer: preliminary results of schedule B

D.W. Fyfe, P. Vasey, P.J. Woll, I.C. Smith, R. Clark, J. Carmichael

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 175 KB

english, 2003

574

578 Post-transcriptional regulation of P-glycoprotein expression in human colon carcinoma cell lines

A. Gómez-Martínez, P. García-Morales, E. García-Poveda, M.D. Castro-Galache, J.A. Ferragut, J.L. Soto, A. Carrato, M.Saceda Sanchez

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 175 KB

english, 2003

575

579 Significant tumor growth inhibition of glioblastoma xenografts by NNC 47-0011 — a low molecular weight tricyclic tyrosine kinase modulator with anti-angiogenic activity

R. Cao, Y. Cao, S. Dissing, A.J. Hansen, P.E.G. Kristjansen, U.B. Olsen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 175 KB

english, 2003

576

580 Selective antimetastatic effect of low molecular weight heparin on human melanoma xenograft

J. Timár, B. Bereczky, R. Gilly, J. Tóvári

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

577

581 Treatment with epoetin beta corrects anaemia and decreases transfusion use in patients with solid tumours or haemotological malignancies

M.R. Nowrousian, R. Voigtman

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

578

582 A phase I study of day 1 and 8 every three weeks docetaxel infusion

P.G. Giannessi, R. Di Marsico, F. Martella, C. Galli, F. Russo, A. Antonuzzo, M. Andreuccetti, A. Falcone

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

579

583 Increased effect in hypoxic tumors and blocking of hypoxic upregulation of vascular endothelial growth factor by topotecan

E.L. Lund, P.E.G. Kristjansen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 314 KB

english, 2003

580

584 In vivo action of VEGF, bFGF and angiopoietins in a quantitative angiogenesis assay

C.D. Ley, M.W. Olsen, P.E. Kristjansen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

581

585 VEGF-C and VEGF-D mRNA expressions are rarely involved in the progression of esophageal squamous cell carcinoma

K. Kaneko, Y. Koyama, H. Honma, T. Kanda, S. Nakagawa, K. Hatakeyama

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

582

586 Expression of a novel MMP inhibitor, RECK, in relation with expression of MMPs and angiogenic factors in non-small cell lung cancer

F. Tanaka, K. Takenaka, S. Ishikawa, H. Oyanagi, K. Yanagihara, C. Takahashi, M. Noda, H. Wada

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

583

587 Glomeruloid microvascular proliferations are superior to microvessel density as a marker of angiogenesis in non-small cell lung cancer

F. Tanaka, M. Li, S. Ishikawa, H. Oyanagi, K. Takenaka, Y. Kawano, R. Miyahara, K. Yanagihara, Y. Otake, H. Wada

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 309 KB

english, 2003

584

588 HARP peptides modulate the in vitro angiogenic activity of VEGF

A. Polykratis, E. Papadimitriou, J. Delbe, J. Courty, P. Katsoris

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 154 KB

english, 2003

585

589 The dependence of the in vitro HUVECs proliferation of the TGF-beta concentration in the serum of gastric cancer patients

I. Hipp, V. Brylka, V. Piddubnjak, M. Ohorchak, N. Volodtko, B. Bilynskyj

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 154 KB

english, 2003

586

590 Amifostine modulates endothelial cell proliferation and migration

E. Giannopoulou, D. Kardamakis, E. Papadimitriou

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 319 KB

english, 2003

587

591 Microvessel density of bone metastasis is dependent on the cancer type and therapy

J. Timár, T. Lrincz, J. Tóth, M. Szendri

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

588

592 1p chromosomal deletion and candidate genes mapping in liver fluke related cholangiocarcinoma

P. Jearanaikoon, T. Limpaiboon, B. Sripa, V. Bhudhisawasdi, K. Uchida

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

589

593 Gene expression profilling in papillary thyroid carcinoma: Are there different pathways of carcinogenesis?

B. Jarzab, M. Wiench, J. Wloch, K. Fujarewicz, K. Simek, M. Oczko, A. Czarniecka, S. Szpak, E. Gubala, A. Swierniak

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

590

594 The role of XPD exon 10 polymorphism in susceptibility to ovarian and breast cancer

S. Costa, D. Pereira, D. Pinto, A. Vasconcelos, H. Rodrigues, R. Medeiros

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 336 KB

english, 2003

591

595 UGT1A1 polymorphisms correlate with adverse side effects and clinical response in metastatic colorectal cancer patients treated with irinotecan

E. Marcuello, A. Menoyo, E. Del Rio, M. Gomez-Pardo, M. Balcells, M. Baiget

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

592

596 Ha-ras oncogene induces the metastatic ability of transformed cells in vivo through RalGDS downstream signalling pathway

E. Tchevkina, A. Martinjuk, A. Komelkov, A. Tatosyan

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

593

597 A cytogenic study of Burkitt's lymphoma cell lines; Daudi, Namalwa and Raji

M. Salehi, R. Salehi, M.H. Goyns

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 335 KB

english, 2003

594

598 Identification of two loci of frequent allelic deletion on chromosome 6 involved in cervical cancer progression

I. Beliakov, F. Kisseljov, N. Mazurenko

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

595

599 Promoter hypermethylation of hMLH1 gene in liver fluke related cholangiocarcinoma

T. Limpaiboon, P. Khaenam, M. Soonklang, P. Jearanaikoon, B. Sripa, V. Bhuhisawasdi, C. Pairojkul

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

596

600 The expression of the transcript isoforms oh human Arg gene is differently regulated in different cell types

M. Corizzato, C. D'Orlando, C. Bianchi, P. Mocarelli, R.A. Perego

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

597

601 p53 codon 72 polymorphism in basal cell carcinoma of skin

A. Pezeshki, F. Sari-Aslani, A. Ghaderi, M. Doroudchi

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 331 KB

english, 2003

598

602 Investigating the role of Smad4 in TGF-beta signaling using high density microarrays

J. Collins, T. Cheung, T. Doan, K. Shannon, X. Liu

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

599

603 Polymorphic (CAG)n and (GGC) in androgen receptor and breast and ovarian cancer risk in BRCA12 carriers and non-carriers

H. Zientek, J. Pamula, M. Jarzab, M. Rusin, E. Chmielik, M. Pacocha, W. Pekala, K. Lisowska, E. Grzybowska

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

600

604 HER2 polymorphism and the risk of breast cancer

D. Pinto, D. Pereira, A. Vasconcelos, S. Costa, H. Rodrigues, C. Lopes, R. Medeiros

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

601

605 Reversible deposition of allele-specific primers by excess of complementary oligonucleotides drastically improves the reliability of allele-specific PCR

E. Imyanitov, K. Buslov, E. Suspitsin, E. Kuligina, E. Belogubova, M. Grigoriev, A. Togo, K. Hanson

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 332 KB

english, 2003

602

606 Streptococcal preparation OK-432 is a new GMP-grade maturation factor of monocyte-derived dendritic cells

H. Kuroki, T. Morisaki, K. Matsumoto, A. Tasaki, M. Kubo, K. Nakamura, C. Nakahara, H. Kuga, M. Tanaka, M. Katano

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

603

607 Induction of cytotoxic T lymphocytes that recognize a tumor-associated antigen, 90K/Mac-2 binding protein with an HLA-A2 restriction

Y. Ozaki, K. Kontani, K. Teramoto, N. Tezuka, S. Sawai, S. Fujino

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

604

608 Streptococcal preparation ok-432 induces human dendritic cells maturation via up-regulation of toll-like receptors

N. Kanzaki, M. Terashima, S. Matsuyama, H. Endo, I. Oshibe, T. Saito, H. Yaginuma, Y. Hoshino, M. Kogure, M. Gotoh

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

605

609 Tumour burden and interleukin-2 dose affect the synergism between low-dose total body irradiation and interleukin-2

A. Safwat, N. Aggerholm, J. Overgaard, M. Hokland

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 335 KB

english, 2003

606

610 Dolichol as tumour marker in pancreatic cancer control

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

607

611 EBV-DNA in unfractionated whole blood specimens of patientw with EBV-related diseases and seropositive healthy individuals

C. Karanikiotes, K. Vlachtsis, I. Skiadas, S. Georgakopoulou, M. Karina, S. Papandreou, E. Georgakopoulos, G. Fountzilas

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

608

612 ProteinChip® proteomics for early detection of cancer

M. Caspersen, P. Iversen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

609

613 Effects of p53 status and wortmannin treatment on potentially lethal damage repair in vivo, with emphasis on the response of intratumor quiescent cell populations

S. Masunaga, A. Takahashi, K. Ohnishi, T. Ohnishi, M. Suzuki, K. Nagata, Y. Kinashi, K. Ono

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 331 KB

english, 2003

610

614 Increased sensitivity in the detection of isolated tumor cells (ITC) in bone marrow by automated screening analysis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

611

615 Correlation between sensitivity to capecitabine in xenograft models and mRNA expression levels of pyrimidine-metabolizing enzymes in tumor tissues

K. Mori, H. Yasuno, M. Kurasawa, M. Yanagisawa, Y. Sato, Y. Tanaka

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

612

616 Expression of hMLH1 and hMSH2 proteins in normal tissues and cancer predisposition in hereditary non-polyposis colon cancer

P. Plevova, E. Sedlakova, J. Zapletalova, Z. Kolar

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

613

617 Apoptotic morphology of adherent cells in vital phase-contrast microscopy compared to scanning electron microscopy images

P. Behnam-Motlagh, P. Horstedt, K.G. Engstrom, R. Henriksson, K. Grankvist

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 326 KB

english, 2003

614

617 Urokinase-type plasminogen activator is transcriptionally repressed during 12-o-tetradecanoylphorbol-13-acetate-dependent differentiation of hl-60 cells

C. Park, J.U. Bang, E.J. Yun, J.I. Park, Y.S. Kim, S.G. Paik, W.H. Yoon, S.K. Park, B.D. Hwang, K. Lim

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

615

619 Depending on the microenvironment, nitric oxide may switch to another way of cell death in cervical carcinoma cell lines treated with staurosporine

Y. Baskin, H. Baskin, N. Olgun, I.H. Bahar

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

616

620 Cellular potassium ion deprivation may enhance apoptosis induced by cisplatin

K. Grankvist, P. Behnam-Motlagh, P.-E. Sandstrom, R. Henriksson, L. Marklund

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

617

621 Cell cycle arrest and induction of apoptosis by novel Cdk inhibitor MCS-C2 is associated with deregulated ubiquitination pathway in prostate cancer cells

C. Lee, M. Kim, Y. Cho

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 285 KB

english, 2003

618

622 Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of NF-kappaB activation in human gastric carcinoma cells

C. Nakahara, T. Morisaki, H. Matsunaga, K. Nakamura, N. Yamanaka, H. Kuga, H. Kuroki, E. Baba, M. Tanaka, M. Katano

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 125 KB

english, 2003

619

623 Origin of apoptosis and development of main proapoptic and antiapoptotic signal transduction pathways

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

620

624 DNA damage-inducible interaction of a novel protein with p53

S.L. Wang, T.H. Lao

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

621

625 A naturally occurring constitutively variant of the epidermal growth factor receptor increases cell motility

M.W. Pedersen, V. Tkach, N. Pedersen, V. Berezin, H.S. Poulsen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

622

626 Raltitrexed up-regulate dihydropyrimidine dehydrogenase activity, resulting in antagonism of anti-tumor effect in its combination with 5-fluorouracil

Y. Ogata, Y. Nozoe, Y. Araki, T. Sasatomi, M. Kanazawa, K. Matono, S. Torigoe, Y. Sato, H. Fukumori, K. Shirouzu

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

623

627 Novel trans-acting factor, MMP-2-specific sequence binding protein, is related to TGF-b1-dependent regulation of MMP-2 gene in HL-60 cells

M.Y. Son, C. Park, J.I. Park, Y.S. Kim, S.G. Paik, W.H. Yoon, S.K. Park, B.D. Hwang, K. Lim

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

624

628 Influence of exogenous PTEN on multidrug resistance of human and rodent cells

E. Sherbakova, T. Stromskaya, E. Rybalkina, A. Stavrovskaya

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

625

629 Localization of beta-catenin and its role in the biological characteristics of oral squamous cell carcinoma cells

S. Iwai, W. Katagiri, T. Imai, M. Nakazawa, Y. Yura

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

626

630 Angiotensin Converting Enzyme (ACE)-inhibitor inhibits tumour growth and metastases formation in the Lewis lung carcinoma

H. Lindberg, J. Eriksen, P. Kristjansen, T. Skovsgaard, D. Nielsen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 330 KB

english, 2003

627

631 Nitric oxide up- regulates cyclooxygenase-2 expression through the cAMP- response element in its promoter in a head and neck cancer cell line

S.W. Park, M.W. Sung

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

628

632 Genomic DNA amplification of Decoy receptor 3 (DcR3) correlates with cancer progression of well-differentiated colorectal adenocarcinoma

M. Kawahara, Y. Koyama, C. Kanbayashi, V. Valera, T. Iiai, H. Okamoto, T. Suda, K. Hatakeyama

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

629

633 Specific activation of Akt3 in ovarian cancer

B.E. Cristiano, N.Marmy Cornus, K.M. Hannan, I. Campbell, R.B. Pearson

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 315 KB

english, 2003

630

634 The cytochrome p450 (CYP) family 1 at early stages of carcinogenesis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 154 KB

english, 2003

631

635 Second tumors after treatment for Hodgkin's lymphoma (HL) in children

S. Safonova, A. Malinin, Yu. Punanov

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 154 KB

english, 2003

632

636 Neuroblastoma in adolescents and adults: analysis of a mono-institutional series of 33 consecutive patients

M. Podda, D. Polastri, M. Massimino, P. Collini, L. Gandola, L. Piva, M. Terenziani, M. Casanova, F. Fossati Bellani, R. Luksch

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 154 KB

english, 2003

633

637 Evidence for a redox mechanism of action of prednisolone in childhood acute lymphoblastic leukaemia through the identification of the novel gene CGI-31

A. Burke, P. Kearns, N. Goulden

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 316 KB

english, 2003

634

638 Pharmacodynamics of apilidinR (APL) in experimental models of haematological malignancies (HAMA)

B. Debabrata, G. Kaspers, E. Erba, A. Grossi, M. D'Incalci, J. Jimeno, J. Bertino

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

635

639 Ganglioneuroma in childhood: the Italian experience

P. Angelini, C. Carlini, M. Conte, M. Testa, S. Biasotti, B. De Bernardi

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

636

640 Delay in diagnosis of children with cancer: a retrospective study of 315 children

M. Weyl Ben Arush, M. Haimi, M. Peretz Nahum, H.F. Rennert, K. Katz

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

637

641 Seeking for a second opinion in paediatric oncology

M. Weyl Ben Arush, R. Levy, J. Eid, S. Makhoul

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 334 KB

english, 2003

638

642 Use of high dose fractionated cyclophosphamide and coordinated high dose methotrexate and cytarabine in childhood B cell Non Hodgkin's Lymphoma

S. Sandip, N. Shah, P. Shah, K. Patel, S. Shukla, B. Parikh, A. Anand, S. Talati, H. Panchal, A. Patel

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

639

643 Factors affecting the success or failure of sperm banking in adolescent male cancer patients

G. Makin, B. Edge, D. Holmes

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

640

644 Imminent ovarian failure in childhood cancer survivors

G.M. Lantinga, A.H.M. Simons, A. Postma

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

641

646 Plasma levels of brain natriuretic peptide in children with solid tumors treated by anthracycline chemotherapy

A. Oquz, F.G. Pinarli, C. Karadeniz, S. Tunaoglu, N. Gokcora, S. Elbeg

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

642

647 Elevated blast glutathione levels are associated with decreased sensitivity to prednisolone and to proliferative rate in the in vitro t-cell lymphoblatic leukaemia model CCRFCEM

G.A.A. Burke, S.J. Townend, D.B. Patel, N.J. Goulden, P.R. Kearns

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

643

648 The impact of infectious events in morbidity and mortality in children with ALL treated with ALL-BFM-90 protocol

S. Glamocanin, O. Muratovska, K. Martinova, Z. Antevska, A. Jancevska, B. Conevska, S. Koceva

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

644

649 Treatment results and prognostic factors in osteosarcoma relapse in children

Z. Bekic, V. Svesko, B. Sbutega, R. Jakovic, S. Savic, D. Babic, M. Atanackovic

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 317 KB

english, 2003

645

650 Childhood cancer incidence in the Kyrgyz Republic 1985–1999

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

646

651 Blood and bone marrow transcripts of tyrosine hydroxylase, dopa decarboxylase, and GD2 synthase in neuroblastoma

A. Kullman, C. Träger, P. Kogner, B. Kágedal

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

647

652 Severe sepsis in children treated for leukemia in a single unit in Romania

C.L. Blag, G. Popa, N. Miu, M. Giurgiulescu

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

648

653 Epidemiology of childhood cancer in Bihor and Timis counties during the years 1981–2000

G. Miculschi, M. Serban, L. Ritli, R. Spineanu

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 319 KB

english, 2003

649

654 Symptomatic avascular necrosis of the femoral head in children with ALL

M. Baka, A. Pourtsidis, D. Bouhoutsou, M. Varvoutsi, A. Stassinopoulou, C. Zabakidis, E. Vlachos, H. Kosmidis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

650

655 Dental abnormalities in long-term survivors of childhood cancer

A. Navajas, M. Alapont, J.M. Aguirre, I. Astigarraga, A. Fernandez-Teijeiro, A. Urberuaga

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

651

656 Gonodal toxicity following treatment of lymphoma in childhood

C. Karadeniz, M. Boyraz, A. Oguz, P. Cinaz, G. Pinarli, A. Bideci, H. Bora

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

652

657 The therapeutic approach - a main prognostic factor in paediatric acute lymphoblastic leukemia

S. Arghirescu, M. Serban, L. Ritli, E. Boeriu, C. Jinca, M. Matsiris, B. Zoica

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 274 KB

english, 2003

653

658 Psychological disorders in children with cancer

M. Gerali, D. Paikopoulou, M. Servitzoglou, E. Theophilopoulou, H. Kosmidis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 116 KB

english, 2003

654

659 Space-time clustering analyses of childhood cancers supports a common infectious aetiology

R. McNally, O. Eden, F. Alexander, A. Kelsey, J. Birch

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 116 KB

english, 2003

655

660 IMRT in head and neck as a model in other sites

W. De Neve, W. Duthoy

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

656

661 Integrating molecular biology in the breast cancer management

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

657

662 Neuroendocrine gastrointestinal tumours - diagnosis and treatment

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 319 KB

english, 2003

658

663 Genetic counselling for cancer predisposition

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

659

664 Recording of morbidity

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

660

665 Nuclear medicine in the diagnosis and treatment of paediatric tumours

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

661

666 Will oral drug replace IV treatment?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 328 KB

english, 2003

662

667 Cancer clinical trials - the key to improving outcome

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

663

668 The usefulness of meta-analysis in decision making

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

664

669 A phase III randomized trial of bendamustinehydrochloride, methotrexate, and 5-FU (BMF) versus CMF as first-line treatment of patients with metastatic breast cancer

G. von Minckwitz, I. Chemozemsky, R. Souchon, N. Stuart, J. Vermorken, K. Merkle, M. Kaufmann

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 141 KB

english, 2003

665

670 Phase III comparison of docetaxel (D)and pacilitaxel (P) in patients with metastatic breast cancer (MBC)

P. Ravdin, J. Erban, B. Overmoyer, G.T. Budd, L. Hutchins, E. Lower, L. Laufman, S. Sundaram, W. Urba, S. Olsen, M.L. Meyers, S. Jones

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 141 KB

english, 2003

666

671 Phase III study comparing AT (Adriamycin, Docetaxel) to FAC (Fluorouracil, Adriamycin, Cyclophosphamide) as first-line chemotherapy (CT) in patients with metastatic breast cancer (MBC)

M. Bontenbal, J.J. Braun, G.J. Creemers, A.C. de Boer, J.Th.P. Janssen, M.B.L. Leys, K.L.C. Schothorst, P.I.M. Schmitz, J.J. Bokma, C. Seynaeve

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 310 KB

english, 2003

667

672 Randomised phase II trial (M77001) of trastuzumab (Herceptin®) plus docetaxel versus docetaxel alone, as first-line therapy in patients with HER2-positive metastitic breast cancer

J.-M. Extra, F. Cognetti, S. Chan, D. Maraninchi, R. Snyder, a. Lluch, M. Tubiana-Hulin, D. Grimes, K. Mayne, M. Marty

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

668

673 Shorter survival times following adjuvant endocrine therapy in oestrogen (ER) — and progesterone receptor (PgR) positive breast cancer (BC) overexpressing c-erbB-2 or with an increased expression of vascular endothelial growth factor (VEGF)

B. Linderholm, J. Andersson, E. von Schoultz, R. Fernstad, M. Linderholm, T. Hägerström, A.-L. Borg, L. Skoog, J. Bergh

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

669

674 Topoisomerase II alpha (TOP2A) alterations as a predictive marker for epirubicin sensitivity in 805 high-risk breast cancer patients. A randomised DBCG trial (DBCG89D)

A. Knoop, H. Knudsen, E. Balslev, B. Rasmussen, J. Overgaard, K. Nielsen, A. Schønau, K. Gunnarsdóttir, H. Mouridsen, B. Ejlertsen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 311 KB

english, 2003

670

675 Anastrozole is an effective neoadjuvant therapy for patients with hormone-dependent, locally-advanced breast cancer irrespective of cerbB2 status

A. Milla-Santos, L. Milla, N. Calvo, J. Portella, L. Rallo, J.M. Casanovas, M. Pons, J. Rodes

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 141 KB

english, 2003

671

676 An assessment of fracture rates over time (between 6 and 48 months) in the ATAC (‘Arimidex’, Tamoxifen, Alone or in combination) trial

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 141 KB

english, 2003

672

677 Results of a phase II study of cetuximab in combination with carboplatin in patients (pts) with recurrent or metastatic nasopharyngeal carcinoma (R&M NPC) who failed to a platinum-based chemotherapy

A.T. Chan, M.M. Hsu, B.C. Goh, B.B. Ma, T.W. Liu, M. Millward, A. Chang, M. Mueser, N. Amellal, E. Bessa

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 293 KB

english, 2003

673

678 EGFr expression and histopathological differentiation influence the response to accelerated fractionation in squamous cell carcinomas of the head and neck (HNSCC). Analysis of 702 patients from the randomized DAHANCA 6 and 7 trial

J.G. Eriksen, T. Steiniche, J. Overgaard

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 156 KB

english, 2003

674

679 Pretreatment gene expression profiling value in predicting the clinical outcome of patients with oropharyngeal carcinoma

N. Boehringer-Wyss, S. Clarkson, A.S. Allal

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 156 KB

english, 2003

675

680 HPV infection as prognostic factor in squamous cell cancers (SCC) of oropharynx treated with surgery with or without radiotherapy (RT)

P. Bossi, M. Squadrelli, M. Oggionni, S. Suardi, L.D. Locati, A. Biffi, G. Rinaldi, L. Licitra, G. Cantù, S. Pilotti

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 313 KB

english, 2003

676

681 The FDG standardized uptake value in predicting the outcome in head and neck cancer patients

A.S. Allal, D.O. Slosman, T. Kabdani, M. Allaoua, W. Lehmann, P. Dulgerov

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

677

682 Validation of CT-based Rotterdam/Brussels neck nodal delineation protocol cranial boundary of level II and relevance for sparing of the parotid gland

P. Levendag, H. Est van der, P. Voet, V. Gregoire, B. Heijmen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

678

683 Integration of fractionated stereotactic radiation therapy into the management of nasopharyngeal carcinoma

J. Waldron, L. Gitterman, S. Ladak, S. McKinnon, M. Heydarian, B. Cummings, A. Bayley, J. Kim, J. Ringash, B. O'Sullivan

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 320 KB

english, 2003

679

684 Radiotherapy combined with cisplatin, carboplatin, mitomycin C, and 5-FU single drug or two drug chemotherapy compared to radiotherapy alone in unresectable head and neck cancer — a meta-analysis

W. Budach, T. Hehr, C. Belka, K. Dietz

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

680

685 A phase 3, randomized, double-blind, placebo-controlled study of darbepoetin alfa in patients (pts) with lymphoproliferative malignancies

M. Hedenus, J. San Miguel, D. Watson, J. Matchum, G. Rossi, T.J. Littlewood

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

681

686 Epoetin alfa rapidly increases hemoglobin levels in anemic cancer patients receiving chemotherapy: results from a meta-analysis of nine randomized, placebo-controlled studies

M. Dicato, M. Zagari

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 323 KB

english, 2003

682

687 The oral NK1 antagonist aprepitant for the prevention of chemotherapy induced nausea and vomiting: pooled data from 2 randomized, double-blind, placebo controlled trials

R. Gralla, P. Hesketh, S. Grunberg, D. Warr, F. Roila, S. Chawla, A. Carides, K. Beck, F. Lawson, K. Horgan

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

683

688 Prevention and management of radiation skin reactions: a randomised controlled trial of skin care approaches in patients with breast, head and neck and anorectal cancer

M. Wells, G. Raab, S. MacBride, N. Bell, K. MacKinnon, A. Munro, L. Samuel, R.H. MacDougall, M. MacMillan

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

684

689 Nutrition & patient outcomes: prospective randomised controlled trial in head-neck cancer patients undergoing radiotherapy

P. Ravasco, I. Monteiro Grillo, P. Marques Vidal, M. Camilo

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 323 KB

english, 2003

685

690 Psychological and social aspects of survival of childhood cancer

M. Servitzoglou, D. Papadatou, M. Gerali, I. Tsiantis, H. Kosmidis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

686

691 Impact of the nutritional status in geriatric oncology

C. Terret, G. Albrand, D. Perol, P. Bachmann, C. Fingal, Y. Lallemand, P. Roux, J.P. Droz

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

687

692 Massage and aromatherapy massage for symptom relief in patients with cancer: a Cochrane systematic review

S. Wilkinson, D. Fellowes, K. Barnes, K. Lockhart-Wood

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

688

693 Does increasing dose intensity in patients with operable osteosarcoma of the extremity improve outcome? A randomised controlled trial of the European Osteosarcoma Intergroup (EOI)

M. Nooij, I. Lewis, J. Whelan, S. Casak, M. Memon, P. Hogendoorn, S. Weeden, B. Uscinska, M. van Glabbeke, A. Kirkpatrick

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

689

694 EORTC 62011: phase II trial of brostallicin for soft tissue sarcoma

M.G. Leahy, J.Y. Blay, J. Verweij, A. Le Cesne, F. Duffaud, P.C.W. Hogendoorn, C. de Balincourt, V. Evrard, I. Judson

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

690

695 An EORTC phase I study to determine the safety of combined caelyx and ifosfamide in previously untreated adult patients with advanced or metastatic soft tissues sarcomas

O.S. Nielsen, P. Reichardt, D. Pink, J. Lindegaard, S. Daugaard, C. Hermans, M. van Glabbeke, I. Judson

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

691

696 Management of local recurrences of soft tissue sarcomas in an irradiated field after prior surgery and radiotherapy: the role of TNF-based isolated limb perfusions to achieve limb salvage

D. Grünhagen, T.E. Lans, J.H.W. de Wilt, A.N. van Geel, A.M.M. Eggermont

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

692

697 Assessment of the tolerability, safety and efficacy of increasing doses of peginterferon alfa-2a (40KD) in a randomised study in patients with metastatic malignant melanoma

R. Dummer, C. Garbe, J.A. Thompson, A.M. Eggermont

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

693

698 Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft tissue sarcoma

T. van Dalen, A. Hennipman, F. van Coevorden, H.J. Hoekstra, A.N. van Geel, P. Slootweg, Ch.F. Albus Lutter, M.F. Brennan, S. Singer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

694

699 Synergistic antitumor activity of histamine in combination with chemotherapy in the regional treatment of soft tissue sarcomas

F. Brunstein, S. Hoving, S. van Tiel, T.L.M. ten Hagen, A.M.M. Eggermont

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 321 KB

english, 2003

695

700 High serum levels of total MMP-9 and active MMP-13 are associated with rapid progression in patients with metastatic melanoma

P. Vihinen, J. Nikkola-Paakkarinen, M.-S. Vuoristo, P. Kellokumpu-Lehtinen, V.-M. Kähäri, S. Pyrhönen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

696

701 Quantification of angiogenesis as a prognostic marker in 977 human carcinomas: A critical evaluation of the consensus on histopathological methods for estimation of vascular density

B. Offersen, M. Borne, J. Overgaard

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

697

702 Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo

S. Ohtani, S. Kagawa, T. Fujiwara, Y. Tsunemitsu, N. Tokunaga, J. Roth, N. Tanaka, T. Fujiwara

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

698

703 Expression of the Ets-2 transcription factor in human breast cancer

Y. Buggy, T. Maguire, G. McGreal, A.D.K. Hill, E. McDermott, N. O'Higgins, M.J. Duffy

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

699

704 Expression of maspin in gastric cancer

M. Terashima, C. Maesawa, K. Oyama, S. Ohtani, N. Kanzaki, M. Gotoh, A. Takagane, K. Saito, M. Shirane, K. Mori

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

700

705 A naturally occurring type III variant mutant EGF receptor confers a strong cytoprotective response to ionizing radiation

G. Lammering, T. Hewitt, J. Contessa, K. Valerie, P.-S. Lin, R. Mikkelsen, G. Schmitt, R. Schmidt-Ullrich

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

701

706 In vitro and in vivo efficacy of a HIF-1alpha-antisense oligonucleotide containing locked nucleic acids

A. Hoeg, C. Thrue, H. Oerum, P. Kristjansen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 334 KB

english, 2003

702

707 Identification and characterization of DEGA, a novel leucine-rich repeat family member differentially expressed in human gastric adenocarcinoma: effects on cell cycle and tumorigenicity

D.S. Pereira, K.E. Rabenau, J. O'Toole, K.A. Kobylarz, S.B. Kaplan, H. Kotanides, R. Bassi, L. Witte

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

703

708 MSD-EACR research award. Celecoxib activates a novel mitochondrial apoptosis signaling pathway

V. Jendrossek, R. Handrick, C. Belka

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

704

709 Outcome and patterns of failure in solitary plasmacytoma: a multicenter rare cancer network study on 258 patients

M. Ozsahin, R. Tsang, P. Poortmans, Y. Belkacemi, M. Bolla, F. Oner, C. Landmann, B. Castelain, J. Buijsen, D. Knobel

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 327 KB

english, 2003

705

710 In vivo assessment of radiation induced apoptosis in follicular lymphoma patients by 99mTc-Annexin V scintigraphy

R.L.M. Haas, R.A. Valdés-Olmos, D. de Jong, S.F. Zerp, I. van den Heuvel, C.A. Hoefnagel, H. Bartelink, M. Verheij

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

706

711 Localized mucosa-associated lymphoid tissue (MALT) lymphoma treated with radiation therapy has excellent clinical outcome

R.W. Tsang, M.G. Gospodarowicz, M. Pintillie, W. Wells, D.C. Hodgson, A. Sun, M. Crump, B.J. Patterson

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

707

712 Improved survival at the cost of neurotoxicity in primary CNS lymphoma (PCNSL). Long-term follow-up of a Phase 2 multicentre combined modality study (Trans-Tasman Radiation Oncology Group-TROG)

P.C. O'Brien, D.R. Roos, G. Pratt, K. Liew, M. Barton, M. Poulsen, I. Olver, G. Trotter

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

708

713 Prospective study of 18FDG-PET in patients with cervical lymph node metastases from an unknown primary tumor

J. Johansen, A. Eigtved, S. Buus, T. Bundgaard, J. Marving, J. Kirkegaard, S. Kelding, M. Overgaard, H.S. Hansen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

709

714 Hypoxia within human prostate cancer: a correlation of quantified BOLD MRI with pimonidazole immunohistochemistry

D.M. Carnell, N.J. Taylor, R.E. Smith, J.J. Stirling, A.R. Padhani, P.J. Hoskin

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

710

715 Biodistribution of radiolabelled liposomal doxorublcin in mice by scintigraphic imaging

M. Frier, S.H. Yong, A.C. Perkins, M. Garnett, P. Daza-Ramirez

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 266 KB

english, 2003

711

716 Detection and characterisation of novel billary metabolites of the anticancer agent ifosfamide using in-vivo and analytical 31P MRS and mass spectrometry

G.S. Payne, A.S.K. Dzik-Jurasz, L. Mancini, B. Nutley, F. Raynaud, M.O. Leach

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 105 KB

english, 2003

712

717 Risk adapted treatment for childhood hepatoblastoma (HB): final report of the second study of the International Society of Paediatric Oncology SIOPEL' 2

G. Perilongo, E. Shafford, L. Brugieres, P. Brook, R. Maibach, P. Czauderna, G. Mackinlay, D. Aroson, M. Childs, J. Plaschkes

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 265 KB

english, 2003

713

718 Treatment results in high risk hepatoblastoma: analysis of prognostic factors. Results from SIOPEL 2 and 3 trials

J. Zsiros, R. Maibach, G. Perilongo, P. Brock, P. Czauderna, L. Brugieres, G. MacKinlay, A. Zimmermann, D. Roebuck, J. Plaschkes

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

714

719 Hepatocellular carcinoma in children — results of the second prospective study of the International Society of Paediatric Oncology (SIOP) - siopel-2

P. Czauderna, R. Maibach, J. Pritchard, D. Aronson, G. MacKinlay, E. Shafford, A. Zimmerman, J. Plaschkes, J.B. Otte, G. Perilongo

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

715

720 Indefinite radiotherapy of anaplastic ependymomas and supratentorial PNET in babies and infants: results of the German HIT-SKK 87 and 92 trials

B. Timmermann, R.D. Kortmann, J. Kühl, S. Rutkowski, C. Meisner, M. Bamberg

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 328 KB

english, 2003

716

721 Risk of second primary cancer in hereditary and non-hereditary retinoblastoma: results from a population based study with more than 40 years follow-up

J. Alsner, J.H. Olsen, N. Ehiers, J. Overgaard

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

717

722 Detection of relapse in childhood solid tumours

L. Howell, A. Mensah, B. Brennan, T. Eden, A. Will, R. Stevens, G. Makin

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

718

723 CPMP guidance in paediatric oncology

F. Rotblat, Ö. Anak, G. Apolone, E. Baumelou, J. Boos, H.N. Caron, J. Ersbøll, M. Gárdmark, U. Hermes, A. Mathieu-Boué, B. Morland, J. Otten, I. Papadouli, F. Pignatti, M.T. San Miguel, G. Vassal

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

719

724 Caring for survivors of childhood cancers: the size of the problem

J.R. Mann, H.L. Curry, S.E. Parkes, J.E. Powell

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 330 KB

english, 2003

720

725 Socio-economic status and breast cancer in Denmark

H. Danø, K. Kasper Daniel Hansen, M. Marianne Ewertz, J. Jørgen Holm Petersen, E. Elsebeth Lynge

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

721

726 Influence of obesity on prognosis after breast cancer in Denmark

M. Ewertz, S. Cold, K.A. Gunnarsdottir, M. Jensen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

722

727 Prognostic characteristics and mortality from breast cancer in women using hormone replacement therapy (HRT)

C. Stahlberg, E. Lynge, Z.J. Andersen, N. Keiding, Y.H. Andersen, E.B. Obel, S. Moeller, B. Ottesen, A.T. Pedersen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 248 KB

english, 2003

723

728 Breast cancer incidence among mothers of a population-based series of 2604 children with cancer: evidence of mother-fetal interaction

D. Pang, J. Birch

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 86 KB

english, 2003

724

729 Self reported stress levels predict subsequent breast cancer in a cohort of Swedish women

Ö. Helgesson, C. Cabrera, L. Lapidus, C. Bengtsson, L. Lissner

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 86 KB

english, 2003

725

733 Genetic predisposition to breast cancer: what can be done?

A. Costa, W. Gatzemeier

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

726

734 Genetic predisposition to colon cancer: what is known?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

727

735 Genetic predisposition to colon cancer: what can be done?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

728

736 Molecular concepts

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

729

737 Integration of functional imaging (PET) into radiotherapy planning of non-small cell lung cancer

K. De Jaeger, E.F.I. Comans

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

730

738 Has the page turned for adjuvant treatments?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

731

739 The role of chemotherapy

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 334 KB

english, 2003

732

740 Secondary cancer as a side-effect to treatment of malignancies

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

733

741 Late effects of paediatric bone marrow transplantation. Results of a single institution

O. Oberlin, C. Soler, P. Nottoghem, D. Valteau, E. Benahmou, N. Corradini, M.C. Mathieu, O. Hartmann

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

734

742 Long-term risk of cardiovascular disease following treatment for cancer

F.E. van Leeuwen, M.J. Hooning, B.M.P. Aleman

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 322 KB

english, 2003

735

743 Understanding of treatment related late effects using radiation induced fibrosis as an example

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

736

744 FECS EUROCARE pilot study on late outcomes of colorectal cancer treatment

J.P. Gérard, G. Gatta, A. Zurlo, J. Foubert, P. Casali, J. Faivre, J. Esteve, M. Feneley, F. Berrino

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

737

745 An overview of decision making — who has a right to decide?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 315 KB

english, 2003

738

746 The European approach to approving new anticancer medicines

M. Marty, N. Bedairia, J.P. Armand

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

739

747 Setting priorities in health budgeting in Finland

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

740

750 Combined chemo-radiotherapy

A. Alimonti, E.M. Ruggeri, F. Cognetti

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

741

751 Larynx preservation: What is new in radiotherapy?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

742

752 There is still a place for surgery

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

743

753 Chemokines, chemokine receptors and selectin ligands expression by tumour cells: Involvement in extravasation and metastasis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

744

754 Role of plasminogen activation system

K. Danø, L.R. Lund, K. Almholt, M. Johnsen, T.H. Bugge, B.S. Nielsen, J. Rømer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

745

755 Stroma activation and anglogenesis in tumour progression

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

746

756 The role of TGF-β in radiation responses

M.H. Barcellos-Hoff

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

747

757 Hypoxic tumour environment and its implication for cancer treatment

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

748

758 Clinical consequences of node negative being positive in breast cancer

M. Colleoni, N. Rotmensz, G. Viale, G. Renne, A. Luini, P. Veronesi, M. Intra, G. Peruzzotti, A. Cardillo, A. Goldhirsch

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

749

759 Minimal tumour cell involvement in lymph nodes in GI-and NSCL cancer

J.R. Izbicki, S.B. Hosch

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

750

760 Can we trust the sentinel lymph node in melanoma?

O.E. Nieweg, S.H. Estourgie, R.A. Valdés Olmos, C.A. Hoefnagel, B.B.R. Kroon

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

751

761 Micrometastases in lymph nodes in urological tumours

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

752

762 The importance and validation of molecular imaging

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 336 KB

english, 2003

753

763 Developments in MRI and MRS for biological/functional imaging

J.R. Griffiths, C. Ludwig, D.J.O. McIntyre

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

754

764 Prioritising PK/PD endpoints for molecular imaging

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

755

766 Clinical molecular imaging in oncology drug development and radiotherapy

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

756

767 Biological insights into breast cancer: results from the ATAC and prevention trials

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 69 KB

english, 2003

757

768 Efficacy of oral UFT for adjuvant chemotherapy after complete resection of non-small cell lung cancer: Meta-analysis of six randomized trials in 2003 patients

C. Hamada, M. Ohta, H. Wada, S. Fujimura, K. Kodama, M. Imaizumi, Y. Nakanishi, N. Matsuoka

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 147 KB

english, 2003

758

769 Reducing health care burden for the treatment of toxicity associated with pemetrexed or docetaxel in patients with advanced non-small cell lung cancer who previously received chemotherapy: application to the UK setting

L. Bushill-Matthews, D. Jackson, M. Aristides, J. von Pawel, F. De Marines, R. Gervals, F. Shepard, N. Leighl, A. Liepa

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 147 KB

english, 2003

759

770 Final results of phase II trial of s-1 plus cisplatin (CDDP) in patients with non-small-cell lung cancer (NSCLC)

K. Yoshimori, Y. Ichinose, H. Sakai, Y. Nakai, T. Sugiura, M. Kawahara, H. Niitani

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 312 KB

english, 2003

760

771 Paclitaxel and carboplatin as adjuvant treatment in high-risk patients with operable non-small cell lung cancer (NSCLC): A feasibility study conducted by the hellenic cooperative oncology group (HeCOG)

H. Timotheadou, Ch. Christodoulou, Ch. Papakonstantinou, S. Papadopoulos, J. Skrickova, E. Samantas, P. Papakostas, G. Fountzilas

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

761

772 Comparison of two cisplatin based doublets (Gemcitabine/Cisplatin, Etoposide/Cisplatin) in advanced non-small cell lung cancer

M. Marian, T.E. Ciuleanu, N. Todor, C.L. Cebotaru, D. Iancu, N. Ghilezan

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

762

773 Clinical usefulness of tumor marker CYFRA 21-1 in surgical treatment of lung cancer

R. Pavicevic, G. Bubanovic, Z. Janevski, A. Krajna, D. Stancic-Rokotov, J. Karadza, I. Nikolic, D. Jalsevac, Z. Slobodnjak

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 339 KB

english, 2003

763

774 Quality of life assessment and final results of a randomized Phase II study with single-agent gemcitabine and docetaxel given sequentially every 3 weeks show effective treatment in advanced NSCLC

L.R. Pilz, G. Koschel, J. Mezger, K. Schott, W. Spengler, C. Manegold

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

764

775 Standards of care for patients with small cell lung cancer (SCLC): a survey of clinical practice within the European Union (EU)

P.E. Postmus, G. Dane, G.A. Ross

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

765

776 An economic analysis of the TAX 326 trial: a multicenter randomized study of docetaxel + cisplatin (DC) or docetaxel + carboplatin (DCb) vs. vinorelbine + cisplatin (VC) as first-line therapy in advanced non-small cell lung cancer (NSCLC)

N. Leighl, F.A. Shepherd, W.S. Tsao, P. Lindgren, C.B. Belani, F.V. Fossella, P.G. Goodwin

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 336 KB

english, 2003

766

777 A multi-institutional trial comparing survival of patients with brain metastases from lung cancer treated with temozolomide plus radiotherapy versus radiotherapy alone

D. Antonadou, N. Coliarakis, M. Paraskevaidis, H. Athanasiou, G. Sarris, M. Synodinou, G. Georgakopoulos, C. Beroukas, P. Karageorgis, N. Throuvalas

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

767

778 UPA and PAI-1 are associated with angiogenesis but not prognosis in non-small cell lung carcinoma

B. Offersen, P. Pfeiffer, P. Andreasen, J. Overgaard

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

768

779 A pilot study of hyperfractionated accelerated radiotherapy (HART) following induction cisplatin and vinorelbine for stage III non-small cell lung cancer (NSCLC)

S. Ishikura, Y. Ohe, K. Nihei, K. Kubota, R. Kakinuma, H. Ohmatsu, K. Goto, S. Niho, Y. Nishiwaki, T. Ogino

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

769

780 A phase II study of cisplatin (CDDP) and epirubicin (EPI) in malignant pleural mesothelloma (MPM). A study by the European Lung Cancer Working Party (ELCWP)

T. Berghmans, J.J. Lafitte, B. Stach, P. Recloux, J. Lecomte, C. Collon, V. Ninane, J. Klastersky, J.P. Sculier

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 337 KB

english, 2003

770

781 A randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non-small cell lung cancer (NSCLC)

J. Iglesias, C. Crombie, W.I. Burns, C. Karapetis, R.M. Lowenthal, F. Kirsten, J.A. Davidson, F. Abell, W.H.H. Reece, P. DeSouza

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

771

782 CPT-11-Gemcitabine as second line chemotherapy in small cell lung cancer (SCLC). A multicentric phase II trial

M. Domine, M. Provencio, R.Garcia Gomez, J.L. Gonzalez Larriba, D. Isla, J. Terrasa, J. Andrade, I. Maeslu, L.G. Estevez, F. Lobo

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

772

783 New EGFR variants around the EGFRvIII region in non-small cell lung cancers(NSCLC)

M. Sugita, F.R. Hirsch, W.A. Franklin

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 304 KB

english, 2003

773

784 Increased tumor control probability (TCP) and radiation dose escalation by FDG-PET planning of patients with N2/N3 Mo non-small cell lung cancer (NSCLC): A modeling study

A. van der Wel, S. Nijsten, S. Bentzen, M. Hochstenbag, U. Bull, L. Lutgens, R. Wanders, B. Wouters, P. Lambin, D. De Ruysscher

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 133 KB

english, 2003

774

785 The value of the expression of thyroid transcription factor-1 (TTF-1) in malignant pleural effusion smears for distinguishing primary from metastatic lung carcinomas

P. Athanassiadou, M. Gonidi, A. Liossi, E. Petrakakou, A. Bandis, P. Athanassiades

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 133 KB

english, 2003

775

786 Intratumoral homogeneity of gelatinolytic activity in resected lung adenocarcinoma

R. Nakahara, K. Nagai, Y. Nishiwaki, A. Ochiai

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 133 KB

english, 2003

776

787 Pharmacodynamic study of serum EGFR and HER2 in patients with non-small cell lung cancer treated with ZD 1839

V. Gregorc, G.L. Ceresoli, F. Cappuzzo, I. Floriani, V. Ludovini, K. Bencardino, A. Spreafico, L. Pistola, M. Tonato, E. Villa

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

777

788 Pretreatment clinical prognostic factors influencing survival in patients with stage III non-small cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy (HFX RT) with or without concurrent chemotherapy (CHT)

B. Jeremic, B. Millicic, A. Dagovic, S. Dagovic, J. Stankovic, J. Aleksandrovic, S. Bosnjakovic

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

778

789 A meta-analysis of efficacy data from two randomised studies on oral topotecan in patients with relapsed SCLC

J. Eckardt, J. von Pawel, Z. Papai, P. Wissel, G.A. Ross

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

779

790 Evaluation of six serum tumour markers in patients with non-small cell lung cancer

M. Vaslamatzis, V. Vrionis, L. Kyriou, P. Stassinopoulou, C. Petraki, N. Alevizopoulos, E. Patila, K. Delaki, S. Xynogalos, C.G. Alexopoulos

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 324 KB

english, 2003

780

791 Phase I study with topotecan and simultaneous radiation in patients with non small cell lung cancer stage III B

T. Hehr, G. Grabenbauer, F. Zimmermann, W. Hoffmann, M. Bamberg, W. Budach

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

781

792 Novel DAF variants in human lung and non-small cell lung cancers

F. Osuka, Y. Endo, M. Higuchi, H. Suzuki, Y. Sio, K. Fujiu, R. Kanno, T. Fugita, M. Gotoh

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

782

793 Multicenter phase II study of gemcitabine-oxaliplatin (GEMOX) chemotherapy in untreated locally advanced or metastatic non-small cell lung cancer (NSCLC) patients

F. Cappuzzo, S. Novello, F. De Marinis, M. Maur, G. Scagliotti, S. Salvagni, E. Crucitta, S. Bartolini, A. Maestri, L. Crino

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

783

794 Weekly paclitaxel (W-PAC) as second-line therapy in cisplatin pretreated patients with advanced non-small cell lung cancer (NSCLC)

G.L. Ceresoli, V. Gregorc, S. Cordio, K. Bencardino, A. Spreafico, C. Cozzarini, R. Bordonaro, E. Villa

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

784

795 Vinorelbin (VNB) and gemcitabine (gem) in unfit or elderly patients (pts) affected by advanced non small cell lung cancer (NSCLC): may sequential administration

P. Amadio, D. Priolo, G. Antonelli, S. Cali, P. Colina, M. Mattina, F. Vitale, F. Ferrau

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

785

796 Bronchoscopic radioisotope injection for sentinel lymph-node mapping in potentially resectable non-small-cell lung cancer

D. Lardinois, T. Brack, A. Gaspert, T. Spahr, D. Schneiter, H.C. Steinert, W. Weder

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

786

797 Effects of concomittant cisplatin and normofractionated radiotheraphy on inoperable non-small-cell lung cancer

O. Pradier, K. Lederer, H. Schmidberger, E. Weiss, C.F. Hess

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 325 KB

english, 2003

787

798 Impact of third line ZD 1839 therapy on patients with advanced non-small cell lung cancer (NSCLC) who had failed prior platinum and/or docetaxel-based regimens (Astra Zeneca Expanded Access Programme)

F. De Marinis, A. Mancuso, O. Martelli, M.R. Migliorino, R. Di Salvia

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

788

799 Randomized trial of docetaxel plus clsplatin (DC) versus etoposide plus cisplatin (EC) in locally advanced, recurrent, or metastatic non-small cell lung cancer (NSCLC)

H.S. Park, S.J. Lee, J.H. Kim, M.J. Ahn, J.A. Lee, C.Y. Yim, C.S. Kim, S. Mun, Y.S. Lee

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

789

800 The placental growth factor (PIGF) gene is more highly expressed in small cell lung cancers compared to non-small cell lung cancers

I.S. Woo, M.J. Park, J.A. Lee, Y.I. Park, Y.S. Park, H.K. Ahn, Y.S. Hong, K.S. Lee

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

790

801 Oral chemotherapy and upper gastro-intestinal tolerance (UGT) improvement of nausea and vomiting in non-small-cell-lung-cancer (NSCLC) patients (pts) treated with oral navelbine (NVB) and standard antiemetic prophylaxis

C. Gridelli, Y. Parlier, M. Brandely, D. Aubert, L. Nguyen, J. Jassem

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 327 KB

english, 2003

791

802 Multicenter phase II trial of weekly Taxol and paraplatine as first line treatment in elderly patients with non small cell lung cancer (NSCLC): preliminary results

J.-L. Pujol, B. Milleron, E. Quoix, A. Depierre, J.-L. Breton, R. Gervais, D. Debieuvre, S. Hominal

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

792

803 Phase I/II and pharmacokinetic study of vinflunine (VFL) in combination with clsplatin (CDCP) for treatment of advanced non-small cell lung cancer (NSCLC) in chemonaive patients: Preliminary results

M. Krzakowski, R. Ramlau, M. Pinel, G. Zorza, C. Colin, P. Souquet

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

793

804 Navelbine and cisplatin with concurrent radiotherapy for unresectable stage III NSCLC

P. Rusu, T.E. Ciuleanu, D. Cernea, D. Pelau, V. Gaal, C. Cebotaru, D. Lancu, T. Guttman, N. Todor, N. Ghilezan

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 338 KB

english, 2003

794

805 Mitogen-activated protein kinase (MAPK) and Akt as predictive factors for response to ZD 1839 therapy in non-small cell lung cancer (NSCLC) patients

F. Capuzzo, V. Gregorc, K. Bencardino, L. Lombardo, E. Magrini, T.C. Paties, G.L. Ceresoli, S. Bartolini, E. Villa, L. Crino

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

795

806 Phase 2 study of first line chemotherapy using CT-2103 (XYOTAX) in patients with non-small-cell lung cancer who are > 69 years of age or who have performance status (PS) = 2

D. Bodkin, M. Neubauer, M.G. Bolton

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

796

807 Phase I trial of cisplatin, etoposide and CPT-11 triplet in patients with advanced stage SCLC. A hellenic cooperative oncology group study

E. Briasoulis, E. Samantas, H. Kalofonos, D. Skarlos, C. Christodoulou, G. Fountzilas, A. Barnias, M.A. Dimopoulos, P. Kosmidis, N. Pavlidis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 325 KB

english, 2003

797

808 Early recognition of local relapse of lung cancer by follow-up of tumor marker CYFRA 21-1 level

R. Pavicevic, G. Bubanovic, A. Krajna, M. Samarjija, D. Stancic-Rokotov, L. Pavlovic, I. Aleric, Lj. Pavellic

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

798

809 CT-guided stereotactic radiation therapy for stage I non-small cell lung cancers

M. Uematsu, J. Wong, A. Shioda, H. Taira, Y. Hama

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

799

810 The influence of radiotherapy of lung function in patients with non-small cell lung cancer

P. Sørensen, A. Darnkier, J. Baekke, O. Hansen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

800

811 Adjuvant therapy with gefitinib (‘Iressa’, ZD1839) following complete resection in Japanese patients with non-small-cell lung cancer: safety report of the first 38 patients recruited

H. Tada, M. Tsuboi, T. Mistudomi, M. Aoe, Y. Ichinose, K. Nakagawa, T. Koike, H. Saeki, M. Fukuoka, H. Kato

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

801

812 The impact of gender on outcomes in limited stage small cell lung cancer treated with concurrent chemoradiation

G. Videtic, F. Whiston

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

802

813 Preoperative concurrent chemoradiotherapy in non-small-cell lung cancer. Feasibility, toxicity and long-term results of a phase II study

N. Viñolas, F. Casas, Jm. Gimferrer, C. Agusti, J. Belda

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

803

814 Quantitative analysis of LUN expression, trans-activator of e-cadherin gene

H. Oyanagi, K. Takenaka, S. Ito, S. Ishikawa, Y. Kawano, K. Yanagihara, Y. Adachi, K. Ueda, F. Tanaka, H. Wada

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

804

815 Elderly patients (pts) with unresectable localised or metastatic non-small-cell-lung-cancer (NSCLC): results of a phase II study with oral navelbineâ (nvb) given as a weekly monotherapy and first line treatment

U. Gatzemeier, F. De Marinis, C. Manegold, P. Mali, L. Portalone, O. Castelnau, R. Stahel, D. Betticher, J.Terrassa Pons, C. Gridelli

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 336 KB

english, 2003

805

816 Malignant pleural mesothelioma (MPM): analysis of consecutive 65 patients (pts)

A. Santo, M. Giovannini, A. Terzi, R. Pedersini, A. Tommasini, G. Festi, A. Cipriani, G. Falezza, G.A. Soardi, G. Cesaro, P. Manno, M. Pavarana, F. Maluta, F. Calabrò, G.L. Cetto

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 177 KB

english, 2003

806

817 Optimized schedule of gemcitabine (G), paclitaxel (T) and cisplatin (P) in the treatment of stage IIIB/IV non-small cell lung cancer (NSCLC): results of a phase II study

F. Nelli, F. De Marinis, G. D'Auria, A. De Pasquale Ceratti, M.R. Migliorrino, G. Metro, M. Di Molfetta, M.L. Evangelista, E. Cortesi

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 177 KB

english, 2003

807

818 Results of postoperative radiotherapy for pathological stage III and surgical margin close or positive T3N0 NSCLC

F.Oner Dincbas, B. Ceylaner, M. Sar, B. Eren, B. Oz, S. Koca

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 322 KB

english, 2003

808

819 Induction carboplatin-paclitaxel-gemcitabine (CPG) followed by concurrent weekly carboplatin-paclifaxel (CP) and radiation therapy in unresectable stage iii non-small cell lung cancer (NSCLC). A phase II study

O. Francesco, A. Paccagnella, S. Fasan, S. Ardit, C. Gatti, R. Biason, M. Medici, P. d'Amanzo, M.G. Ghi, O. Nasicmben

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

809

820 TGF-beta1 suppression by the antisense oligonucleotide AP 11014 as treatment strategy for non-small cell lung cancer and colorectal cancer

P. Jachimczak, K.-H. Schlingensiepen, R. Schlingensiepen, A. Bischof, K. Graf, M. Hafner, M. Kielmanowicz, M. Szyrach, G. Stauder

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

810

821 MRP functional activity is revealed in most non-small cell lung cancer (NSCLC)

T.A. Bogush, A. Ravcheeva, A. Bogush, Y. Shishkin, T. Zabontina, Z. Kadagidze, K. Laktionov, B. Polotskiy, A. Barishnikov

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 304 KB

english, 2003

811

822 Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients

F. Guadagni, P. Ferroni, S. Basil, F. Facciolo, S. Carlini, M. Crecco, F. Martini, A. Spilla, T.C. Mineo, M. Roselli

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

812

823 A full navelbine oral (NVB oral) treatment in combination with cisplatin (P) followed by NVB oral single agent as consolidation therapy in advanced non small-cell lung cancer (NSCLC)

R. Ramlau, O. Hansen, L. Wagner, S. Barni, V. Alberola, R. Huber, C. Colin, M. Mitrovic, J. Gasmi, M. De Lena

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

813

824 Role of gross tumour volume and dose parameters on outcome and toxicity of patients undergoing concurrent chemoradiotherapy for locally advanced non-small cell lung cancer

L. De Petris, S. Friesland, I. Lax, F. Sirzen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 322 KB

english, 2003

814

825 Statistical analysis of survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib (‘Iressa’, ZD1839) in an expanded access program (EAP): preliminary results

M. Wolf, D. Farina-Sisofo, J. Grous, G. Kennealey, J. Ochs

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

815

826 The role of her-2/neu expression on the survival of patients with non-small cell lung cancer (NSCLC). A systematic review of the literature with meta-analysis

T. Berghmans, A.P. Meert, M. Paesmans, B. Martin, C. Mascaux, J.M. Verdebout, P. Delmotte, J.J. Lalittle, J.P. Sculier

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

816

827 A phase II randomized study comparing docetaxel/clsplatin induction therapy followed by thoracic radiotherapy with or without weekly docetaxel in unresectable stage IIIA–IIIB non-small cell lung cancer

C. Manegold, J. Debus, E. Buchholz, G.V. Scagliotti, U. Ricardi, F. Cardenal, K. Mattson, R. Ramlau, A. Szczesna, N. van Zandwijk, A. Price, A. Morel

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 318 KB

english, 2003

817

828 cKIT expression in adult primitive neuroectodermal tumor (PNET) and Ewing's sarcoma: a retrospective immunohistochemical study

I.O. Kara, S. Erdogan, B. Sahin, M. Ergin, G. Gönlüsen, S. Paydas

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 156 KB

english, 2003

818

828A Vascular endothelial growth factor levels in melanoma, relationship with coagulation and platelet activation markers

F. Guadagni, P. Ferroni, S. Bucher, F. Di Filippo, V. Ferraresi, C. Catricalà, M. Roselli, F. Cognetti

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 156 KB

english, 2003

819

829 Adults with Ewing's sarcoma/PNET: Is it possible to improve survival (Phase II trial: Induction chemostherapy adriablastin-cisplatin)

Z. Tomasevic, M. Mihailovic, S. Jellic, D. Ristic, N. Milanovic, A. Karaferic

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 156 KB

english, 2003

820

830 A clinicopathologic review of uncommon vascular hemagioperlycytomas with follow up and analysis of outcome: a 12 year study

K. Gupta, O.P. Singh, N. Kapoor, H.U. Ghori

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 315 KB

english, 2003

821

831 Post-operative radiotherapy for soft tissue sarcoma of the anterior compartment of the thigh: should the sartorius muscle be included?

G.C. Barnett, A. Hoole, N. Twyman, S. Jefferies, N. Burnet

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

822

832 Ifosfamide, carboplatin, etoposide induces a 50% overall response rate and 1 year overall survival rate in patients with recurrent/refractory soft tissue and bone sarcoma: Embryonal rhabdomyosarcoma histology and complete response to ICE are independent factors significantly associated with improved survival

M.S. Cairo, V. Davenport, P. Van Winkle, K. Cheung, A. Angiolillo

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

823

833 Pterin-dependent tyrosine hydroxylase mRNA is not expressed in human melanoma cells

B. Kågedal, M. Johansson, A. Kullman, L. Lenner, C. Träger

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 302 KB

english, 2003

824

834 Second-line treatment of disseminated malignant melanoma with Fotemustine

M. Weichenthal, M. Weichenthal, K. Neuber, P. Mohr, U. Trefzer, M. Fluck, J. Ulrich, J.C. Becker, U. Reinhold, M. Volkenandt

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 143 KB

english, 2003

825

835 Primary mucosal malignant melanoma - a retrospective single centre study

N. Costa, V. Angélico, M. Soares, I. Azevedo, J. Dinis, M. Lopes, C. Azevedo

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 143 KB

english, 2003

826

836 Interferon-induced STAT 1 activation in malignant melanoma cells and tumor tissues

V. Boudny, L. Lauerova, I. Kocak, V. Fait, J. Kovarik

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

827

837 Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous (SC) interleukin-2 (IL-2) and interferon-alpha-2b (IFN) in metastatic melanoma

E. Bajetta, M. Del Vecchio, P. Nova, L. Gattinoni, M. Santinami, D. Santangelo, A. Daponte, M.R. Sertoli, P. Queirolo, M.G. Bernengo

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

828

838 Randomised trial of dacarbazine versus BOLD chemotherapy combined with natural or recombinant alfa-interferon in patients with advanced melanoma

M.-S. Vuoristo, M. Hahka-Kemppinen, L.-M. Parvinen, S. Pyrhönen, H. Seppä, M. Korpela, P. Kellokumpu-Lehtinen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

829

839 Hypoxia-inducible factors 1a and 2a in skin malignant melanomas

A. Giatromanolaki, E. Sivridis, C. Kouskoukis, K.C. Gatter, A.L. Harris, M.I. Koukourakis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 323 KB

english, 2003

830

840 Quality assurance in conformal prostate radiation therapy: technology questionnaire for EORTC trial 22991

F. Ataman, P. Poortmans, B.J. Davis, J. Bernier, V.E. Kouloulias, J.Y. Giraud, M. Pierart, M. Bolla

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

831

841 Prognostic factors in advanced nonseminomatous germ cell tumors (NSGCT): Importance of primary tumor (PT) histology and numbers of negative prognostic factors (NPF)

A. Tryakin, S. Tjulandin, O. Scherbakova, D. Nosov, M. Narimanov, V. Goutnik, A. Garin

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

832

842 The effect of total radiation dose and overall treatment time on local control for bladder cancer

W. Majewski, B. Maciejewski, R. Tarnawski, S. Majewski

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

833

843 Role of surgery in patients with liver metastases from nonseminomatous germ cell tumors

J.T. Hartmann, O. Rick, K. Oechsie, T. Gauler, P. Schoeffski, J. Schleicher, M. Kuczyk, L. Kanz, C. Bokemeyer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

834

844 A phase II study testing intravenous (iv) vinflunine (VFL) as second line therapy in patients with advanced transitional cell cancer (TCC) of the bladder

S. Culine, C. Théodore, M. De Santis, B. Bui, T. Demkow, J. Lorenz, F. Rolland, F. Fabry, B. Longerey, N. James

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

835

845 Long-term colorectal, bladder and sexual dysfunction in patients treated with radical radiotherapy for urinary bladder cancer

L.U. Fokdal, M. Høyer, P. Meldgaard, H. von der Maase

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

836

847 HDR vs. IDR brachytherapy for bladder cancer: disappointing local control and unexpected late toxicity

F. Pos, S. Horenblas, C. Schneider, J. Lebesque, L. Moonen, H. Bartelink

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 139 KB

english, 2003

837

848 Does the clinical outcome correlate to altered expression of the EGF receptor-family in renal cell carcinoma?

M. Thomasson, H. Hedman, B. Ljungberg, R. Henriksson

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 139 KB

english, 2003

838

849 Multidisciplinary treatment of central nervous system (CNS) metastases in patients with metastatic testicular germ cell tumor (GCT)

J.T. Hartmann, M. Bamberg, J. Classen, P. Albers, R. Souchon, K. Oechsle, L. Weissbach, L. Kanz, C. Bokemeyer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

839

850 Refractory germ-cell tumors (GCTs): salvage high-dose chemotherapy (HDCT) combining 2 mobilization regimen followed by 3 HDCT with blood stem cell transplantation (the taxif regimen — Getug group)

J.P. Lotz, B. Bui, C. Théodore, C. Caty, R. Delva, G. Gravis, F. Gomez, S. Culine, J.P. Droz, P. Biron

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

840

851 Cost-effectiveness of treatment with zoledronic acid (Zometa®) in prostate cancer patients

K. El ouagari, J.F. Baladi

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

841

852 Post-operative irradiation of prostate carcinoma: results of the Italian survey performed by the AIRO National Working Group on prostate radiotherapy

G. Malinverni, L. Busutti, E. Cagna, P. Franzone, C. Greco, C. Italia, S. Nava, M. Signor, G. Zini, R. Valdagni

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 337 KB

english, 2003

842

853 Conformal irradiation for prostate cancer: biochemical relapse-free survival with standard fractionation versus hyperfractionation

R. Valdagni, P. Lattuada, C. Italia, P. Montanaro, A. Lanceni, T. Magnani

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

843

854 Postoperative dilemma of rising PSA levels in patients with prostatectomy: Evaluation of 11C-Choline-PET/CT examination for radiation therapy

N. Blumstein, F. Wollenweber, A. Wahl, P. Messer, C. Blumstein, S. Reske

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

844

855 Detection of local recurrence by means of 11C-Choline-PET/CT after radical prostatectomy for conformal radiation therapy

N. Blumstein, F. Wollenweber, C. Blumstein, S. Reske

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

845

856 11C-Choline-PET/CT determines potentially curative patients with prostate cancer recurrencies

N. Blumstein, F. Wollenweber, P. Messer, C. Blumstein, S. Reske

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

846

857 Phase II study of low dose thalidomide and interferon-alpha in metastatic renal cell carcinoma (RCC)

S. Avishay, C. Sternberg, N. Yarom, T. Sava, F. Calabrò, G.L. Cetto

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

847

858 Urinary incontinence in prostate cancer patients treated with external beam radiotherapy

M. Liu, T. Pickles, E. Berthelet, A. Agranovich, W. Kwan, S. Tyldesley, M. McKenzie, M. Keyes, J. Morris, H. Pai

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

848

859 Intravesical gemcitabine in the treatment of intermediate risk superficial transitional cell carcinoma (TCC) of the bladder: a marker lesion study

P. Gontero, G. Casetta, G. Maso, F. Sogni, A. Zitella, B. Frea, A. Tizzani

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 337 KB

english, 2003

849

860 Proton therapy for invasive bladder cancer: Treatment results of a bladder-preserving therapy with x-ray irradiation and concurrent intra-arterial chemotherapy followed by proton irradiation boost

M. Hata, N. Miyanaga, K. Tokuuye, K. Ohara, Y. Saida, S. Sugahara, K. Kagei, T. Hashimoto, H. Akaza, Y. Akine

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

850

861 Risk-adapted brachytherapy of prostate cancer using J - 125 permanent implantation

P.M. Messer, H.-W. Gottfried, N.M. Blumstein, E. Schneider, E.M. Röttinger

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

851

862 Evaluation of a superantigen- mediated immune response as therapy for superficial bladder cancer

P.L. Willert, F.G.E. Perabo, D.H. Schmidt, M. Sitzia, E. Wardelmann, A. Von Rücker, A. Wirger, P. Albers, S.C. Müller

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

852

863 Intraoperative and interactive planning for permanent prostate brachytherapy: dosimetric and clinical results

R. Baumann, A. Warszawski, S. Machtens, J.H. Karstens

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 330 KB

english, 2003

853

864 Intravenous (IV) vinorelbine (VRL) plus hormone therapy (HT) versus hormone therapy alone in hormone-refractory prostate cancer (HRPC). Final report of a randomised phase III study

R.P. Abratt, D. Brune, M.A. Dimopoulos, J. Kliment, J. Breza, P. Selvaggi, P. Beuzeboc, T. Demkow, S. Oudard

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

854

866 A novel system for high-dose radiotherapy for localized prostate cancer using a dual X-ray fluoroscopy and amorphous silicon flat panels system

K. Britton Gallardo, Y. Takai, K. Nemoto, Y. Ogawa, M. Mitsuya, S. Yamada

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 332 KB

english, 2003

855

867 Thymidine phosphorylase (TP) expression in tumor cells of metastatic renal cell carcinoma (RCC) patients treated with capecitabine and interferon-alfa2A (IFNa)

P. Padrik, H. Saar, K. Leppik, A. Arak

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

856

868 A tolerance and efficacy study of thalidomide, paclitaxel, estramustine combination for patients with chemotherapy refractory androgen independent prostate carcinoma

D. Daliani, P. Dieringer, P. Matthew, L. Pagliaro, K. Davies, N. Tannir, I. Chen, E. Jonash, C. Papandreou, C. Logothetis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

857

869 Gemcitabine (GEM) and oxaliplatin (I-OHP) to treat immunotherapy-resistant advanced renal cell carcinoma (ARCC) patients (pts.): preliminary results of a single institution phase II study

C. Porta, C. Paglino, I. Imarisio, L. Bonomi, E. Biscaldi, A. Natalizi, M. Zimatore, M. Danova, A. Riccardi

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 329 KB

english, 2003

858

870 Long term follow-up in seminoma patients stage I and II A/B after adjuvant irradiation of lymphatic pathways

I. Schulz, P. Suhr, E.M. Röttinger, P.M. Messer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

859

871 Acute toxicity and late GI and GU complications in organ sparing treatment of bladder cancer

M. Kurt, N. Kucuk, G.B. Cebelli, S.K. Cetintas, K. Engin

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

860

872 Rectal toxicity and quality of life after definitive conformal radiation therapy (CRT) of patients with prostate cancer

H. Geinitz, F. Zimmermann, R. Thamm, C. Erber, M. Keller, T. Mueller, U. Kraus, R. Busch, M. Molls

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

861

873 Predictors of late rectal and urologic side-effects after conformal radiation therapy (CRT) of patients with prostate cancer

H. Geinitz, F. Zimmermann, R. Thamm, A. Schumerti, R. Busch, M. Molls

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 318 KB

english, 2003

862

874 Ir192 conformal brachytherapy and external beam radiation (EBR-CU.ir192) with or without hormonotherapy for locally advanced prostate adenocarcinoma: the centre françois baclesse experience

D. Brune, F. Lesaunier, D. Benabid, M. M'vondo, M. Henry-Amar

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 157 KB

english, 2003

863

875 A prospectively randomized phase II trial of pegylated doxorubicin in hormone refractory prostate cancer

A. Heidenreich, P. Olbert, J. Goecke, F. Sommer, U.H. Engelmann

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 157 KB

english, 2003

864

876 Protein microchips for the analysis of prostate specific antigen

E. Dementieva, E. Daril, A. Rubina, A. Zasedatelev, T. Osipova, T. Ryabykh, A. Baryshnikov, A. Mirzabekov

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 316 KB

english, 2003

865

877 Hormone-refractory prostate cancer in the lobund-wistar rat

M. Pollard, M. Suckow

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

866

878 3-year prospective patient evaluated urinary and intestinal side effects after stereotactic dose-escalated radiotherapy of prostate cancer with the beamcath(R) technique

P. Fransson, P. Bergström, P.-O. Löfroth, A. Widmark

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

867

879 Docetaxel (DOC) and mitoxantrone (MIT) in the management of hormone-refractory prostate cancer

A. Heidenreich, C. Ohlmann, P. Olbert, A. Hegele

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

868

880 Prostate cancer cell proliferation is strongly reduced by combination treatment with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (‘Iressa’) and the anti -androgen bicalutamide (‘casodex’)

M. Bologna, A. Angelucci, C. Festuccia, G.L. Gravina, P. Muzi, C. Vicentini

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

869

881 Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced breast pain and gynaecomastia in prostate cancer

H. Van Poppel, C. Tyrrell, P. Van Cangh, F. Keuppens, T. Morris, L. Garside

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

870

882 Is a short course of neoadjuvant/concurrent androgen deprivation beneficial for prostate cancer patients treated with a locally dose escalated radiation protocol?

A. Martinez, R. Galalae, C. Mitchell, N. Nuemberg, G. Gustafson, G. Edmundson, G. Kovacs

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

871

883 Expression and clinical relevance of the lung resistance protein in germ cell testicular tumours

L. Mandoky, L. Geczi, Z. Doleschall, I. Bodrogi, O. Csuka, M. Bak

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

872

884 Long-term results following one course of adjuvant chemotherapy for high-risk stage I non-seminomatous germ cell tumors: the Spanish germ cell cancer group experience

X.Garcia del Muro, P. Maroto, A. Barnadas, J. Terrasa, A. Saenz, M. Lomas, J. Valdivia, E. Batiste-Alentorn, G. Berenguer, J.R. Germa-Lluch

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

873

885 Does prostate cancer dedifferentiate over time?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

874

886 Concordance/discordance of pathological evaluation of radical prostatectomy (RP) specimen between a community hospital and a tertiary teaching hospital

R. Choo, L. Sugar, K. MacKenzie, C. Danjoux

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 309 KB

english, 2003

875

887 Impact of mean rectal dose on late rectal bleeding following conformal radiotherapy for prostate cancer: dose volume effect

A. Zapatero, F. Garcia-Vicente, I. Modolell, P. Alcantara, A. Floriano, A. Cruz-Conde, L. Perez-Gonzalez, M. Lopez, A. Marin, A. Perez-Torrubia

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 145 KB

english, 2003

876

888 Cranial nerve palsies in metastatic prostate caner-results of base of skull radiotherapy

J.M. O'Sullivan, A.R. Norman, H. McNair, D.P. Dearnaley

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 145 KB

english, 2003

877

889 Estrogens and a phytoestrogen (genistein) induce hypersensitivity of prostate carcinoma cell lines to low dose radiation in vitro

R.M. Hermann, H.A. Wolff, O. Balzer, H. Jarry, W. Wuttke, M. Rave-Fränk, C.F. Hess, H. Schmidberger

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 307 KB

english, 2003

878

890 Acute small bowel and colon toxicity after pelvic IMRT for prostate cancer

G. Sanguineti, L. Culp, J. Pena, J. Bayouth

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

879

891 Impact of urethrography in high-precision prostate cancer radiotherapy

M. Lock, E. Wong, E. Paradis, V. Moiseenko, G. Rodrigues, D. D'Souza, T. Kron, J. Chen, R. Ash, G. Bauman

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

880

892 Partial volume irradiation in 3D conformal radiotherapy for the treatment of prostate adenocarcinoma: a poor man's solution to rectum sparing

S. Cvilic, L. Renard, M. Prignot, S. Vynckier, P. Scalliet

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

881

893 Changes in prostate volume during permanent brachytherapy with JOD 125 and influence on dose distribution (D 90)

P.M. Messer, H.-W. Gottfried, E. Schneider, E.M. Röttinger

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

882

894 Effects of 5 alpha reductase inhibitors on prostatic carcinoma cells grown in primary culture

C. Festuccia, A. Angelucci, G.L. Gravina, P. Muzi, C. Vicentini, M. Bologna

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

883

895 The effect of pelvic lymph node irradiation in salvage therapy for prostate cancer patients with a biochemical relapse following radical prostatectomy

B. Kim, A. Lashkari, R. Vonglama, S. Lee, R. Parker

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

884

896 Expression of bcl-2 and p53 as biomarkers in imprint smears of prostate carcinomas and their prognostic value

A. Bantis, A. Giannopoulos, M. Gonidi, P. Athanassiades, A. Liossi, E. Aggelonidou, E. Petrakakou, P.D. Miller, P. Athanassiadou

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 326 KB

english, 2003

885

897 High-dose ibandronate is effective and well tolerated in the treatment of pain and hypercalcaemia due to metastatic urologic cancer

A. Heidenreich, C. Ohlmann, P. Olbert, A. Hegele

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

886

898 Chemotherapy induced peripheral neuropathy in testicular cancer patients treated with cisplatin, etoposide and bleomycin(PEB)

V.Vesna Stojanovic, S.Stojan Radic, M.Miroljub Petrovic, Z.Zoran Pejcic, S.Slavica Veselinovic, S.Sanja Dencic

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

887

899 Indirubin, the active constituent of a Chinese antileukaemia medicine induces growth arrest and apoptosis in renal cell cancer cells

G. Landwehrs, F.G.E. Perabo, C. Frössler, D.H. Schmidt, A. von Rücker, A. Wirger, P. Albers, S.C. Müller

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

888

900 Adjuvant chemotherapy(CHTH) in patients with high-risk urothelial cancer of urinary tract

A. Chaladaj, K. Nietupski, G. Poniatowska, I. Skoneczna, T. Demkow, M. Pilichowska, P. Peczkowski, W. Rogowski, A. Sieczych, A. Zakoscielny

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 324 KB

english, 2003

889

901 Effective first-line chemotherapy with docetaxel and gemcitabine in advanced bladder cancer (ABC)

A. Ardavanis, A. Alexopoulos, D. Tryfonopoulos, C. Kandylis, G. Lainakis, G. Rigatos

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

890

902 Nonseminomatous germ cell testicular tumors clinical stage I: a retrospective analysis

T. Sava, F. Merlin, A.P. Fraccon, M. Frisinghelli, F. Valcamonico, S. Pessa, M.A. Bassetto, T. Franceschi, C. Sava, G.L. Cetto

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

891

903 Capecitabine-monotherapy and in combination with immunotherapy in the treatment of metastatic renal cell carcinoma

C. Wenzel, R. Bartsch, U. Pluschinig, D. Hussian, C.C. Zielinski, G.G. Steger

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

892

904 Health-related quality of life in randomised controlled trials in colorectal cancer

F. Efficace, A. Bottomley, J.M. Blazeby

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 323 KB

english, 2003

893

904A An open-label study of figrastim in diverse nonmyeloid malignancies: phase 4 experience in community practice

J. Harvey, J. Epstein, N. Al-Bussam, J. O'Byrne, B. McGuire, S.M. Donnelly

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

894

905 Documenting symptom palliation with chemotherapy using the LCSS-Meso: Results from the randomized trial of pemetrexed plus cisplatin vs cisplatin alone in patients with malignant pleural mesothelloma

R. Gralla, P. Hollen, A. Liepa, J. Symanowski, J. Rusthoven, M. Boyer, J. Jassem, N. Vogelzang

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

895

906 Nutritional counselling vs commercial supplements vs ad lib: a prospective randomised controlled trial in head-neck cancer patients undergoing radiotherapy

P. Ravasco, I.Monteiro Grillo, P.Marques Vidal, M. Camilo

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

896

907 Nutrition intervention: a prospective randomised controlled trial in colorectal cancer patients undergoing radiotherapy

P. Ravasco, I.Monteiro Grillo, P.Marques Vidal, M. Camilo

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

897

908 Effect of amifostine to prevent radiotherapy-induced acute and late toxicity in head and neck cancer patients who had normal or mild impaired salivary gland function

V. Veerasarn, P. Phromratanapongse, N. Suntornpong, V. Lorvidhaya, I. Chitapanarux, C. Tesavibul, Y. Kongthanarat, K. Shotelersuk, S. Chiewvit, P. Pusuwan

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

898

909 Neuropsychological functioning in women following adjuvant treatment for breast cancer

M. Verrill, J. Rodgers, R. Morse, K. Kendell, K. Wesnes, I. Marshall, T. Manktelow

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

899

910 The level of reporting of health-related quality of life in cancer research. Evidence from 123 randomised controlled trials enrolling 36220 cancer patients

F. Efficace, A. Bottomley, V. Vanvoorden, G. Velikova, E. Greimel, G. van Andel

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

900

911 Frontloading of darbepoetin alfa improves hemoglobin more rapidly than recombinant human erythropoietin: a combined analysis of data

J. Glapsy, L. Schwartzberg, P. Hesketh, G. Rossi, A. Colowick

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

901

912 Optimizing anemia management: flexible epoetin alfa dosing and schedules

P. Gascón, J. Gralow

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

902

913 Information needs of men with breast cancer in the United Kingdom

B. Williams, K. Brain, R. Iredale, J. Gray, E. France

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

903

914 Characteristics and extent of unconventional therapies used by cancer patients

E. Robinson, H. Geva, T. Mashiach, G. Bar-Sela, Z. Dashkowsky

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

904

915 Long-term quality of life (QoL) following prostate irradiation: relationship to anorectal symptoms employing a proctitis-specific QoL instrument

S. Turner, A. Kneebone, T. Bolin, N. Spry, V. Gebski

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

905

916 Terminal cancer care: the “Home-Care” model as an efficient and cost-effective treatment

M. Ranuzzi, G. Palmeri, D. Manzo, R. Scirocchi, A. Taddei, S. Brunetti, P. Ranaldi, A. Sabbi, S. Gentile, R. Vercelloni

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 328 KB

english, 2003

906

917 Improvement in quality of life is similar in anaemic patients with solid tumours and lymphoid malignancies treated with epoetin beta

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

907

918 The role of patients and doctors in making decisions about the choice of the kind of adjuvant treatment in early breast cancer

A. Jagiello-Gruszfeld, E. Szybicka-Flisikowska, E. Wachula, M. Sikorska, A. Kazarnowicz, R. Adamowska, K. Gugala, J. Godlewski

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

908

919 Clinically meaningful improvement in disease-related symptoms by gefitinib (‘Iressa’, ZD1839) in patients with advanced non-small-cell lung cancer: relationship between lung cancer subscale scores and radiographic response and survival

J.-Y. Douillard, D. Cella, R.B. Natale, T.J. Lynch, C. Lee, D. Carbone, A. Kay, M. Wolf, A. Heyes, J. Ward

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 316 KB

english, 2003

909

920 Protective activity of levo-thyroxine medication on latrogenic hypothyroidism after radiotherapy for childhood cancer

M. Massimino, A. Serra, P. Navarria, F. Spreafico, E. Seregni, A. Bianchi, F. Pallotti, M. Terenziani, F. Fossati-Bellani, L. Gandola

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

910

921 Is there an optimal target hemoglobin level for improved quality of life in cancer-related anemia?

Y. Brandberg, A. Österborg

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

911

922 Lung changes following radiotherapy (RT) for breast cancer using high resolution computed tomography (HRCT) matched with 3D-treatment plan images, and functional tests

M. Krengli, M. Sacco, G. Loi, M. Ronco, G. Gambaro, A. Cotroneo, A. Carriero

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 325 KB

english, 2003

912

923 Clinical outcomes of palliative interventions for bowel obstructions in patients suffering from peritoneal carcinomatosis from non-gynecological cancer

E. Thanopoulou, A. Stamatelopoulos, G. Karavitis, G. Lazaridis, N. Sarantzis, K. Vlachos, D. Vassilakos, M. Arnaouti, G. Economou

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

913

924 A pilot study of influences on decisions to receive chemotherapy in patients with advanced cancer

G.C. Higgins, A. Price

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

914

925 An examination into the cultural validity and reliability of the Turkish version of EORTC QLQ-C30

A. Guzelant, T. Goksel, S. Ozkok, S. Tasbakan, T. Aysan, A. Bottomley

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 336 KB

english, 2003

915

926 Final results of a randomized phase II study evaluating the role of erythropoietin during radiochemotherapy for pelvic tumors

D. Antonadou, N. Throuvalas, R. Lavey, A. Sagriotis, M. Boufi, A. Petridis, N. Malamos

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

916

927 Prevention of chemotherapy-related episodes of febrile neutropenia (FN) in small-cell-lung-cancer (SCLC) patients: in practice not theory

J. Timmer-Bonte, V. Tjan-Heijnen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

917

928 What factors predict family physician referral for palliative radiotherapy?

J. Meng, E. Fitzgibbon, R. Samant, I. Graham

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

918

929 Antiemetic patterns of care for radiotherapy-induced nausea and vomiting

P.Ch. Feyer, M.H. Seegenschmiedt

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 329 KB

english, 2003

919

930 The efficacy and safety of lanreotide (28-day prolonged release) in relieving clinical symptoms associated with carcinoid tumours: a 6-month, open, multicentre, dose-titration study

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

920

931 Reflexology for symptom relief in patients with cancer: a cochrane systematic review

S. Wilkinson, M. Gambles, D. Fellowes

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

921

932 French physicians' attitudes toward legalisation of euthanasia and the ambiguous relation between euthanasia and palliative care

P. Peretti-Watel, M.K. Ben Diane, R. Favre, A. Galinier, J.-P. Moatti

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 325 KB

english, 2003

922

933 Incidence and burden of chemotherapy-induced nausea and vomiting in the context of current Canadian practice

J. Lachaine, L. Yelle, L. Kaizer, A. Dufour, B. Desjardins, R. Deuson

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

923

934 Improvements in pain and functional interference following palliative radiotherapy for painful bone metastases: an analysis of brief pain inventory assessments

J. Wu, T. Clark, G. Monk, R. Wong

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

924

935 Neglected information needs of breast cancer patients and spouses

E. Salminen, S. Knifsund, T. Poussa, J. Vire

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

925

936 Long-term salivary output and quality of life in patients with head and neck cancer treated with radiotherapy

P.M. Braam, J.M. Roesink, C.H.J. Terhaard

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 335 KB

english, 2003

926

937 Superiority of aprepitant, an oral NK1 antagonist, over standard antiemetic therapy: Reducing the impact of nausea and vomiting on patients' daily lives

A.R. Martin, G.J. Ma, A.D. Carides, K. Horgan, F. Lawson, M. Elmer, C. Schmidt, C.M. Lindley, M. Aapro

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

927

938 Psychiatric morbidity in cancer patients and importance of awareness of disease

B. Baltalarli, F. Atesci, N.Kalkan Oguzhanoglu, O. Ozdel, F. Karadag, N. Karagöz

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

928

939 Prevention of urinary tract infections by bladder installations of hyaluronic acid in patients with metastatic acute medullar compression

A. Manas, C. Pena, A. Sotoca, E. Lanzos, M. Riviere

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 336 KB

english, 2003

929

940 Intraoperative radiotherapy for metastatic spinal tumors

T. Umezawa, K. Karasawa, Y. Niibe, T. Hozumi, T. Kondo

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

930

941 Prophylactic use of smectite (ST) significantly reduces the incidence of acute diarrhoea for patients undergoing radio-chemotherapy (RT-CX) for rectal cancer: results of a double-blind phase III trial

J. Classen, W. Hoffmann, C. Meisner, E.-M. Freitag, R. Souchon, T. Feyerabend, T. Hehr, M. Bamberg

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

931

942 An assessment of weekly dosing regimens of recombinant human erythropoietins (rHuEPOs) for anemia correction in a broad range of patients (pts) with hematologic malignancies (HMs)

T.J. Littlewood, B. Schenkel

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 326 KB

english, 2003

932

943 Early administration of hemoglobin-adapted doses of erythropoletin with intravenous iron for the prevention of chemotherapy-induced anemia

C. Monnerat, M. Pless, B. Biedermann, N. Ketterer, R. Stupp, J. Bauer, E. Mueller, R. Herrmann, S. Leyvraz

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

933

944 Does selective gut decontamination in oncology patients reduce the number of bacteraemia's?

M.A. de Witte, M.D. van de Wetering, L. Kremer, H.C. Caron

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

934

945 Analysis of pooled data from two Phase III studies of the NK-1 antagonist aprepitant to assess relationships between the incidence and control of cisplatin-induced acute vomiting and delayed vomiting

K. Horgan, S. Grunberg, P. Hesketh, J. Guoguang-Ma, J. Ianus, J. Evans, A. Carides

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 323 KB

english, 2003

935

946 Compulsory constipation? — an evaluation of the prevalence and management of constipation in pallative care

M. Goodman, S. Wilkinson, D. Fellowes

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

936

947 Chemotherapy-associated anemia in breast cancer patients: prevalance and incidence from the European Cancer Anemia Survey (ECAS)

H. Ludwig, S. Van Belle, P. Barrett-Lee

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

937

948 The “comprehensive geriatric assessment” evaluation: a selection of informative questionnaires for essential parameters. Preliminary experience by a single institution

E. Massa, L. Ferreli, G. Astara, M. Dessì, M.R. Lusso, G. Gramignano, C. Madeddu, G. Mantovani

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

938

949 Fecal human DNA as a marker of intestinal toxicity in patients undergoing abdominal radiotherapy

J. Giralt, R. Verges, E. Varela, M. Antolin, J. Maldonado, F. Guarner, J.-R. Malagelada

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

939

950 Darbepoetin alfa significantly improved fatigue in patients with lymphoproliferative malignancies undergoing chemotherapy: results of a phase 3 multicenter, randomized, double-blind, placebo-controlled study

H. Michael, J. Kallich, J. San Miguel, D. Watson, J. Matcham, T.J. Littlewood

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 333 KB

english, 2003

940

951 Quality of life in breast cancer patients eighteen months after diagnosis

A. Montazeri, M. Vahdaninia

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

941

952 Treatment of radiation — induced lung damages after breast conserving therapy

V. Parvanova, M. Beeva, V. Ivanov, A. Tzonevska

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

942

953 The health related quality of life and preference of breast conservation for breast cancer patients in north Taiwan

J.T. Chang, S. Chen, Y. Lin

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

943

954 Role of palliative radiotherapy in pediatric solid tumours

H. Umapathy, K.C. Pandey, M. Malik, S. Bhasker, V. Kouchipillai

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 339 KB

english, 2003

944

955 Cancer patients: patterns of internet use

C. Weissenberger, G. Witucki, J. Beranek-Chiu, S. Jonassen, M. Neumann, D. Mueller, F. Momm, S. Bartelt

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

945

956 Websolution for the prescription of antineoplastic drugs

K.M. Nelausen, G. Daugaard, T. Goeth

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

946

957 Ectopic expression of the amino-terminal peptide of androgen receptor leads to androgen receptor dysfunction and inhibition of androgen receptor-mediated prostate cancer growth

K. Minamiguchi, M. Kawada, S. Ohba, K. Takamoto, M. Ishizuka

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 334 KB

english, 2003

947

958 Adenoviral transfer of a natural antisense to survivin mRNA down-regulates survivin expression and promotes apoptosis in breast cancer

Y. Manome, H. Yoshinaga, T. Yamamoto, N. Tanigawa, M. Watanabe

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

948

959 Expression of functional CXCR4 on colorectal human cancer

A. Ottaiano, S. Scala, A. di Palma, M. Napolitano, M. Di Bonito, P.A. Ascierto, F. Tatangelo, S. Pignata, R.V. Iaffaioli

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

949

960 Therapy of MHC class I+ and class I- HPV16-associated tumours with IL-2, IL-12, and genetically modified tumour vaccines

J. Bubenik, R. Mikyskova, M. Indrova

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 333 KB

english, 2003

950

961 Phase I study of escalating doses of TroVax® in patients wtih advanced colorectal cancer (CRC)

N. Connolly, R. Harrop, H. McNeill, C. Garner, J. Fenemore, M. Saunders, J. Valle, S. Kingsman, M. Carroll, R. Hawkins

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

951

962 Dendritic cell vaccines targeting MUC1 against breast and lung cancer

K. Kontani, K. Teramoto, Y. Ozaki, N. Tezuka, S. Sawai, S. Fujino

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

952

963 Clinical trial of a peptide based vaccine targeting telomerase in patients with inoperable pancreatic cancer

G. Gaudernack, A.M. Meo, M.K. Gjertsen, J.A. Eriksen, M. Moller, T. Buanes

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

953

964 p53-Independent cdk1 induction in response to irinotecan in the HT29 human colon cancer cell line

M. Abal, R. Bras-Goncalves, J.-G. Judde, P. de Cremoux, D. Louvard, H. Magdelenat, S. Robine, M.-F. Poupon

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 332 KB

english, 2003

954

965 Molecular therapy for peritoneal dissemination of gastric cancer with adenovirus-mediated Bax gene transfer

Y. Tsunemitsu, S. Kagawa, N. Tokunaga, S. Otani, T. Umeoka, N. Tanaka, T. Fujiwara, J. Roth, B. Fang

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

955

966 Activation of a plasma membrane-cationic channel and apoptosis in prostate cancer cells overexpressing Bax

A.A. Gutiérrez, D. González-Espinosa, J. Hernández, A. Guerrero-Hernández, F. Martinez, V. Martinez

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

956

967 The detection of metastatic cancer cells in peripheral blood using reverse transcriptase polymerase chain reaction for CK 19

R. Salman, E. Henessey, C. Curren, V. Uhlmann, F. Given

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

957

968 FCU1: a highly potent suicide gene therapy based on 5-FU

P. Erbs, A. Findeli, P. Cordier, C. Hoffmann, K. Dott, J.M. Balloul

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 335 KB

english, 2003

958

969 Pre-clinical safety and immunogenicity studies of a HER-2 protein vaccine in cynomolgus monkeys

D. Leach, A. Østergaard, T. Oshodi, Y. McGovern, B. Volck

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

959

970 Increased gap junctional intercellular communication in esophageal cancer augments the bystander effect in HSV-tk/GCV suicide gene therapy

S. Matono, T. Tanaka, S. Sueyoshi, H. Sasahara, H. Yamana, H. Fujita, K. Shirouzu

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

960

971 Additive and synergistic effects on TRAIL/Apo2L induced apoptosis after irradiation and eradication of clonogenic cells in solid tumor cell lines in vitro

P. Marini, A. Betsch, V. Jendrossek, W. Budach, C. Belka

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

961

972 RNAI mediated downregulation of bcl-2 and xIAP may have therapeutical potential in human breast adenocarcinoma

R.T. Lima, L.M. Martins, J.E. Guimarães, C. Sambade, M.H. Vasconcelos

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

962

973 Which complement regulatory proteins could be a good target for a breast cancer vaccine?

Z. Madjd, S. Pinder, I. Spendlove, L. Durrant

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

963

974 Additive cytotoxic and proapoptotic effects of external radiation and Rituximab on B cell lymphoma cell lines in vitro

H. Schmidberger, S. Dingeldein, M. Rave-Fraenk, J. Hasenkamp, W. Jung, A. Rokita, O. Pradier, B. Glass

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

964

975 A phase I/II single arm trial to determine the safety, tolerability, and biological activity of intrahepatic delivery of doxorubicin hydrochloride adsorbed to magnetic targeted carriers (MTC-DOX) in patients with metastatic tumors in the liver

R. Just, C. Hoh, T. Vogl, P. Neese, J. Doemeny, M. Schechter, R. Varney, W. Stanton, M. Schiemann, P. Goldfarb

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 342 KB

english, 2003

965

976 Stromal contribution to elevated YKL-40 in human cancer

N. Junker, J.S. Johansen, P.E.G. Kristjansen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

966

977 Phase I/II trial evaluating blockade of tumour blood supply and tumour cell proliferation with combined bevacizumab and erlotinib HCl as targeted cancer therapy in patients with recurrent non-small cell lung cancer

R.S. Herbst, E. Mininberg, T. Henderson, E. Kim, W.K. Hong, R. Mass, W. Novotny, B. Garcia, D. Johnson, A. Sandler

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

967

978 Microvascular transfers in the elderly in oncology

P. Vico, D. Dequanter, B. Nokerman

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 174 KB

english, 2003

968

979 Antiangiogenetic therapy with pioglitazone, rofecoxib and metronomic trofosfamide in advanced malignant vascular tumors

A. Reichle, Th. Vogt, C. Hafner, K. Bross, F. Bataille, K.W. Jauch, A. Berand, M. Landthaler, R. Andreesen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

969

980 Preliminary results of a phase I study of rhumab VEGF (bevacizumab) with concurrent radiotherapy (XRT) and capecitabine (CAP) in locally advanced pancreatic cancer

C.H. Crane, L.M. Ellis, H.Q. Xiong, M. O'Reilly, M.E. Delclos, J.L. Abbruzzese, D.B. Evans, P.W.T. Pisters, R.A. Wolff

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

970

981 Antitumor activity of trastuzumab (Herceptin®) in human gastric cancer models

K.F. Ouchi, F. Sekiguchi, Y. Tanaka

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

971

983 The impact on human renal cell carcinoma cell line by transfection of Cox-2

Q. Chen, N. Shinohara, T. Abe, S. Suzuki, K. Nonomura, T. Koyanagi

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

972

985 Molecular mechanisms of G1 arrest of antineoplaston AS2-1 against colon cancer

K. Matono, Y. Yutaka Ogata, Y. Yasumi Araki, T. Teruo Sasatomi, N. Nobuya Ishibashi, M. Masamitu Kanazawa, T. Takamasa Fukumitu, Y. Yuichirou Sato, S. Syoujirou Torigoe, K. Kazuo Shirouzu

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

973

986 Immunization with mutant p53-and K-ras-derived peptides in cancer patients: Immune responses and clinical outcome

I.F. Ciernik, D.P. Carbone, M. Kelley, B.E. Johnson, B. Seifert, D. Contois, J. Greenblatt, C. Carter, J.D. Minna, J.A. Berzofsky

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 322 KB

english, 2003

974

987 DNA encoding a Pan-MHC class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy

K. Teramoto, K. Kontani, Y. Ozaki, S. Kitamura, S. Sawai, N. Tezuka, S. Fujino, Y. Itoh, K. Ogasawara

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

975

988 Preventive vaccination of mice with human melanoma cells injected subcutaneously into encapsulated polyacrylamide gel

N. Sergeeva, S. Severin, I. Sviridova, E. Moskaleva, V. Kirsanova, I. Rodina, A. Rodina, V. Frolov

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

976

989 Identification of highly active, cancer specific promoters for use in targeted gene therapy of small cell lung cancer

N. Pedersen, M.W. Pedersen, S. Mortensen, K. Rieneck, L.F. Bovin, H.S. Poulsen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

977

990 Treatment with a combination of mMAb17-1A, GM-CSF, alpha-interferon and 5-fluorouracil of patients with advanced colorectal carcinoma (CRC)

M. Liljefors, J.-E. Frödin, P. Ragnhammar, H. Mellstedt

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

978

991 Serial monitoring of serum HER-2 extracellular domain (H-ECD) during herceptin-taxol chemotherapy (CT) for metastatic breast cancer (MBC) pts: preliminary results from the French experience (HER.ME.S protocol)

J.P. Lotz, D. Brault, K. Le Lay, M. Campione, P. Kerbrat, H. Hocini, F. Maindrault-Goebel, C. Tsé, S. Provent, R. Launois

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

979

992 Human phase II/A study of a novel somatostatin analogue, TT-232 in malignant melanoma patients

F. Gyergyay, M. Gödény, T. Szüts, Gy. Kéri, G. Sármay, I. Bodrogi

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

980

993 Positive correlation between expression of vascular endothelial growth factor (VEGF) and highest microvascular density in esophageal carcinoma

T. Nomiya, K. Nemoto, H. Miyachi, K. Fujimoto, K. Takeda, Y. Ogawa, Y. Takai, S. Yamada

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 335 KB

english, 2003

981

994 The Casein kinase 1 delta (CK1 delta) specific inhibitor IC261 impinges growth of pancreatic tumor cells and the expression of CK1delta in healthy young adult BALB/c mice

I. Guthoff, A. Hillenbrand, C. Brockschmidt, M. Stoeter, D. Henne-Bruns, U. Knippschild

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

982

995 A novel adenoviral vector encoding angiogenin cDNA from cancerous liver tissue

D. González-Espinosa, A. Luz, E. Gómez, K. Gazarian, C. Velasquillo, A.A. Gutiérrez

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

983

996 Effect of retinoic acid analogue on tumor growth and angiogenesis

M. Hountala, E. Arsenou, S. Nikolaropoulos, M. Hatziapostolou, E. Papadimitriou

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

984

997 Activity of trastuzumab plus vinorelbine in patients with erb-B2 overexpressing metastatic breast cancer

R. Lara, I. Alvarez, E. Polo, A. Yubero, J.I. Mayordomo, D. Isla, R. Andres, P. Escudero, A. Saenz, A. Tres

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 331 KB

english, 2003

985

998 A phase II study of a novel taxane BAY 59-8862 in patients with aggressive refractory non-Hodgkin's lymphoma

R. Turner, A. Delmer, T. Gentile, P. Sonneveld, D. Vesole, S. Turri, F. Barouki, S. Coppieters

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

986

999 Immunomonitoring in stage II melanoma patients treated with adjuvant GM-CSF

I. Timofeev, G. Kharkevitch, Z. Kadagidze, L.V. Demidov

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

987

1000 Pioglitazone and rofecoxib combined with angiostatic scheduling of chemotherapy in far advanced malignancies

A. Reichle, K. Bross, T. Vogt, F. Bataille, P. Wild, A. Berand, F. Klebl, S.W. Krause, R. Dengler, R. Andreesen

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

988

1001 Novel strategy of mature dendritic cells generation, suitable for adoptive immunotherapy of the ovarian cancer patients

N. Khranovskaya, N. Tsip

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 337 KB

english, 2003

989

1002 Evaluation of RFLP, DNA sequencing, PCR-SSCP and line probe assay for HPV genotyping

N. Milutin, K. Husnjak, M. Matovina, M. Grce

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

990

1003 Chemopreventive administration of EB1089, a vitamin D analogue, on spontaneous mouse mammary and hepatocellular carcinoma

D. Sahpazidou, P. Stravoravdi, Th. Toliou, G. Geromichalos, P. Tsikaras, K. Dimitriadis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

991

1004 Effects of docetaxel on apoptosis-related proteins in patients with adenocarcinoma of the esophagus

J. Rigas, A. Eastman, K. Dragnev, S. Gordon, J. Sutton, V. Memoli, V. Beggs, W. DiSalvo, S. Hammond, I. Williams

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

992

1005 Indirubin-3′-monoxime, a novel cdk-inhibitor induces cdk-1 and survivin dependent growth arrest and apoptosis in bladder cancer cells

C. Froessler, F.G.E. Perabo, G. Landwehrs, D.H. Schmidt, A. Von Rücker, A. Wirger, P. Albers, S.C. Müller

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

993

1006 Prognostic value of bone marrow involvement by Hodgkin's disease

S. Kanaev, S.N. Novikov, L. Jukova, M. Girschovich

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

994

1007 Accuracy of end of treatment 18F-FDG PET for predicting relapse in patients with Hodgkin's disease (HD) and Non-Hodgkin's lymphoma (NHL)

G. Jerusalem, V. Warland, Y. Beguin, R. Hustinx, M.F. Fassotte, J. Foidart-Willems, G. Fillet

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

995

1109 Young cancer patients between 15–21 years get their own youth section at an adult hospital department. The first in Denmark

Hove, N., Thykjær, S.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 157 KB

english, 2003

996

1105 Older patients' experiences of colorectal cancer: functional status and service use following treatment

Bailey, C., Corner, J., Addington-Hall, J., Kumar, D., Haviland, J.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 146 KB

english, 2003

997

1255 Supervised walking program for cancer patients

Jonasdottir, L.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

998

1125 You have been very lucky, there is no need for after-treatment

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 139 KB

english, 2003

999

1189 The influence of nurses on health care policy — a global view

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 144 KB

english, 2003

1000

1227 Verification of set up deviation with tangential post operative irradiation technique using electronic portal imaging in clinical practice

Khoshbakht, Z., Skoglund, A.-S., Beckman, L., Bjoreland, A., Franzen, L.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

1001

1198 The changing nurse in cancer care — support our clients

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

1002

1054 Cost analysis comparing brachytherapy versus surgery for carcinoma of the tonsillar fossa and/or soft palate

Nijdam, W., Levendag, P., Noever, I., Uyl-de Groot, C., van, M.Agthoven

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

1003

1145 A nurse led out patient clinic for patients after stemcell transplantation

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

1004

1062 Signal transduction therapy

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 128 KB

english, 2003

1005

1224 Effect of pain on quality of life in patients with mastectomy in Turkey

Uzun, O., Eti Aslan, F., Selimen, D., Koc, M.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

1006

1121 Surviving cervical cancer: sexual health and psychosocial morbidity

Burns, M., Costello, J., Davidson, S.E.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

1007

1165 Quality of life: patients and care-givers view

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 130 KB

english, 2003

1008

1265 The courage to care: a report of a working party addressing sexuality and fertility concerns in cancer care

Quinn, B., Scott, K., Trevatt, P., Baxter, A., Scholtes, S., Stephens, M., Dunnell, C.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

1009

1074 Continuity and quality from the time of the cancer diagnosis until the treatment is completed

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

1010

1069 Prostate cancer screening — status ad perspectives

Schröder, F.H.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 150 KB

english, 2003

1011

1278 Palliative consultation team: functions in a university hospital

Magnusdóttir, S.L., Fridriksdóttir, N.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 150 KB

english, 2003

1012

1221 An impact of internal quality control in oncology nursing care

Velepic, M., Skela Savic, B., Koren, P.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 321 KB

english, 2003

1013

1142 How electronic nursing documentation can demonstrate oncology nursing

Bragadóttir, G., Thorsteinsdóttir, L.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 305 KB

english, 2003

1014

1285 Spiritual care, Katie Eriksson and Joyce Travelbee in a new light

Overgaard, A.E.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 146 KB

english, 2003

1015

1010 Hairy cell leukemia: early immunological diagnosis and quantitative analysis of flow cytometry

Babusikova, O., Tomova, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 180 KB

english, 2003

1016

1144 The nurse management of trastuzumab infusions for patients with breast cancer

Pace, E., McIlroy, P.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 142 KB

english, 2003

1017

1266 Nurse-managed follow-up by telephone for patients with brain metastases

Braat, C., Nijdam, W., Pool, A., Lagerwaard, F., Koorevaar, E., Nowak, P., Levendag, P.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

1018

1107 Choices and decisions for men with prostate cancer. results of a psycho-educative group for men with prostate cancers

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 157 KB

english, 2003

1019

1292 Do patients benefit from nursing research? An overview of a service user/patient need identified from our research, how it is being addressed and the impact and benefit to the individual

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 127 KB

english, 2003

1020

1137 Implementation of new biological knowledge into cancer management

Piccart, M., Awada, A., Delabaye, I.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 102 KB

english, 2003

1021

1161 From prevention to survivorship — an overview

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 129 KB

english, 2003

1022

1197 Breaking bad news guidelines

Morris, M., Lord, D., Fitzimmons, M., Dand, P.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

1023

1086 Cetuximab in a randomized phase II trial as a single agent or in combination with irinotecan in patients with epidermal growth factor receptor (EGFR)-expressing, irinotecan-refractory metastatic colorectal cancer (CRC)

Van Cutsem, E., Gascón Vilaplana, P., Seitz, J.F., Van Laethem, J.L., Grossi, F., Bianco, A.R., Dueland, S., Bets, D., Mueser, M.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1024

1239 Cancer and nutrition — an educational program for patient and health professionals

Holthe, K., Oskarsen, E.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

1025

1094 High dose radiation therapy with intensity modulated radiation therapy (IMRT) improves outcomes in localized prostate cancer. A large single institution experience

Mahadevan, A., Reddy, C., Klein, E., Kupelian, P.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1026

1249 Train the trainer — about fatigue

Young, C., Gyldenvang, H., Ris-Pedersen, K., Svejstrup Mølgård, J., Thomsen, B., Phillipsen, G., Pallesen, D.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1027

1065 A randomized trial with 1485 patients evaluating the importance of accelerated versus conventional fractionated radiotherapy in squamous cell carcinoma of the head and neck. Final results of the DAHANCA 6&7 study

Overgaard, J., Sand Hansen, H., Overgaard, M., Grau, C., Specht, L., Andersen, E., Bastholt, L., Hansen, O., Andersen, L., Evensen, J.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 156 KB

english, 2003

1028

1060 Filling the gap — reconstructive surgery

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 267 KB

english, 2003

1029

1123 Women's perceptions of seroma and their drainage following mastectomy and axillary lymph node dissection

Borman, L., Lindgren, A., Sandelin, K.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 139 KB

english, 2003

1030

1082 Can we optimize timing of initial follow-up after radiotherapy from study of patterns of first failure? — Evidence from patients with NSCLC

Ataman, O., Kramar, A., Barrett, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 332 KB

english, 2003

1031

1131 Critical care in oncology nursing — an ethical dilemna?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 176 KB

english, 2003

1032

1182 Redesigning the cancer patient journey: what is the feasibility of nurse-led chemotherapy services from a user perspective?

Fitzsimmons, D., Hawker, S.E., Middleton, J., Corner, J.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1033

1140 Barriers in implementing research findings in cancer care. The Hellenic registered nurses perceptions

Karlou, C., Patiraki, E., Papadopoulou, D., Spuridou, A., Bare, E., Kouloukoura, C.H., Merkouris, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

1034

1040 Retroperitoneal lymphnodes scintigraphy in the staging and treatment of Hodgkin's disease

Kanaev, S.V., Novikov, S., Jukova, L.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 146 KB

english, 2003

1035

1293 Ethical dilemmas in patients with breast cancer in clinical research

Jelecanin, D., Neskovic-Konstantinovic, Z.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 127 KB

english, 2003

1036

1222 Improving standards of care through communication within a oncology haematology team - the clinical nurse specialists role

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

1037

1199 Carcinoembryonic antigen testing in colorectal cancer follow-up: a study of patients' attitudes and preferences

Peaston, R.C., Mackean, M.J., Fernie, N.L., Knowles, G.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

1038

1195 Development by using flow charts- a way to collaborate

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

1039

1129 Cure and palliative care in elderly people with cancer

Esbensen, B.A., Roer, O., Østerlind, K., Hailberg, I.R.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 121 KB

english, 2003

1040

1044 High incidence of mutations in BRCA1 in breast and ovarian cancer patients in Latvia

Eglitis, J., Tihomirova, L., Sinicka, O.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 327 KB

english, 2003

1041

1023 Analyses of percentage CD23 cell membrane molecule expressed in ratio to the immunoglobulines concentration in B-CLL

Jurisic, V., Colovic, M., Colovic, N., Kraguljac, N.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 335 KB

english, 2003

1042

1241 An evaluation of formal staff support sessions within a specialist breast unit

Mc Loughlin, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

1043

1034 Imaging of prostate cancer with [11C] choline PET

Sutinen, E., Nurmi, M., Roivanen, A., Varpula, M., Tolvanen, T., Lehikoinen, P., Minn, H.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

1044

1122 SKUB-Nurses' consultation for women, who have received curative radiation therapy for breast cancer

Andersen Graabæk, C., Brath Vinge, E.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 285 KB

english, 2003

1045

1261 Cancer patients existential questions — a qualitative interview study with hermeneutic analysis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

1046

1219 What nursing-sensitive patient outcomes are most relevant to oncology patients at an acute-care university hospital?

Gudmundsdottir, E., Delaney, C., Thoroddsen, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

1047

1093 Local dose escalation using temporary interstitial source brachytherapy (high-dose-rate) for clinically localized prostate cancer: Long-term outcome in hormone naïve men

Galalae, R., Martinez, A., Kovács, G., Mitchell, C., Edmundson, G., Nuernberg, N., Gustafson, G., Kohr, P., Kimmig, B.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1048

1181 The research nurse in cancer care: the development of a masters level module to meet the needs of nurses in this challenging role

Handscomb, K., Phillips, H.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1049

1057 Screening methodology

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 143 KB

english, 2003

1050

1172 Feasibility, physical capacity, and health benefits of a multidimensional exercise program for cancer patients undergoing chemotherapy

Adamsen, L., Midtgaard, J., Rørth, M., Borregaard, N., Quist, M., Madsen, J., Knutsen, L., Andersen, C., Moeller, T., Zacho, M.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 139 KB

english, 2003

1051

1066 Adjuvant chemotherapy in colorectal cancer: Joint analyses of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group

Glimelius, B., Cedermark, B., Dahl, O., Tveit, K.M., Jakobsen, A., Bentzen, S.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 303 KB

english, 2003

1052

1020 Evolution of lymphocytopenia prognostic value in advanced Hodgkin's disease: a single-center experience

Bogatyreva, T., Konova, O., Pavlov, V.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

1053

1050 Informing about biomedical research using an educational booklet: opinion survey in 129 French cancer patients

Genre, D., Viens, P., Macquart Moulin, G., Maraninchi, D.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1054

1110 Older people with cancer: issues in clinical practice and research

Kearney, N., Chouliara, Z., Miller, M., Molassiotis, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 157 KB

english, 2003

1055

1270 Anxiety and depression in breast cancer patients

Vahdaninia, M., Montazeri, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 152 KB

english, 2003

1056

1248 The use of a written treatment plan to improve patient information. An audit of patient satisfaction

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

1057

1166 Development, implementation and evaluation of a structured nursing intervention to prevent nausea/nutrition deficit experienced by patients undergoing chemotherapy — a randomized controlled clinical trial

Landenberger, M.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 130 KB

english, 2003

1058

1154 Development of a best practice statement for skincare of radiotherapy patients

Chadwick, G., Fletcher, J.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

1059

1075 Advocacy for cancer patients

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 205 KB

english, 2003

1060

1055 Economic burden of seven tumors by course of therapy and treatment failure

Kutikova, L., Bowman, L., Chang, S., Long, S.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

1061

1233 Developing chemotherapy education: A collaborative approach

Grundy, M., Preston, J., Brown, M., Devlin, J., Gillies, E., McIntosh, N., Molloy, D.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

1062

1185 A cross-organisational clinical rotation programme for nurses in cancer and palliative care; a pilot project evaluation

Ream, E., Menon, A., Johnson, M., Richardson, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 124 KB

english, 2003

1063

1022 Dexamethasone, etoposide, ifosfamide, and cisplatin (DVIP) as salvage therapy in low-grade Non Hodgkin's lymphoma (NHL), following prior anthracycline containing therapy

Haim, N., Agbarya, A., Leitzin, L., Ben-Shachar, M., Epelbaum, R.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

1064

1103 Cancer across the lifespan

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 75 KB

english, 2003

1065

1282 The appropriate treatment assures quality (ATAQ) project: improving the management of neutropenia

Knoop, T., Bush, A.P., Wujcik, D.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

1066

1169 Needs of family members of patients receiving palliative care services in Iceland

Fridriksdottir, N., Sigurdardottir, V.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

1067

1211 Evidence based symptom management for patients with breast cancer: clinical pathways teach process, implementation and evaluation

Bryce, J., Rossi, V.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

1068

1036 Nuclear medicine in diagnosis of skeletal invasion by Hodgkin's disease

Kanaev, S., Novikov, S.N., Gukova, L., Girsovich, M.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

1069

1088 Irinotecan improves the activity of the AIO regimen in metastatic colorectal cancer: results of EORTC GI group study 40986

Köhne, C.-H., Van Cutsem, E., Wils, J., Bokemeyer, C., El-Serafi, M., Lutz, M., Lorenz, M., Anak, O., Genicot, B., Nordlinger, B.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 320 KB

english, 2003

1070

1038 Radioimmunoscintigraphy with indium-111-labelled monoclonal antibody b72.3 in epithelial ovarian cancer

Gil, M., Majem, M., Mora, J., Perez, J., Ponce, J., Izquierdo, M.A., Zurita, A., Germa, J.R.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 146 KB

english, 2003

1071

1217 Nurse-led peripheral inserted central catheter (PICC) program: an audit of the St James's experience

O'Reilly, P., O'Mahoney, D., Kerlin, J., O'Brien, C.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 325 KB

english, 2003

1072

1118 The use of herbal preparations in cancer rehabilitation nursing

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 108 KB

english, 2003

1073

1213 Implementing change in a inpatient chemotherapy service

Sutton, G., Lansdell, K.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 330 KB

english, 2003

1074

1134 Do patients benefit from nursing research?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 74 KB

english, 2003

1075

1013 Pharmacokinetic parameters of methotrexate as predictors of toxicity, activity and efficacy in patients with primary central nervous system lymphoma (PCNSL)

Ferreri, A.J.M., Guerra, E., Regazzi, M., Pasini, F., Gubkin, A., Calderoni, A., Spina, M., Brandes, A., Dell'Oro, S., Reni, M.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

1076

1026 In vivo monitoring of NK cell mediated host defence against lung micrometastasis using positron emission tomography (PET) and [18F]-2-deoxyglucose (FDG)-labeling of tumor cells

Hama, Y., Kruschinski, C., von Hörsten, S., Zielinska-Skowronek, M., Knapp, W., Vaske, B., Pabst, R., Schmidt, R.E., Hofmann, M.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 339 KB

english, 2003

1077

1179 Integrated medical and nursing care in oncology

Kamphuis-van der Poel, M., Van der Velden, P.C.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 99 KB

english, 2003

1078

1126 Cancer in the elderly: facts and figures in Europe

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

1079

1085 Multicenter international randomized study of oxaliplatin/5FU/LV (folfox) in stage II and III colon cancer (mosaic trial): final results

Topham, C., Boni, C., Navarro, M., Hickish, T., Tabernero, J., Bonetti, A., Andre, T., de Gramont, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 324 KB

english, 2003

1080

1200 Mouthcare compliance in neutropenic haematology patients

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

1081

1083 Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma (NSCLC) treated by chemotherapy and radiotherapy

Berghmans, T., Lafitte, J.J., Thiriaux, J., VanHoutte, P., Lecomte, J., Efremidis, A., Giner, V., Paesmans, M., Klastersky, J., Sculier, J.P.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

1082

1243 Principles and nursing implications of patients receiving chemotherapy: A Hellenic course accredited by EONS

Pantell, V., Patiraki, E., Karlou, C.H., Kouloukoura, C.H., Pappa, D.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

1083

1163 Exchanging clinical guidelines and standards

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 79 KB

english, 2003

1084

1031 99mTc-MIBI myocardial perfusion scintigraphy for assessment of radiation induced cardiac damage — preliminary results

Tzonevska, A., Parvanova, V., Piperkova, E., Dimitrova, D.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

1085

1104 Quality of life of elderly people with cancer at time of diagnosis

Esbensen, B.A., Roer, O., Østerlind, K., Hallberg, I.R.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 146 KB

english, 2003

1086

1024 Etoposide, platinum, ifosfamide and dexamathasone (EPID) as second line treatment in patients with non-Hodgkin's lymphoma (NHL)

Aldaco, F., Gomez, A., Cerna, M., Vazquez, L., Valdez, M., Sanchez, G., Erazo, A., Cervantes, G., Torrecillas, L., Cortes, P.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

1087

1070 Cervical cancer screening — status and perspectives

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 150 KB

english, 2003

1088

1173 Nutrition therapy for the cancer patient

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 139 KB

english, 2003

1089

1256 The meaning of lymphedema in the life of women with breast cancer

Mamede, M.V., Panobianco, M.S.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 307 KB

english, 2003

1090

1119 Rehabilitation program for cancer patients

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 108 KB

english, 2003

1091

1250 The nursery development program in the hematology and oncology clinic of Tartu university clinics

Saag, A., Lehtsaar, A., Kaalep, V.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1092

1045 Rare tumour survival in adult European patients

Gatta, G., Ciccolallo, L., Casali, P.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

1093

1215 Cancer nurse coordinator: the introduction, development and impact of a new oncology nurse specialist role in Ireland

de Zeeuw, N., Hanan, T., Eyre, S., Moore, J.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

1094

1245 Impact of the National Cancer Research Network clinical trials portfolio at Guy's & St. Thomas' Hospital and peripheral trusts in SE London

Quennell, A., Kent, M., Poole, A., McVicars, H., Shepherd, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

1095

1279 Posttraumatic stress disorder in parents of children with cancer and benign brain tumors

Pöder, U., Ljungman, G., von Essen, L.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 150 KB

english, 2003

1096

1058 Cox-2 inhibition in gastrointestinal cancer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 143 KB

english, 2003

1097

1216 Education in groups — the path for improved clinical practise? — a comparative study on benefits from preparatory education in radiation therapy measured before and after modified educational procedure

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

1098

1099 A phase II study of ABR-214936 (anatumomab mafenatox) tumour targeted superantigen (TTS) therapy in patients with advanced renal cell carcinoma (RCC)

Connolly, N., Shaw, D., Patel, P., Garner, C., Beirne, D., Kilany, S., Hedlund, G., Forsberg, G., Stern, P., Hawkins, R.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 126 KB

english, 2003

1099

1290 Longitudinal assessment of fatigue in Greek women with breast cancer undergoing radiotherapy

Patiraki, E., Lavdaniti, M., Sotiropoulou, A., Dafni, U.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

1100

1139 The emerging role of the cancer research nurse in promoting evidence based care in radiotherapy

Routledge, J., Burns, M., Davidson, S.E., Johnson, K., Swindell, R., Khoo, V.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

1101

1244 Implementation of new nursing documentation within oncology outpatient unit based on two sites within Guy's and St Thomas' oncology and haematology directorate

Robson, A., Hopkirk, L.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 325 KB

english, 2003

1102

1242 Breast cancer patients' satisfaction with care following changes in length of stay and care delivery

Thorsteinson, H., Fridriksdottir, N.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

1103

1194 The use of complementary therapies among breast and prostate cancer patients in Finland

Salmenperä, L.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 297 KB

english, 2003

1104

1170 Patient education — a new strategy for prevention of infections due to permanent central venous catheters among patients with hematological malignancies: a randomized clinical trial

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

1105

1251 The role of the Clinical Research Nurse (CRN) in conducting clinical trials

Christiansen, B., Bloch, I., Ranek, S.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1106

1283 Having cancer and being a parent

Helseth, S., Ulfsæt, N.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

1107

1287 Nurses' attitudes towards research and related factors

Kuuppelomäki, M., Tuomi, J.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 146 KB

english, 2003

1108

1246 Co-operation and competence in cancer care

Børresen, R., Riise, I.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

1109

1111 Teenagers with cancer: what do we know about their cancer trajectory

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 138 KB

english, 2003

1110

1048 Estimate of the pulmonary neoplastic hazard of inhaled depleted uranium in gulf war veterans

Durakovic, A., Dietz, L., Zimmerman, I.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

1111

1112 What is different about caring for teenagers with cancer?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 138 KB

english, 2003

1112

1203 Sexual care in cancer; the forgotten question

Iglesias Casals, S., Isabel, F.V., Daniel, T.P., Melinda, G.C., Mónica, S.M., Carmen, E.N., Carmen, M.C.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 305 KB

english, 2003

1113

1178 Leadership — a potential for everybody

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 99 KB

english, 2003

1114

1098 Phase III study of neovastat in metastatic renal cell carcinoma patients refractory to immunotherapy

Escudier, B., Venner, P., Bukowski, R., Szczylik, C., Oudard, S., Champagne, P., Hariton, C., Dupont, É.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 126 KB

english, 2003

1115

1049 Development and evaluation of a web-based research ethics board (REB) review template

Sampson, H., Michaelson, T., Panzarella, T.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1116

1092 PSA doubling time (PSADT) is quite variable in untreated, clinically localized, low to intermediate grade, prostate adenocarcinoma (CA)

Choo, R., Klotz, L., DeBoer, G., Danjoux, C., Morton, G.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1117

1077 Integrated PET/CT imaging improves staging of non-small-cell lung cancer

Lardinois, D., Weder, W., Hany, T.F., Kamel, E.F., Korom, S., Seifert, B., von Schultess, G.K., Steinert, H.C.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

1118

1201 Relationships between anemia and polichemotherapy in cancer patients

Rossi, P., Giorgi, M., Minutella, L., Muccini, E., Pacchini, P., Virgili, N.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

1119

1079 A phase II trial of chemoradiotherapy followed by surgery in pancoast tumors: Initial report of the Japan Clinical Oncology Group trial (JCOG 9806)

Ichinose, Y., Kunitoh, H., Kato, H., Ishizuka, N., Tsuchiya, R., Tsuboi, M., Katakami, N., Mitsudomi, T., Nagai, K., Saijo, N.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

1120

1159 The charity approach experience

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1121

1275 The cancer information centre, does it work?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

1122

1277 Chemotherapy induced nausea and vomiting (CINV) in routine practice in Spain: assessing incidence and impact on patient's daily life

Fernandez-Ortega, P., Glaus, A., Hüsler, A., Tsui, K., Bum Kim, S., Bath, S., Nocea, G., Deuson, R.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 312 KB

english, 2003

1123

1028 Contrast-specific ultrasound (CS-US) in staging and follow-up of splenic lymphomas

Lo Bianco, R., Tafuto, S., Catalano, O., Lentini Graziano, M.L., Siani, A., Quattrin, S.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 175 KB

english, 2003

1124

1234 An information and communication booklet for hematological patients

Vrehen, H.M., Breugem, J., Ebbers, J., van Kleij, C., Kniest, J., Petersen, E., Wessels, H.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

1125

1257 An exploration into the health seeking behaviour of men and women with cancer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 152 KB

english, 2003

1126

1253 Effectiveness of rehabilitation for mastectomized woman, before breast reconstruction

Ferrario, R., Bedodi, L.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1127

1286 Assessing the prevalence of anxiety and depression in palliative care cancer patients in Western Australia and New South Wales

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 146 KB

english, 2003

1128

1084 Only colon cancer patients with Dukes stage C benefit from adjuvant chemotherapy with 5-fluorouracil and levamisole among 425 patients with operable colorectal cancer in a Norwegian randomised study

Dahl, O., Tveit, K.M., Carlsen, E., Wiig, J.N., Myrvold, H.E., Gauperaa, T., Skarstein, A., Podhomy, N., Bjerkeset, O., Eide, T.J.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

1129

1029 Quantification of microvasculature in cervix carcinoma with functional CT imaging

Yeung, I., Darko, J., Haider, M., Milosevic, M., Fyles, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 329 KB

english, 2003

1130

1230 The clinical trial nurse in Italy: strategies for role preparation, implementation and evaluation

Bryce, J., Bell, C., Colussi, A.M., De Maio, G., Rossi, V.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

1131

1174 Can nurses and dieticians collaborate to improve the management of cancre-related anorexia and cachexia?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 139 KB

english, 2003

1132

1231 Differences between quality of life questionnaires filled out in the hospital ward and in the “garden of peace” of the hospital

Szalai, M., Remenar, E., Koltai, P., Karoly, P., Kasler, M.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

1133

1106 Survey of current UK practice in vaginal dilatation associated with pelvic radiotherapy

White, I., Faithfull, S.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 300 KB

english, 2003

1134

1272 Brain tumour in childhood

Ferreira, A., Henriques, A., Pereira, L.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 152 KB

english, 2003

1135

1021 The role of hepatitis C virus (HCV) treatment in HCV-related B-cell non-Hodgkin's lymphoma (NHL)

Vallisa, D., Bernuzzi, P., Anselmi, E., Arcari, A., Bertè, R., Bidin, L., Lazzaro, A., Moroni, C.F., Palladino, M., Cavanna, L.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 171 KB

english, 2003

1136

1068 Breast cancer screening — status and perspectives

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 150 KB

english, 2003

1137

1156 Intravenous ports: experience of oncology patients

Goossens, L., Vrebos, M.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 283 KB

english, 2003

1138

1073 Optimizing the time between breast cancer diagnosis and treatment through collaborative care

Mendelsohn, M., Belkora, J., Esserman, L.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

1139

1288 Ethnic language information films — considering cultural, political and religious issues

Thomas, R., Williams, M., Sapariya, R., Deary, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

1140

1087 Randomized phase III trial of chemoradiation treatment amifostine in patients with colorectal cancer

Antonadou, D., Athanassiou, H., Sarris, G., Synodinou, M., Paraskevaidis, M., Georgakopoulos, Gr., Kyprianou, K., Beroukas, K., Karageorgis, P., Throuvalas, N.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1141

1016 Evaluation of cyclic chemotherapy in non Hodgkin's lymphoma patients infected with chronic hepatitis

Kamlesh, K., Sajnani, P., Bhat, G.Ganapathi, Siddique, I.Iqbal, Fuad Al-Ali, F., Al-Shemmari, S.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

1142

1064 Using clinical competencies to underpin cancer and palliative care education for nurses

Johnson, M., Menon, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 156 KB

english, 2003

1143

1025 Long-term outcome and mortality trends in follicular lymphoma treated with radiation therapy

Guadagnolo, B.A., Li, S., Neuberg, D., Ng, A., Hua, L., Silver, B., Stevenson, M.A., Mauch, P.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

1144

1280 “I haven't done my homework today, my mother got cancer yesterday” An information video about children as relatives

Vaerholm, R., Gronsdal, G.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 150 KB

english, 2003

1145

1207 Dendritic cell-based vaccines: implication for oncology nursing

van Riel, C., Peters, M., Lesterhuis, W., Punt, C.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1146

1152 More energy in lesser portions of food for poorly eating cancer patients

Kyed, B., Jensen, G.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 97 KB

english, 2003

1147

1138 The treatment decision-making preferences of people with colorectal cancer

Beaver, K., Luker, K., Jones, D., Susnerwala, S., Craven, O., Tomlinson, M., Witham, G.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 265 KB

english, 2003

1148

1120 Rehabilitation — an integral part of treatment and nursing care for cervical cancer patients undergoing concomitant chemotherapy

Bjerrum Thisted, L.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

1149

1009 Phase II clinical experience with the novel proteasome inhibitor bortezomib (formerly PS-341) in patients with indolent and mantle cell lymphomas

O'Connor, O.A., Wright, J., Moskowitz, C., Straus, D., MacGregor-Cortelli, B., Muzzy, J., Choi, P., Schenkein, D., Zelenetz, A.D.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 180 KB

english, 2003

1150

1032 Impact of positron emission tomography in radiation therapy treatment planning

Schultze, J., Hayen, J., Czech, N., Kimmig, B.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

1151

1274 The Swedish Cancer Society's helpline — a complement to the health care system. The satisfaction of patients and relatives/friends

Lindgren, A., Boman, L.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

1152

1202 Women who talk together learn together. Results of a study of psycho-educative groups for women with gynaecological cancers

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

1153

1051 Conceptual model for the webification of administrative papers

Goeth, T., Nelausen, K.M., Daugaard, G.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1154

1218 Implementation of guidelines about safe manipulation of cytotoxic agents through a cd-rom

Ponnet, G., De Gussem, A., Simons, L., Van den Borne, B., Verpoorten, L., Vranckx, P., Wittockx, G.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

1155

1291 The study registration project — Danish studies of people with cancer from a nursing perspective

Esbensen, B.A., Andersen, C.I., Hoestrup, H., Joergensen, L., Lambaek, K., Madsen, B., Moeller, T., Taps, E.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 284 KB

english, 2003

1156

1162 Integrating support services to enchance continuity of care in an Australian cancer setting

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 129 KB

english, 2003

1157

1080 Induction chemotherapy followed by concurrent RSR13 (Efaproxiral) and trt for patients with locally advanced NSCLC: mature results of a phase II study and comparison with the results from RTOG 94-10

Choy, H., Scott, C., Nabid, A., Stea, B., Roa, W., Souhami, L., Yunus, F., Boyd, A., Cagnoni, P., Curran, W.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

1158

1214 A large scale chemotherapy quality improvement project; initiating standardized treatment, administration and information in the hospitals in the region of the comprehensive cancer centre rotterdam

de Boer-Dennert, M.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

1159

1072 How to cope with cancer?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

1160

1208 Advanced, computerised cold cap for preventing chemotherapy induced alopecia

Henriksen, T., Jensen, B.K.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1161

1158 Nursing care and the competent patient

Berg, A., Soerensen, U., Klausen, A.H., Johansen, G.R., Uhd, B., Moelholm, B., Baxter, A., Hansen, L.D.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 120 KB

english, 2003

1162

1225 Incidence of bacteremia after change of care of tunnellated central venous catheters (CVC) in children with cancer

Kehlet, U., Boelling, K., von der Maase, L., Schroeder, H.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 317 KB

english, 2003

1163

1258 Counselling: a new door opens for cancer patients

Ferrario, R., Piredda, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 152 KB

english, 2003

1164

1117 Prevention and early detection

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 108 KB

english, 2003

1165

1188 ECN37 The status of cancer nursing tomorrow. The influence of nursing on treatment strategies

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 144 KB

english, 2003

1166

1078 A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I (T1N0M0, T2N0M0) adenocarcinoma of the lung

Hata, E., Kato, H., Ohta, M., Tsubota, N., Hamajima, N., Saito, Y., Wada, H., Suemasu, K., Ohta, M.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 313 KB

english, 2003

1167

1168 The phenomenon of fatigue in young people

Gibson, F., Mulhall, A., Richardson, A., Edwards, J., Ream, E., Sepion, B.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

1168

1235 Information needs of women with recently diagnosed ovarian cancer, followed over time

Browall, M., Carlsson, M., Horvath, G.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

1169

1149 Generating questions for nursing research

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 137 KB

english, 2003

1170

1229 Emotional processing — how nurses survive emotionally while caring for cancer patients

Sandgren, A., Thulesius, H., Petersson, K.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 315 KB

english, 2003

1171

982 Induction of apoptosis in herpes semplex virus thymidine kinase/aciclovir transfected experimental breast cancer models

Moscovtsev, A.A., Kaloshin, A.A., Filinova, E.Yu., Vlasenkova, N.K., Blokhin, D.Yu.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 331 KB

english, 2003

1172

1018 Late toxicity of radiotherapy (RT) and chemotherapy (CT) for mallgnant lymphomas

Dimitrovska, A., Nikolova, L., Tolevska, C., Stojkovski, I., Jakimovski, D.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

1173

1220 “Audiovisual information as a supplement to oral and written information” from idea to final product - the story of an audiovisual project

Skaksen, H., Christiansen, B., Fløe Nielsen, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

1174

1226 Dying with dignity — care giving to dying cancer patients in hospitals

Brejnebøl, C., Grindsted, M.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

1175

1247 Education of oncology nurses

Delic, S., Milovic, Lj., Milosevic, M.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

1176

1190 Current and future cancer nursing in Denmark

Olafsdottir, S.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

1177

533 Hyaluronic acid bladder instillations in the prevention of radiation-induced cystitis

Delgado, J.M., Samper, P., Saez Garrido, J.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

1178

984 Interaction between interferon-beta and cellular DNA-repair

Schmidberger, H., Rave-Fränk, M., Weiss, E., Lehmann, J., Dettmar, N., Pradier, O., Hess, C.F.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

1179

1136 Guidelines for antiemetic treatment

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 86 KB

english, 2003

1180

1184 Comparison between nurse-led check-ups on demand and follow-ups by a physician after breast cancer surgery

Koinberg, I., Fridlund, B., Engholm, G.-B., Holmberg, L.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 124 KB

english, 2003

1181

1132 Writing for publication: how to become a successful author

Molassiotis, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 58 KB

english, 2003

1182

1011 Comparison of MOPP versus ABVD as salvage therapy in patients who relapsed after radiation therapy alone for Hodgkin's disease

Ng, A., Li, S., Neuberg, D., Silver, B., Stevenson, M., Fisher, D., Mauch, P.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 341 KB

english, 2003

1183

1058 Interactions radio-chemotherapy

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 143 KB

english, 2003

1184

1056 Cost of skeletal complications in patients with bone metastases of solid tumors

Delea, T., McKieman, J., Liss, M., Edelsberg, J., Brandman, J., Sung, J., Raut, M., Oster, G.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 68 KB

english, 2003

1185

1071 Screening for colorectal cancer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 308 KB

english, 2003

1186

1160 A practical example of a multidisciplinary approach in continuity of care

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 285 KB

english, 2003

1187

1091 How to explain the improvement in survival for colorectal cancer? A French population-based study

Mitry, E., Bouvier, A.M., Estève, J., Falvre, J.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 320 KB

english, 2003

1188

1047 Cohort analysis of prostate cancer mortality in the male population of Belgrade

Pekmezovic, T., Kisic, D., Knezevic, A., Kanazir, M., Jarebinski, M.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

1189

1141 Use of complementary methods by icelandic cancer patients

Fridriksdottir, N., Gretarsdottir, E.Th., Thordardottir, G.K., Gudmundsdottir, S.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

1190

1128 Empowering elderly cancer patients: challenges and solutions

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

1191

1015 Hematological delineation of primary non-Hodgkin's lymphomas of the spleen: diagnostic and prognostic significance

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

1192

1037 Breast cancer staging with 99mTc-tetrofosmin and 99mTc-MIBI: intraindividual comparison

Piperkova, E., Timcheva, K., Garanina, Z., Tzonevska, A., Dimitrova, M., Katerinski, K., Milev, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

1193

1210 Danish national special interest group in nausea and vomiting (SIG N&V) has made an audit on nausea and vomiting with cancer patients receiving chemotherapy

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 324 KB

english, 2003

1194

1273 “Illness became my life” the caregivers perspective

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 152 KB

english, 2003

1195

1232 Influence of educational programme on disease experience by the patients diagnosed with breast cancer and their famillies

Milovic, Lj., Maric, Lj., Vlajkovic, J.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

1196

1019 Study on prognostic factors and on role of radiotherapy (RT) in patients (pts) with aggressive Non Hodgkin's Lymphomas (NHL) treated with MACOP-B or VACOP-B chemotherapy (CT)

Korzeniowski, S.J., Sas-Korczynska, B., Malecki, K.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 338 KB

english, 2003

1197

1116 Spirituality and suffering

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 84 KB

english, 2003

1198

1254 A European perspective of lymphoedema management: travels in The Netherlands, Austria, Germany and Sweden

MacLaren, J.-A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1199

1206 Using handheld computers to support patients receiving outpatient chemotherapy

Kearney, N., Muir, L., Miller, M., Gray, P.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 311 KB

english, 2003

1200

1171 Patients suffering from lung cancer. Experiences during radiotherapy

Ekfors, H., Petersson, K.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 304 KB

english, 2003

1201

1176 Implementation of evidence based guidelines for central venous catheters

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 107 KB

english, 2003

1202

1133 Clinical practice — why do we do what we do?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 74 KB

english, 2003

1203

1067 Analysis of the EORTC Melanoma Group 18952 randomized trial on 2 intermediate dose schedules of IFN-alpha2b compared with observation in 1388 patients with high risk melanoma stages IIB-III

Eggermont, A.M.M., Suciu, S., Ruka, W., Testori, A., Kruit, W., Punt, C.J.A., Delaunay, M., Sales, F., Stoitchkov, K., Groenewegen, G., Mackie, R., Patel, P., Lienard, D.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 150 KB

english, 2003

1204

1153 Quality management — securing the clinical pathway for breast cancer patients

Gyldenvang, H., Ankersen, L., Goldschmidt Mertz, B., Schluter, B., Jusjong, J.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

1205

1114 Teenagers' participation in research — how to recruit and maintain interest

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 138 KB

english, 2003

1206

1236 District nurses perceptions of a home based nursing service for dying patients: a national survey of reasons for referral and non-referral

Wilkinson, S., Fellowes, D., Goodman, M., Low, J., Harvey, F.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

1207

1267 Pain — the use of a cognitative behavioural interventions

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

1208

1061 How to do the sentinel node?

Rutgers, E.J.T.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 128 KB

english, 2003

1209

1263 Nursing staff's experiences of the problems concerning practical, emotional and informational support given for famillies of patients with cancer

Kuuppelomäki, M.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

1210

1155 Cancer wound and cancer ulcer treatment: a multidisciplinary approach

Lintz-Luidens, H., Peters, M.E., Tjan-Heijnen, V.C.G., Derksen, T., Hoogenraad, W.J.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

1211

1193 Networking — transfer of knowledge network of contact nurses in the Oslo region for patients with cancer and other serious diagnosis

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 131 KB

english, 2003

1212

1268 Laser palliation for colorectal tumours: evaluating effectiveness and quality of life

Sherwood, L.A., Knowles, G., Wilson, R.G., Phillips, H.A., McLean, C.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

1213

1041 Diagnostic images for lymph node staging in anal canal carcinoma

Raffetto, N., Carcaterra, M., Messineo, D., Drudi, F.M., Ascolese, A.M., Caruso, C., Maurizi Enrici, R.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 146 KB

english, 2003

1214

1259 A presentation of the project: Adolescents' reactions when diagnosed with cancer

Mattsson, E., Ljungman, G., von Essen, L.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 152 KB

english, 2003

1215

1014 Activation antigen (HLA-DR, CD38, CD23) expression by non-neoplastic background cells in Hodgkin's lymphoma (HL)

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

1216

1027 Evaluation of pulmonary lesions using 99mTc-depreotide and 201Tl-chloride. Preliminary results

Boundas, D., Karatzas, N., Pistevou-Gompaki, K., Sarikos, G., Kalaitzi, Z., Papanicolaou, D., Ekonomidis, D.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 175 KB

english, 2003

1217

1147 Non-adherence in hematology and stemcell transplant patients — is it worth worrying about?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

1218

1081 Stereotactic radiotherapy of primary lung cancer. Results of a phase II trial

Høyer, M., Sengelov, L., Roed, H., Ohlhuis, L., Traberg, A., Petersen, J., Paishof, T., Engelholm, Sv.Aa., von der Maase, H.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

1219

1124 Rehabilitation in cyberspace. Electronic support communities for breast cancer patients

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 139 KB

english, 2003

1220

1150 Chemotherapy and safety aspects for oncology nurses

van Dinther, W.M.Giesbers

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 137 KB

english, 2003

1221

1090 Continuation of irinotecan (CPT-11) beyond 8 cycles does not improve outcome in patients with advanced colorectal cancer resistant to fluoropyrimidines: results of a phase III multi-centre randomised trial

Dickson, J.L.B., Lal, K.R., Norman, A.R., Ross, P.J., Oates, J., Massey, A., Hill, M.E., Middleton, G., Topham, C., Cunningham, D.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

1222

1186 Counselling new colleagues to handle the reality shock

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 124 KB

english, 2003

1223

Author index

Journal:

European Journal of Cancer Supplements

Year:

2003

File:

PDF, 3.67 MB

2003

1224

1209 The use of web based information in handheld computers in supporting patients receiving outpatient chemotherapy

Kearney, N., Hargan, I., Miller, M., Muir, L., Gray, P.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1225

1228 Cancer clinical trials and nursing practice

Vrehen, H.M., Tjia, P.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

1226

1096 What to do with asymptomatic prostate cancer patients with rising PSA after curative treatment with external beam radiotherapy (RT)?

Faria, S.L., David, M., Souhami, L., Duclos, M., Shenouda, G., Mahmud, S., Freeman, C.R.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

1227

1262 Evaluation of the results of a multi disciplinary intervention with patients with colorectal cancer

Ashkenazi, A., Laba, O., Pishniak, L., Figer, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

1228

865 Comparison of ultrasound assisted implantation of the prostate using a look-up nomogram versus ultrasound assisted intraoperative 3D computer optimization: Improved conformality with improved urethral and rectal dose volume histogram: It's time to move forward!

Raben, A., Chen, H., Grebler, A., Geltzeiler, J., Kesleman, I., Litvin, S., Hanlon, A., Yang, J., Sim, S.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

1229

1035 Restaging and local control in diffusion-weighted MRI versus multislice CT (MS-CT) of primary rectum carcinoma after combined radiochemotherapy

Schäfer, S., Lubold, W., Vogl, T.J., Böttcher, H.D.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 162 KB

english, 2003

1230

1033 Magnetic resonance neuroimaging in breast cancer carcinomatous meningitis

Niwinska, A., Rudnicka, H., Wiszniewska-Rawlik, D., Jagiello-Gruszfeld, A., Giermek, J., Pienkowski, T.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

1231

1260 Swedish mothers and fathers of a child diagnosed with cancer — a look at their quality of life

Mattsson, E., Sjödén, P.O., von Essen, L.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 301 KB

english, 2003

1232

1030 CT scans versus 111 in-pentetreotide SPECT imaging in tumour response assessment

Gnanasegaran, G., Gopinath, G., Buscombe, J.R., Caplin, M.E., Hilson, A.J.W.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

1233

1097 Disease presentation and development in bladder cancer is related to outcome following radical cystectomy

Knap, M.M., Lundbeck, F., Overgaard, J.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 280 KB

english, 2003

1234

1192 Port catheters: the incidence of complications. A multicentric approach

Vrebos, M., Rottiers, L., Goossens, L., Stas, M., Evers, G., De Wever, I.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 131 KB

english, 2003

1235

1012 Prediction of severe neutropenia in elderly patients with aggressive lymphoma treated by an anthracycline containing regimen

Dagada, C., Soubeyran, P., Hembert, K., Monnereau, A., Ehgbali, H., Ceccaldi, J., Guichard, P., Hallé, O., Rémuzon, P., Demeaux, H.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

1236

1046 A definition of what a rare tumor is

Casali, P.G., Ciccolallo, L., Capocaccia, R., Bruzzi, P., Licitra, L., Grosso, F., Berrino, F., Gatta, G.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

1237

1212 Evidence based prevention and management of lymphedema in patients affected by melanoma with lymphadenectomy

Esposito, M.R., Lettieri, G., De Maio, G., Bryce, J., Chiofalo, M.G., Caracò, C.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 168 KB

english, 2003

1238

1237 Occupational stress and preferred coping strategies at the division of oncology-hematology and palliative care

Flygenring, B.G.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

1239

1043 Reassessment of GSTM1 and GSTT1 cancer predisposing roles: comparison of genotypes in elderly tumor-free smokers and non-smokers vs. healthy donors vs. lung cancer patients

Togo, A.V., Belogubova, E., Karpova, M., Ulibina, J., Buslov, K., Lemehov, V., Shutkin, V., Hanson, K., Hirvonen, A., Imyanitov, E.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

1240

1130 Children and cancer: a workshop

Gibson, F., Morgan, S.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 121 KB

english, 2003

1241

1113 The teenager perspective: what is the reality

Thykaer, S., Hove, N.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 138 KB

english, 2003

1242

1205 Soya isoflavones as treatment for menopausal symptoms in women with early breast cancer: findings of a randomised placebo controlled trial

Paterson, G., Canney, P.A., McDonald, R.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

1243

Subject index

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 512 KB

english, 2003

1244

1269 Function and quality of life in patients following surgery for rectal cancer

Knowles, G., Dunlop, M.G., Wilson, R.G.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 152 KB

english, 2003

1245

1167 Woman with breast cancer suffering from cancer wounds. A prospective, explorative and descriptive study

Lund-Nielsen, B.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 295 KB

english, 2003

1246

1089 Improved safety of capecitabine vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT phase III study)

Nowacki, M., Kröning, H., Cervantes, A., Husseini, F., McKendrick, J., Schuller, J., Twelves, C., Wong, A., Zaluski, J., Douillard, J.-Y.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

1247

1151 Developing guidelines to inform practice

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 97 KB

english, 2003

1248

1076 The optimal extent of mediastinal lymphadenectomy in patients with non-small cell lung cancer

Traktenberg, A., Frank, G., Volchenko, N., Kolbanov, K., Stukalov, M., Pikin, O.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

1249

1053 Indicators of high chemotherapy-induced nausea and vomiting treatment costs in German cancer centers

Ehlken, B., Lordick, F., Bernard, R., Berger, K., Heichler, H.G., Deuson, R., Thödtmann, J., Ihbe-Heffinger, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

1250

1063 New directions in the treatment of mesothelioma

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 128 KB

english, 2003

1251

1157 Factors associated with delay in presentation and diagnosis of lung cancer: Searching for new approaches to early detection

Hopkinson, J., Fitzsimmons, D., Corner, J.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 120 KB

english, 2003

1252

1187 The status of cancer nursing — a European perspective

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 144 KB

english, 2003

1253

1238 Participating in multi-centre cancer nursing research: experiences of two clinical sites in Scotland

McDonald, R., Hutchinson, C., Macleod, J., Goodwin, M., Bryden, N., Alexander, P., Kearney, N., Miller, M.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

1254

1108 Children, grief and school

Vaerholm, R., Sellevold, T.G.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 157 KB

english, 2003

1255

1240 Pupil to practising nurse; Supporting transition to the world of paediatric oncology nursing

Hanson, S., Robinson, J., Buckley, S.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 334 KB

english, 2003

1256

1183 Planning, delivering and evaluating training in palliative care to community nurses using a multi agency approach

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 280 KB

english, 2003

1257

1180 Review of pre-chemotherapy assessment clinic for oncology patients attending a day case unit

Flanagan, E., Stoner, N., Wellman, S.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

1258

1223 Benchmarking - Does it make a difference at the bedside

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

1259

1115 Parents with cancer and their children

Kleveriaan, C.M., Klein Poelhuis, E.H.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 84 KB

english, 2003

1260

1143 Nutritional action plan

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 142 KB

english, 2003

1261

1191 Lost in a foreign land and searching for help? The role of the oncology nurse coordinator

Robinson, J., Hanson, S., Moodie, J., Grapsas, N.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 131 KB

english, 2003

1262

1101 Mammographic screening and the reduction in breast cancer mortality

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 104 KB

english, 2003

1263

1177 Wound care in oncology — a global approach

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 107 KB

english, 2003

1264

1100 Population based breast cancer screening by mammography: more harm than good?

Gøtszche, P.C.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 104 KB

english, 2003

1265

1095 Analysis of acute and late morbidity and biochemical control for intermediate to high risk prostrate cancer treated with androgen deprivation, HDR and 3D/IMRT: update of a phase I–II dose escalation trial

Raben, A., Grebler, A., Geltzeiler, J., Hanlon, A., Keselman, I., Litvin, S., Sim, S., Weiss, M., Yang, J.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 158 KB

english, 2003

1266

1135 Meeting cancer patient needs — developing symptom management

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 86 KB

english, 2003

1267

1204 Subjective side effects of breast cancer patients on endocrine therapy using C-PET (Checklist for Patients on Endocrine therapy): An outcome research study of 405 patients

Boehme, C., Thuerlimann, B., von Moos, R., Bernhard, J., Glaus, A., Ruhstaller, T.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

1268

1039 Contrast-specific ultrasound (CS-US): a promising diagnostic technique in abdominal oncology

Catalano, O., Tafuto, S., Sandomenico, F., Pisano, A., Quattrin, S., Siani, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 146 KB

english, 2003

1269

1252 Development of chemotherapy advice sheets to support junior staff

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 315 KB

english, 2003

1270

1042 Peritoneal carcinomatosis from colorectal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement

de Bree, E., Koops, W., Kroger, R., van Ruth, S., Witkamp, A.J., Zoetmulder, F.A.N.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

1271

1127 Treatment possibilities — what treatments are available and useful

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

1272

1196 Completing treatment for acute lymphoblastic leukaemia; a parent's perspective

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 169 KB

english, 2003

1273

1164 Implementing evidence based guidelines for radiotherapy

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 79 KB

english, 2003

1274

1102 Creating a culture of compassion: developing supportive care for people with cancer

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 75 KB

english, 2003

1275

1271 Appetizer — a guideline book to prevent malnutrition

Munthe Fogh, M., Jacobsson, S., Saxe, C., Sannung Elze, J., Andersen, E., Flyr, L., Olafsodoltir, S.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 152 KB

english, 2003

1276

25 Repopulation in human squamous cell carcinoma FaDu: possible impact of the impairment of recovery from sublethal damage repair

Petersen, C., Zips, D., Krause, M., Thames, H., Baumann, M.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 157 KB

english, 2003

1277

846 Long term toxicity following definitive radiotherapy of prostate cancer: analysis of EORTC study 22863

Ataman, F., Zurio, A., Artignan, X., van Tienhoven, G., Blank, L.E., Warde, P., Dubois, J.B., Jeanneret, W., Keuppens, F., Bolla, M.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 303 KB

english, 2003

1278

1008 Randomized trial of accelerated hyperfractionated radiotherapy to 24 Gy versus standard 40 Gy in salvage programs for Hodgkin's disease

Bogatyreva, T., Kravchenko, T., Pavlov, V.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 342 KB

english, 2003

1279

1148 Bone marrow transplant (BMT) — nursing in Germany: where are we and where are we going?

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 284 KB

english, 2003

1280

1175 A systematic review of the evidence on symptom management of cancer-related anorexia and cachexia

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 107 KB

english, 2003

1281

1284 Symptom registration — a tool to collaborate with the patient in palliative care

Tonnesen, E., Young, C.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 298 KB

english, 2003

1282

1146 Quality of life after stemcell transplantation — a qualitative study

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

1283

1052 Cost-effectiveness of epoetin alfa (EPO) and darbepoetin alfa (DARB) based on hematopoietic response rates and cost of therapy

Van Hout, B., Gagnon, D., Guastalla, J.-P.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 317 KB

english, 2003

1284

1276 Improving patient access to health care professionals: a pilot study evaluating the usefulness of e-mail communication with patients with lung cancer

Sherwin, A., Moore, S.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

1285

1289 The Sun Awareness/Melanoma-Prone Lifestyle Enquiry (SAMPLE) questionnaire: a new tool for epidemiological melanoma research

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

1286

1281 “Networkgroup for children as relatives in Haukeland University hospital in Bergen”: a collaboration project between the Norwegean cancer society and the Department of oncology and medical physics at Haukeland University hospital in Bergen

Vaerholm, R., Elholm, A.

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

1287

1264 Meeting the needs of male partners of women with breast cancer: An exploratory study

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Tor version

Z-Library

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски